e10vq
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2008
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission File Number 1-11848
REINSURANCE GROUP OF AMERICA, INCORPORATED
(Exact name of Registrant as specified in its charter)
|
|
|
MISSOURI
|
|
43-1627032 |
(State or other jurisdiction
|
|
(IRS employer |
of incorporation or organization)
|
|
identification number) |
1370 Timberlake Manor Parkway
Chesterfield, Missouri 63017
(Address of principal executive offices)
(636) 736-7000
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant is a
large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of large
accelerated filer,
accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer þ |
|
Accelerated filer o |
|
Non-accelerated filer o
(Do not check if a smaller reporting company) |
|
Smaller Reporting Company o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act). Yes o No þ
As of October 31, 2008, there were 33,081,963 shares outstanding of the registrants Class A common stock,
par value $.01 per share, and 29,243,539 shares outstanding of the registrants Class B common stock, par
value $.01 per share.
REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
TABLE OF CONTENTS
2
REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
|
|
2008 |
|
|
2007 |
|
|
|
(Dollars in thousands) |
|
Assets |
|
|
|
|
|
|
|
|
Fixed maturity securities: |
|
|
|
|
|
|
|
|
Available-for-sale at fair value (amortized cost of $9,643,324 and
$8,916,692 at September 30, 2008 and December 31, 2007, respectively) |
|
$ |
9,121,953 |
|
|
$ |
9,397,916 |
|
Mortgage loans on real estate |
|
|
782,282 |
|
|
|
831,557 |
|
Policy loans |
|
|
1,048,517 |
|
|
|
1,059,439 |
|
Funds withheld at interest |
|
|
4,806,642 |
|
|
|
4,749,496 |
|
Short-term investments |
|
|
32,520 |
|
|
|
75,062 |
|
Other invested assets |
|
|
432,982 |
|
|
|
284,220 |
|
|
|
|
|
|
|
|
Total investments |
|
|
16,224,896 |
|
|
|
16,397,690 |
|
Cash and cash equivalents |
|
|
412,255 |
|
|
|
404,351 |
|
Accrued investment income |
|
|
138,414 |
|
|
|
77,537 |
|
Premiums receivable and other reinsurance balances |
|
|
691,120 |
|
|
|
717,228 |
|
Reinsurance ceded receivables |
|
|
746,790 |
|
|
|
722,313 |
|
Deferred policy acquisition costs |
|
|
3,498,152 |
|
|
|
3,161,951 |
|
Other assets |
|
|
132,720 |
|
|
|
116,939 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
21,844,347 |
|
|
$ |
21,598,009 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders Equity |
|
|
|
|
|
|
|
|
Future policy benefits |
|
$ |
6,552,508 |
|
|
$ |
6,333,177 |
|
Interest-sensitive contract liabilities |
|
|
7,517,782 |
|
|
|
6,657,061 |
|
Other policy claims and benefits |
|
|
2,064,578 |
|
|
|
2,055,274 |
|
Other reinsurance balances |
|
|
127,021 |
|
|
|
201,614 |
|
Deferred income taxes |
|
|
399,669 |
|
|
|
760,633 |
|
Other liabilities |
|
|
548,844 |
|
|
|
465,358 |
|
Short-term debt |
|
|
95,000 |
|
|
|
29,773 |
|
Long-term debt |
|
|
922,994 |
|
|
|
896,065 |
|
Collateral finance facility |
|
|
850,094 |
|
|
|
850,361 |
|
Company-obligated mandatorily redeemable preferred securities of subsidiary
trust holding solely junior subordinated debentures of the Company |
|
|
158,990 |
|
|
|
158,861 |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
19,237,480 |
|
|
|
18,408,177 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingent liabilities (See Note 8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity: |
|
|
|
|
|
|
|
|
Preferred stock (par value $.01 per share; 10,000,000 shares authorized; no
shares issued or outstanding) |
|
|
|
|
|
|
|
|
Common stock (par value $.01 per share; 107,700,000 shares Class A authorized;
shares issued: 33,884,734 at September 30, 2008 and 63,128,273 at December 31, 2007;
32,300,000 shares Class B authorized; shares issued: 29,243,539 at September 30, 2008
and none at December 31, 2007) |
|
|
631 |
|
|
|
631 |
|
Warrants |
|
|
66,915 |
|
|
|
66,915 |
|
Additional paid-in-capital |
|
|
1,118,288 |
|
|
|
1,103,956 |
|
Retained earnings |
|
|
1,679,568 |
|
|
|
1,540,122 |
|
Accumulated other comprehensive income: |
|
|
|
|
|
|
|
|
Accumulated currency translation adjustment, net of income taxes |
|
|
143,729 |
|
|
|
221,987 |
|
Unrealized appreciation (depreciation) of securities, net of income taxes |
|
|
(358,273 |
) |
|
|
313,170 |
|
Pension and postretirement benefits, net of income taxes |
|
|
(7,790 |
) |
|
|
(8,351 |
) |
|
|
|
|
|
|
|
Total stockholders equity before treasury stock |
|
|
2,643,068 |
|
|
|
3,238,430 |
|
Less treasury shares held of 802,922 and 1,096,775 at cost at
September 30, 2008 and December 31, 2007, respectively |
|
|
(36,201 |
) |
|
|
(48,598 |
) |
|
|
|
|
|
|
|
Total stockholders equity |
|
|
2,606,867 |
|
|
|
3,189,832 |
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity |
|
$ |
21,844,347 |
|
|
$ |
21,598,009 |
|
|
|
|
|
|
|
|
See accompanying notes to condensed consolidated financial statements (unaudited).
3
REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, |
|
|
Nine months ended September 30, |
|
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
|
(Dollars in thousands, except per share data) |
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net premiums |
|
$ |
1,303,590 |
|
|
$ |
1,227,907 |
|
|
$ |
3,960,210 |
|
|
$ |
3,561,003 |
|
Investment income, net of related expenses |
|
|
220,248 |
|
|
|
190,458 |
|
|
|
674,642 |
|
|
|
681,103 |
|
Investment related losses, net |
|
|
(241,307 |
) |
|
|
(62,113 |
) |
|
|
(403,646 |
) |
|
|
(81,977 |
) |
Other revenues |
|
|
27,764 |
|
|
|
22,089 |
|
|
|
81,962 |
|
|
|
61,637 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
1,310,295 |
|
|
|
1,378,341 |
|
|
|
4,313,168 |
|
|
|
4,221,766 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Claims and other policy benefits |
|
|
1,062,948 |
|
|
|
1,006,864 |
|
|
|
3,311,287 |
|
|
|
2,890,012 |
|
Interest credited |
|
|
9,293 |
|
|
|
30,475 |
|
|
|
146,190 |
|
|
|
205,193 |
|
Policy acquisition costs and other insurance expenses |
|
|
124,836 |
|
|
|
139,081 |
|
|
|
330,370 |
|
|
|
500,078 |
|
Other operating expenses |
|
|
63,886 |
|
|
|
57,284 |
|
|
|
189,223 |
|
|
|
169,325 |
|
Interest expense |
|
|
9,935 |
|
|
|
9,860 |
|
|
|
54,609 |
|
|
|
53,545 |
|
Collateral finance facility expense |
|
|
6,851 |
|
|
|
13,047 |
|
|
|
21,291 |
|
|
|
38,940 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total benefits and expenses |
|
|
1,277,749 |
|
|
|
1,256,611 |
|
|
|
4,052,970 |
|
|
|
3,857,093 |
|
Income from continuing operations before
income taxes |
|
|
32,546 |
|
|
|
121,730 |
|
|
|
260,198 |
|
|
|
364,673 |
|
Provision for income taxes |
|
|
7,296 |
|
|
|
40,932 |
|
|
|
87,553 |
|
|
|
127,901 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
25,250 |
|
|
|
80,798 |
|
|
|
172,645 |
|
|
|
236,772 |
|
Discontinued operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued accident and health
operations, net of income taxes |
|
|
(22 |
) |
|
|
(4,277 |
) |
|
|
(5,210 |
) |
|
|
(6,524 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
25,228 |
|
|
$ |
76,521 |
|
|
$ |
167,435 |
|
|
$ |
230,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
0.41 |
|
|
$ |
1.30 |
|
|
$ |
2.77 |
|
|
$ |
3.83 |
|
Discontinued operations |
|
|
(0.01 |
) |
|
|
(0.07 |
) |
|
|
(0.08 |
) |
|
|
(0.10 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
0.40 |
|
|
$ |
1.23 |
|
|
$ |
2.69 |
|
|
$ |
3.73 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
0.40 |
|
|
$ |
1.26 |
|
|
$ |
2.70 |
|
|
$ |
3.69 |
|
Discontinued operations |
|
|
|
|
|
|
(0.07 |
) |
|
|
(0.08 |
) |
|
|
(0.10 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
0.40 |
|
|
$ |
1.19 |
|
|
$ |
2.62 |
|
|
$ |
3.59 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per share |
|
$ |
0.09 |
|
|
$ |
0.09 |
|
|
$ |
0.27 |
|
|
$ |
0.27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to condensed consolidated financial statements (unaudited).
4
REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, |
|
|
|
2008 |
|
|
2007 |
|
|
|
(Dollars in thousands) |
|
Cash Flows from Operating Activities: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
167,435 |
|
|
$ |
230,248 |
|
Adjustments to reconcile net income to net cash provided by
operating activities: |
|
|
|
|
|
|
|
|
Change in: |
|
|
|
|
|
|
|
|
Accrued investment income |
|
|
(61,713 |
) |
|
|
(52,044 |
) |
Premiums receivable and other reinsurance balances |
|
|
(65,059 |
) |
|
|
(38,713 |
) |
Deferred policy acquisition costs |
|
|
(415,768 |
) |
|
|
(173,596 |
) |
Reinsurance ceded balances |
|
|
(24,477 |
) |
|
|
(125,251 |
) |
Future policy benefits, other policy claims and benefits, and
other reinsurance balances |
|
|
484,914 |
|
|
|
641,536 |
|
Deferred income taxes |
|
|
6,928 |
|
|
|
25,198 |
|
Other assets and other liabilities, net |
|
|
73,627 |
|
|
|
110,478 |
|
Amortization of net investment premiums, discounts and other |
|
|
(73,819 |
) |
|
|
(54,321 |
) |
Investment related losses, net |
|
|
403,646 |
|
|
|
81,977 |
|
Excess tax benefits from share-based payment arrangement |
|
|
(3,763 |
) |
|
|
(2,832 |
) |
Other, net |
|
|
(26,807 |
) |
|
|
15,720 |
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
465,144 |
|
|
|
658,400 |
|
|
|
|
|
|
|
|
|
|
Cash Flows from Investing Activities: |
|
|
|
|
|
|
|
|
Sales of fixed maturity securities available-for-sale |
|
|
1,489,125 |
|
|
|
1,886,028 |
|
Maturities of fixed maturity securities available-for-sale |
|
|
105,352 |
|
|
|
109,806 |
|
Purchases of fixed maturity securities available-for-sale |
|
|
(2,388,376 |
) |
|
|
(2,336,861 |
) |
Cash invested in mortgage loans on real estate |
|
|
|
|
|
|
(141,320 |
) |
Cash invested in policy loans |
|
|
(9,054 |
) |
|
|
(8,750 |
) |
Cash invested in funds withheld at interest |
|
|
(66,834 |
) |
|
|
(69,705 |
) |
Net increase in securitized lending and funding activities |
|
|
112,061 |
|
|
|
62,589 |
|
Principal payments on mortgage loans on real estate |
|
|
49,313 |
|
|
|
44,392 |
|
Principal payments on policy loans |
|
|
19,976 |
|
|
|
5,929 |
|
Change in short-term investments and other invested assets |
|
|
(156,832 |
) |
|
|
(95,560 |
) |
|
|
|
|
|
|
|
Net cash used in investing activities |
|
|
(845,269 |
) |
|
|
(543,452 |
) |
|
|
|
|
|
|
|
|
|
Cash Flows from Financing Activities: |
|
|
|
|
|
|
|
|
Dividends to stockholders |
|
|
(16,799 |
) |
|
|
(16,676 |
) |
Proceeds from long-term debt issuance |
|
|
|
|
|
|
295,311 |
|
Net repayments under credit agreements |
|
|
|
|
|
|
(78,871 |
) |
Purchases of treasury stock |
|
|
(3,104 |
) |
|
|
(3,611 |
) |
Excess tax benefits from share-based payment arrangement |
|
|
3,763 |
|
|
|
2,832 |
|
Exercise of stock options, net |
|
|
4,398 |
|
|
|
12,544 |
|
Net change in payables for securities sold under agreements to repurchase |
|
|
(30,094 |
) |
|
|
|
|
Excess deposits (payments) on universal life and
other investment type policies and contracts |
|
|
440,875 |
|
|
|
(42,174 |
) |
|
|
|
|
|
|
|
Net cash provided by financing activities |
|
|
399,039 |
|
|
|
169,355 |
|
Effect of exchange rate changes on cash |
|
|
(11,010 |
) |
|
|
6,296 |
|
|
|
|
|
|
|
|
Change in cash and cash equivalents |
|
|
7,904 |
|
|
|
290,599 |
|
Cash and cash equivalents, beginning of period |
|
|
404,351 |
|
|
|
160,428 |
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of period |
|
$ |
412,255 |
|
|
$ |
451,027 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplementary information: |
|
|
|
|
|
|
|
|
Cash paid for interest |
|
$ |
69,259 |
|
|
$ |
78,119 |
|
Cash paid for income taxes, net of refunds |
|
$ |
24,715 |
|
|
$ |
20,821 |
|
See accompanying notes to condensed consolidated financial statements (unaudited).
5
REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
1. Organization and Basis of Presentation
Reinsurance Group of America, Incorporated (RGA) is an insurance holding company that was formed
on December 31, 1992. Prior to September 12, 2008, General American Life Insurance Company
(General American), a Missouri life insurance company, directly owned 32,243,539 shares, or
approximately 51.7%, of the outstanding shares of common stock of RGA. General American is a
wholly-owned subsidiary of MetLife, Inc. (MetLife), a New York-based insurance and financial
services holding company. On September 12, 2008 MetLife disposed of the majority of its interest
in RGA by exchanging 29,243,539 of its shares of RGA common stock to MetLife shareholders for
shares of MetLife common stock. See Note 10 Stock Transactions for further details of this
transaction.
The accompanying unaudited condensed consolidated financial statements of RGA and its subsidiaries
(collectively, the Company) have been prepared in conformity with accounting principles generally
accepted in the United States of America for interim financial information and with the
instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all
of the information and footnotes required by accounting principles generally accepted in the United
States of America for complete financial statements. In the opinion of management, all
adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation
have been included. Operating results for the nine-month period ended September 30, 2008 are not
necessarily indicative of the results that may be expected for the year ending December 31, 2008.
These unaudited condensed consolidated financial statements should be read in conjunction with the
consolidated financial statements and notes thereto included in the Companys 2007 Annual Report on
Form 10-K (2007 Annual Report) filed with the Securities and Exchange Commission on February 28,
2008.
The accompanying unaudited condensed consolidated financial statements include the accounts of
Reinsurance Group of America, Incorporated and its subsidiaries. All intercompany accounts and
transactions have been eliminated. The Company has reclassified the presentation of certain
prior-period information to conform to the current presentation.
2. Summary of Significant Accounting Policies
Effective January 1, 2008, the Company adopted Statement of Financial Accounting Standard (SFAS)
No. 157, Fair Value Measurements (SFAS 157). SFAS 157 defines fair value, establishes a
framework for measuring fair value, establishes a fair value hierarchy based on the quality of
inputs used to measure fair value and enhances disclosure requirements for fair value measurements.
In compliance with SFAS No. 157, the Company has categorized its financial instruments, based on
the priority of the inputs to the valuation technique, into a three level hierarchy. The fair
value hierarchy gives the highest priority to quoted prices in active markets for identical assets
or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3).
If the inputs used to measure fair value fall within different levels of the hierarchy, the
category level is based on the lowest priority level input that is significant to the fair value
measurement of the instrument.
In accordance with SFAS 157, assets and liabilities recorded at fair value on the condensed
consolidated balance sheets are categorized as follows:
|
Level 1 |
|
Unadjusted quoted prices in active markets for identical assets or liabilities. |
|
|
Level 2 |
|
Quoted prices in markets that are not active or inputs that are observable either
directly or indirectly. Level 2 inputs include quoted prices for similar assets or
liabilities other than quoted prices in Level 1; quoted prices in markets that are not
active; or other inputs that are observable or can be derived principally from or
corroborated by observable market data for substantially the full
term of the assets or
liabilities. |
|
|
Level 3 |
|
Unobservable inputs that are supported by little or no market activity and are
significant to the fair value of the assets or liabilities. Unobservable inputs reflect
the reporting entitys own assumptions about the assumptions that market participants would
use in pricing the asset or liability. Level 3 |
6
|
|
|
assets and liabilities include financial instruments whose value is determined using pricing
models, discounted cash flow methodologies, or similar techniques, as well as
instruments for which the determination of fair value requires significant management
judgment or estimation. |
See Note 5
- Fair Value Disclosures for further details on the Companys assets and liabilities
recorded at fair value as of September 30, 2008.
3. Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share on income
from continuing operations (in thousands, except per share information):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Nine months ended |
|
|
September 30, |
|
September 30, |
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
|
|
|
Earnings: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
(numerator for basic and diluted
calculations) |
|
$ |
25,250 |
|
|
$ |
80,798 |
|
|
$ |
172,645 |
|
|
$ |
236,772 |
|
Shares: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average outstanding
shares (denominator for basic
calculation) |
|
|
62,323 |
|
|
|
61,995 |
|
|
|
62,251 |
|
|
|
61,806 |
|
Equivalent shares from outstanding
stock options |
|
|
1,284 |
|
|
|
2,217 |
|
|
|
1,689 |
|
|
|
2,412 |
|
|
|
|
Denominator for diluted calculation |
|
|
63,607 |
|
|
|
64,212 |
|
|
|
63,940 |
|
|
|
64,218 |
|
Earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.41 |
|
|
$ |
1.30 |
|
|
$ |
2.77 |
|
|
$ |
3.83 |
|
Diluted |
|
$ |
0.40 |
|
|
$ |
1.26 |
|
|
$ |
2.70 |
|
|
$ |
3.69 |
|
|
|
|
The calculation of common equivalent shares does not include the impact of options or warrants
having a strike or conversion price that exceeds the average stock price for the earnings period,
as the result would be antidilutive. The calculation of common equivalent shares also excludes the
impact of outstanding performance contingent shares, as the conditions necessary for their issuance
have not been satisfied as of the end of the reporting period. For the three and nine months ended
September 30, 2008, approximately 1.3 million stock options and approximately 0.4 million
performance contingent shares were excluded from the calculation. For the three and nine months
ended September 30, 2007, approximately 0.3 million stock options and approximately 0.4 million
performance contingent shares were excluded from the calculation.
4. Comprehensive Income
The following schedule reflects the change in accumulated other comprehensive income (dollars in
thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Nine months ended |
|
|
September 30, |
|
September 30, |
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
|
|
|
Net income |
|
$ |
25,228 |
|
|
$ |
76,521 |
|
|
$ |
167,435 |
|
|
$ |
230,248 |
|
Accumulated other comprehensive
income (loss), net of income tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gains (losses), net
of reclassification adjustment
for gains (losses) included in
net income |
|
|
(405,751 |
) |
|
|
13,853 |
|
|
|
(671,443 |
) |
|
|
(117,620 |
) |
Currency translation adjustments |
|
|
(71,853 |
) |
|
|
56,311 |
|
|
|
(78,258 |
) |
|
|
129,200 |
|
Unrealized pension and
postretirement benefit
adjustment |
|
|
292 |
|
|
|
(239 |
) |
|
|
561 |
|
|
|
(552 |
) |
|
|
|
Comprehensive income (loss) |
|
$ |
(452,084 |
) |
|
$ |
146,446 |
|
|
$ |
(581,705 |
) |
|
$ |
241,276 |
|
|
|
|
7
5. Fair Value Disclosures
The following table presents the carrying amounts and estimated fair values of the Companys
financial instruments at September 30, 2008 and December 31, 2007. Fair values have been
determined by using available market information and the valuation methodologies described in Note
6 of the consolidated financial statements accompanying the 2007 Annual Report. Considerable
judgment is often required in interpreting market data to develop estimates of fair value.
Accordingly, the estimates presented herein may not necessarily be indicative of amounts that could
be realized in a current market exchange. The use of different assumptions or valuation
methodologies may have a material effect on the estimated fair value amounts (dollars in
thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2008 |
|
December 31, 2007 |
|
|
Carrying |
|
Estimated |
|
Carrying |
|
Estimated |
|
|
Value |
|
Fair Value |
|
Value |
|
Fair Value |
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities |
|
$ |
9,121,953 |
|
|
$ |
9,121,953 |
|
|
$ |
9,397,916 |
|
|
$ |
9,397,916 |
|
Mortgage loans on real estate |
|
|
782,282 |
|
|
|
775,416 |
|
|
|
831,557 |
|
|
|
841,427 |
|
Policy loans |
|
|
1,048,517 |
|
|
|
1,048,517 |
|
|
|
1,059,439 |
|
|
|
1,059,439 |
|
Funds withheld at interest |
|
|
4,806,642 |
|
|
|
4,796,683 |
|
|
|
4,749,496 |
|
|
|
4,683,496 |
|
Short-term investments |
|
|
32,520 |
|
|
|
32,520 |
|
|
|
75,062 |
|
|
|
75,062 |
|
Other invested assets |
|
|
432,982 |
|
|
|
442,636 |
|
|
|
284,220 |
|
|
|
298,573 |
|
Cash and cash equivalents |
|
|
412,255 |
|
|
|
412,255 |
|
|
|
404,351 |
|
|
|
404,351 |
|
Accrued investment income |
|
|
138,414 |
|
|
|
138,414 |
|
|
|
77,537 |
|
|
|
77,537 |
|
Reinsurance ceded receivables |
|
|
133,376 |
|
|
|
34,877 |
|
|
|
111,172 |
|
|
|
32,044 |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest-sensitive contract liabilities |
|
$ |
5,677,030 |
|
|
$ |
4,969,012 |
|
|
$ |
4,941,858 |
|
|
$ |
4,196,617 |
|
Long-term and short-term debt |
|
|
1,017,994 |
|
|
|
812,614 |
|
|
|
925,838 |
|
|
|
873,614 |
|
Collateral finance facility |
|
|
850,094 |
|
|
|
612,000 |
|
|
|
850,361 |
|
|
|
761,111 |
|
Company-obligated mandatorily
redeemable preferred securities |
|
|
158,990 |
|
|
|
178,638 |
|
|
|
158,861 |
|
|
|
177,523 |
|
Effective January 1, 2008, the Company adopted SFAS 157, which defines fair value, establishes a
consistent framework for measuring fair value and expands disclosure requirements about fair value
measurements. SFAS 157, among other things, requires the Company to maximize the use of observable
inputs and minimize the use of unobservable inputs when measuring fair value. The Companys
adoption of SFAS 157 resulted in a pre-tax gain of approximately $3.9 million, included in interest
credited, related primarily to the decrease in the fair value of embedded derivative liabilities
associated with equity-indexed annuity products primarily from the incorporation of nonperformance
risk, also referred to as the Companys own credit risk, into the fair value calculation.
SFAS 157 defines fair value as the exchange price that would be received for an asset or paid to
transfer a liability (an exit price) in the principal or most advantageous market for the asset or
liability in an orderly transaction between market participants on the measurement date. In
accordance with SFAS 157, valuation techniques utilized by management for invested assets and
embedded derivatives reported at fair value are generally categorized into three types:
Market Approach. Market approach valuation techniques use prices and other relevant information
from market transactions involving identical or comparable assets or liabilities. Valuation
techniques consistent with the market approach include comparables and matrix pricing. Comparables
use market multiples, which might lie in ranges with a different multiple for each comparable. The
selection of where within the range the appropriate multiple falls requires judgment, considering
both quantitative and qualitative factors specific to the measurement. Matrix pricing is a
mathematical technique used principally to value certain securities without relying exclusively on
quoted prices for the specific securities but comparing the securities to benchmark or comparable
securities.
Income Approach. Income approach valuation techniques convert future amounts, such as cash flows
or earnings, to a single present amount, or a discounted amount. These techniques rely on current
expectations of future amounts. Examples of income approach valuation techniques include present
value techniques, option-pricing models and binomial or lattice models that incorporate present
value techniques.
Cost Approach. Cost approach valuation techniques are based upon the amount that, at present,
would be required to replace the service capacity of an asset, or the current replacement cost.
That is, from the perspective of a market
8
participant (seller), the price that would be received
for the asset is determined based on the cost to a market participant (buyer) to acquire or
construct a substitute asset of comparable utility.
The three approaches described within SFAS 157 are consistent with generally accepted valuation
methodologies. While all three approaches are not applicable to all assets or liabilities reported
at fair value, where appropriate and possible, one or more valuation techniques may be used. The
selection of the valuation method(s) to apply considers the definition of an exit price and the
nature of the asset or liability being valued, and significant expertise and judgment is required.
The Company performs regular analysis and review of the various methodologies utilized in
determining fair value to ensure that the valuation approaches utilized are appropriate and
consistently applied, and that the various assumptions are reasonable. The Company also utilizes
information from third parties, such as pricing services and brokers, to assist in determining fair
values for certain assets and liabilities; however, management is ultimately responsible for all
fair values presented in the Companys financial statements. The Company performs analysis and
review of the information and prices received from third parties to ensure that the prices
represent a reasonable estimate of the fair value. This process involves quantitative and
qualitative analysis and is overseen by the Companys investment and accounting personnel.
Examples of procedures performed include, but are not limited to, initial and ongoing review of
third party pricing services and methodologies, review of pricing trends and monitoring of recent
trade information. In addition, the Company utilizes both internal and external cash flow models
to analyze the reasonableness of fair values utilizing credit spread and other market assumptions,
where appropriate. As a result of the analysis, if the Company determines there is a more
appropriate fair value based upon the available market data, the price received from the third
party is adjusted accordingly.
For invested assets reported at fair value, when available, fair values are based on quoted prices
in active markets that are regularly and readily obtainable. Generally, these are very liquid
investments and the valuation does not require management judgment. When quoted prices in active
markets are not available, fair value is based on the market valuation techniques described above,
primarily a combination of the market approach, including matrix pricing and the income approach.
The assumptions and inputs used by management in applying these methodologies include, but are not
limited to: interest rates, credit standing of the issuer or counterparty, industry sector of the
issuer, coupon rate, call provisions, sinking fund requirements, maturity, estimated duration and
assumptions regarding liquidity and future cash flows.
The significant inputs to the market standard valuation methodologies for certain types of
securities with reasonable levels of price transparency are inputs that are observable in the
market or can be derived principally from or corroborated by observable market data. Such
observable inputs include benchmarking prices for similar assets in active, liquid markets, quoted
prices in markets that are not active and observable yields and spreads in the market.
When observable inputs are not available, the market standard valuation methodologies for
determining the estimated fair value of certain types of securities that trade infrequently, and
therefore have little or no price transparency, rely on inputs that are significant to the
estimated fair value that are not observable in the market or cannot be derived principally from or
corroborated by observable market data. These unobservable inputs can be based in large part on
management judgment or estimation, and cannot be supported by reference to market activity. Even
though unobservable, these inputs are based on assumptions deemed appropriate given the
circumstances and are consistent with what other market participants would use when pricing such
securities.
The use of different methodologies, assumptions and inputs may have a material effect on the
estimated fair values of the Companys securities holdings.
For embedded derivative liabilities associated with the underlying products in reinsurance
treaties, primarily equity-indexed annuity treaties, the Company utilizes a market standard method,
which includes an estimate of future equity option purchases and an adjustment for the Companys
own credit risk that takes into consideration the Companys financial strength rating, also
commonly referred to as a claims paying rating. The capital market inputs to the model, such as
equity indexes, equity volatility, interest rates and the Companys credit adjustment, are
generally observable. However, the valuation models also use inputs requiring certain actuarial
assumptions such as future interest margins, policyholder behavior, including future equity
participation rates, and explicit risk margins related to non-capital market inputs, that are
generally not observable and may require use of significant management judgment. Changes in
interest rates, equity indices, equity volatility, the Companys own credit risk, and actuarial
assumptions regarding policyholder behavior may result in significant fluctuations in the value of
embedded derivatives liabilities associated with equity-indexed annuity reinsurance treaties.
9
The fair value of embedded derivatives associated with funds withheld reinsurance treaties is
determined based upon a total return swap methodology with reference to the fair value of the
investments held by the ceding company that support the Companys funds withheld at interest asset.
The fair value of the underlying assets is generally based on market observable inputs using
market standard valuation methodologies. However, the valuation also requires certain significant
inputs based on actuarial assumptions about policyholder behavior, which are generally not
observable.
For the quarter ended September 30, 2008, the application of valuation methodologies applied to
similar assets and liabilities has been consistent.
SFAS 157 also establishes a fair value hierarchy which requires an entity to maximize the use of
observable inputs and minimize the use of unobservable inputs when measuring fair value. The
standard describes three levels of inputs that may be used to measure fair value:
|
|
|
Level 1
|
|
Quoted prices in active markets for identical assets or
liabilities. The Companys Level 1 assets and liabilities include
investment securities and derivative contracts that are traded in
exchange markets. |
|
|
|
Level 2
|
|
Observable inputs other than Level 1 prices such as quoted prices
for similar assets or liabilities; quoted prices in markets that
are not active; or market standard valuation methodologies and
assumptions with significant inputs that are observable or can be
corroborated by observable market data for substantially the full
term of the assets or liabilities. The Companys Level 2 assets
and liabilities include investment securities with quoted prices
that are traded less frequently than exchange-traded instruments
and derivative contracts whose values are determined using market
standard valuation methodologies. This category primarily
includes U.S. and foreign corporate securities, Canadian and
Canadian provincial government securities, and residential and
commercial mortgage-backed securities, among others. Management
values most of these securities using inputs that are market
observable. |
|
|
|
Level 3
|
|
Unobservable inputs that are supported by little or no market
activity and that are significant to the fair value of the related
assets or liabilities. Level 3 assets and liabilities include
financial instruments whose value is determined using market
standard valuation methodologies described above. When observable
inputs are not available, the market standard methodologies for
determining the estimated fair value of certain securities that
trade infrequently, and therefore have little transparency, rely
on inputs that are significant to the estimated fair value and
that are not observable in the market or cannot be derived
principally from or corroborated by observable market data. These
unobservable inputs can be based in large part on management
judgment or estimation and cannot be supported by reference to
market activity. Even though unobservable, management believes
these inputs are based on assumptions deemed appropriate given the
circumstances and consistent with what other market participants
would use when pricing similar assets and liabilities. For the
Companys invested assets, this category generally includes U.S.
and foreign corporate securities (primarily private placements),
asset-backed securities (including those with exposure to subprime
mortgages), and to a lesser extent, certain residential and
commercial mortgage-backed securities, among others.
Additionally, the Companys embedded derivatives, all of which are
associated with reinsurance treaties, are classified in Level 3
since their values include significant unobservable inputs
associated with actuarial assumptions regarding policyholder
behavior. Embedded derivatives are reported with the host
instruments on the condensed consolidated balance sheet. |
As required by SFAS 157, when inputs used to measure fair value fall within different levels of the
hierarchy, the level within which the fair value measurement is categorized is based on the lowest
priority level input that is significant to the fair value measurement in its entirety. For
example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2)
and unobservable (Level 3). Therefore, gains and losses for such assets and liabilities
categorized within Level 3 may include changes in fair value that are attributable to both
observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
10
Assets and liabilities measured at fair value on a recurring basis are summarized below (dollars in
thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2008 |
|
|
|
|
|
|
Fair Value Measurements Using: |
|
|
Total |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities available-for-sale: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities |
|
$ |
3,101,320 |
|
|
$ |
|
|
|
$ |
2,225,805 |
|
|
$ |
875,515 |
|
Canadian and Canadian provincial governments |
|
|
1,968,114 |
|
|
|
|
|
|
|
1,953,281 |
|
|
|
14,833 |
|
Residential mortgage-backed securities |
|
|
1,262,715 |
|
|
|
|
|
|
|
1,190,474 |
|
|
|
72,241 |
|
Foreign corporate securities |
|
|
1,088,255 |
|
|
|
1,881 |
|
|
|
870,544 |
|
|
|
215,830 |
|
Asset-backed securities |
|
|
395,907 |
|
|
|
|
|
|
|
118,436 |
|
|
|
277,471 |
|
Commercial mortgage-backed securities |
|
|
905,431 |
|
|
|
|
|
|
|
828,556 |
|
|
|
76,875 |
|
U.S. government and agencies securities |
|
|
8,548 |
|
|
|
3,516 |
|
|
|
5,032 |
|
|
|
|
|
State and political subdivision securities |
|
|
42,068 |
|
|
|
6,301 |
|
|
|
|
|
|
|
35,767 |
|
Other foreign government securities |
|
|
349,595 |
|
|
|
101,781 |
|
|
|
141,014 |
|
|
|
106,800 |
|
|
|
|
Total fixed maturity securities available-for-sale |
|
|
9,121,953 |
|
|
|
113,479 |
|
|
|
7,333,142 |
|
|
|
1,675,332 |
|
Funds withheld at interest embedded derivatives |
|
|
(351,867 |
) |
|
|
|
|
|
|
|
|
|
|
(351,867 |
) |
Short-term investments |
|
|
976 |
|
|
|
|
|
|
|
|
|
|
|
976 |
|
Other invested assets equity securities |
|
|
148,593 |
|
|
|
89,280 |
|
|
|
48,493 |
|
|
|
10,820 |
|
Other invested assets derivatives |
|
|
24,747 |
|
|
|
|
|
|
|
24,747 |
|
|
|
|
|
Reinsurance ceded receivable embedded derivatives |
|
|
71,341 |
|
|
|
|
|
|
|
|
|
|
|
71,341 |
|
|
|
|
Total |
|
$ |
9,015,743 |
|
|
$ |
202,759 |
|
|
$ |
7,406,382 |
|
|
$ |
1,406,602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest sensitive contract liabilities embedded derivatives |
|
$ |
(568,337 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
(568,337 |
) |
Other liabilities derivatives |
|
|
(6,856 |
) |
|
|
|
|
|
|
(6,856 |
) |
|
|
|
|
|
|
|
Total |
|
$ |
(575,193 |
) |
|
$ |
|
|
|
$ |
(6,856 |
) |
|
$ |
(568,337 |
) |
|
|
|
The tables below present reconciliations for all assets and liabilities measured at fair value on a
recurring basis using significant unobservable inputs (Level 3) for the three and nine months ended
September 30, 2008 (dollars in thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Fair Value Measurements for the three months ended September 30, 2008 |
|
|
|
|
|
|
Total gains/losses |
|
|
|
|
|
|
|
|
|
|
|
|
{(realized/unrealized) included in: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases, |
|
Transfers |
|
|
|
|
Balance |
|
|
|
|
|
Other |
|
issuances |
|
in and/or |
|
Balance |
|
|
July 1, |
|
|
|
|
|
comprehensive |
|
and |
|
out of |
|
September |
|
|
2008 |
|
Earnings, net |
|
loss |
|
disposals |
|
Level 3 |
|
30, 2008 |
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity
securities
available-for-sale |
|
$ |
1,502,373 |
|
|
$ |
(56,953 |
) |
|
$ |
(75,744 |
) |
|
$ |
86,606 |
|
|
$ |
219,050 |
|
|
$ |
1,675,332 |
|
Funds withheld at
interest embedded
derivatives |
|
|
(245,070 |
) |
|
|
(106,797 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(351,867 |
) |
Short-term investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
976 |
|
|
|
976 |
|
Other invested assets
equity securities |
|
|
11,339 |
|
|
|
8 |
|
|
|
(1,717 |
) |
|
|
1,370 |
|
|
|
(180 |
) |
|
|
10,820 |
|
Reinsurance ceded
receivable
embedded derivatives |
|
|
81,163 |
|
|
|
(11,552 |
) |
|
|
|
|
|
|
1,730 |
|
|
|
|
|
|
|
71,341 |
|
|
|
|
Total |
|
$ |
1,349,805 |
|
|
$ |
(175,294 |
) |
|
$ |
(77,461 |
) |
|
$ |
89,706 |
|
|
$ |
219,846 |
|
|
$ |
1,406,602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest sensitive
contract liabilities
embedded
derivatives |
|
$ |
(588,870 |
) |
|
$ |
19,544 |
|
|
$ |
|
|
|
$ |
989 |
|
|
$ |
|
|
|
$ |
(568,337 |
) |
|
|
|
Total |
|
$ |
(588,870 |
) |
|
$ |
19,544 |
|
|
$ |
|
|
|
$ |
989 |
|
|
$ |
|
|
|
$ |
(568,337 |
) |
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Fair Value Measurements for the nine months ended September 30, 2008 |
|
|
|
|
|
|
Total gains/losses |
|
|
|
|
|
|
|
|
|
|
|
|
{(realized/unrealized) included in: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases, |
|
Transfers |
|
|
|
|
Balance |
|
|
|
|
|
Other |
|
issuances |
|
in and/or |
|
Balance |
|
|
January 1, |
|
|
|
|
|
comprehensive |
|
and |
|
out of |
|
September |
|
|
2008 |
|
Earnings, net |
|
loss |
|
disposals |
|
Level 3 |
|
30, 2008 |
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity
securities
available-for-sale |
|
$ |
1,500,054 |
|
|
$ |
(64,504 |
) |
|
$ |
(153,528 |
) |
|
$ |
213,694 |
|
|
$ |
179,616 |
|
|
$ |
1,675,332 |
|
Funds withheld at
interest embedded
derivatives |
|
|
(85,090 |
) |
|
|
(266,777 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(351,867 |
) |
Short-term investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
976 |
|
|
|
976 |
|
Other invested assets
equity securities |
|
|
13,950 |
|
|
|
9 |
|
|
|
(3,436 |
) |
|
|
15,100 |
|
|
|
(14,803 |
) |
|
|
10,820 |
|
Reinsurance ceded
receivable
embedded derivatives |
|
|
68,298 |
|
|
|
(6,966 |
) |
|
|
|
|
|
|
10,009 |
|
|
|
|
|
|
|
71,341 |
|
|
|
|
Total |
|
$ |
1,497,212 |
|
|
$ |
(338,238 |
) |
|
$ |
(156,964 |
) |
|
$ |
238,803 |
|
|
$ |
165,789 |
|
|
$ |
1,406,602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest sensitive
contract liabilities
embedded
derivatives |
|
$ |
(531,160 |
) |
|
$ |
(18,152 |
) |
|
$ |
|
|
|
$ |
(19,025 |
) |
|
$ |
|
|
|
$ |
(568,337 |
) |
|
|
|
Total |
|
$ |
(531,160 |
) |
|
$ |
(18,152 |
) |
|
$ |
|
|
|
$ |
(19,025 |
) |
|
$ |
|
|
|
$ |
(568,337 |
) |
|
|
|
The tables below summarize gains and losses due to changes in fair value, including both realized
and unrealized gains and losses, recorded in earnings for Level 3 assets and liabilities for the
three and nine months ended September 30, 2008 (dollars in thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Gains and Losses |
|
|
Classification of gains/losses (realized/unrealized) included in earnings for the three months |
|
|
ended September 30, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policy |
|
|
|
|
Investment |
|
|
|
|
|
Claims & |
|
|
|
|
|
acquisition |
|
|
|
|
income, net |
|
Investment |
|
other |
|
|
|
|
|
costs and other |
|
|
|
|
of related |
|
related gains |
|
policy |
|
Interest |
|
insurance |
|
|
|
|
expenses |
|
(losses), net |
|
benefits |
|
credited |
|
expenses |
|
Total |
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity
securities
available-for-sale |
|
$ |
194 |
|
|
$ |
(57,147 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(56,953 |
) |
Funds withheld at
interest embedded
derivatives |
|
|
|
|
|
|
(106,797 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(106,797 |
) |
Other invested assets
equity securities |
|
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 |
|
Reinsurance ceded
receivable
embedded derivatives |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(11,552 |
) |
|
|
(11,552 |
) |
|
|
|
Total |
|
$ |
202 |
|
|
$ |
(163,944 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
(11,552 |
) |
|
$ |
(175,294 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest sensitive
contract liabilities
embedded
derivatives |
|
$ |
|
|
|
$ |
(34,209 |
) |
|
$ |
699 |
|
|
$ |
53,054 |
|
|
$ |
|
|
|
$ |
19,544 |
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(34,209 |
) |
|
$ |
699 |
|
|
$ |
53,054 |
|
|
$ |
|
|
|
$ |
19,544 |
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Gains and Losses |
|
|
Classification of gains/losses (realized/unrealized) included in earnings for the nine months |
|
|
ended September 30, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policy |
|
|
|
|
Investment |
|
|
|
|
|
Claims & |
|
|
|
|
|
acquisition |
|
|
|
|
income, net |
|
Investment |
|
other |
|
|
|
|
|
costs and other |
|
|
|
|
of related |
|
related gains |
|
policy |
|
Interest |
|
insurance |
|
|
|
|
expenses |
|
(losses), net |
|
benefits |
|
credited |
|
expenses |
|
Total |
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity
securities
available-for-sale |
|
$ |
352 |
|
|
$ |
(64,856 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(64,504 |
) |
Funds withheld at
interest embedded
derivatives |
|
|
|
|
|
|
(266,777 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(266,777 |
) |
Other invested assets
equity securities |
|
|
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
|
Reinsurance ceded
receivable
embedded derivatives |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,966 |
) |
|
|
(6,966 |
) |
|
|
|
Total |
|
$ |
361 |
|
|
$ |
(331,633 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
(6,966 |
) |
|
$ |
(338,238 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest sensitive
contract liabilities
embedded
derivatives |
|
$ |
|
|
|
$ |
(33,268 |
) |
|
$ |
2,420 |
|
|
$ |
12,696 |
|
|
$ |
|
|
|
$ |
(18,152 |
) |
|
|
|
Total |
|
$ |
|
|
|
$ |
(33,268 |
) |
|
$ |
2,420 |
|
|
$ |
12,696 |
|
|
$ |
|
|
|
$ |
(18,152 |
) |
|
|
|
The tables below summarize changes in unrealized gains or losses recorded in earnings for the three
and nine months ended September 30, 2008 for Level 3 assets and liabilities that are still held at
September 30, 2008 (dollars in thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in Unrealized Gains and Losses |
|
|
Changes in unrealized gains/losses relating to assets and liabilities still held at the reporting |
|
|
date for the three months ended September 30, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policy |
|
|
|
|
Investment |
|
|
|
|
|
Claims & |
|
|
|
|
|
acquisition |
|
|
|
|
income, net |
|
Investment |
|
other |
|
|
|
|
|
costs and other |
|
|
|
|
of related |
|
related gains |
|
policy |
|
Interest |
|
insurance |
|
|
|
|
expenses |
|
(losses), net |
|
benefits |
|
credited |
|
expenses |
|
Total |
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity
securities
available-for-sale |
|
$ |
129 |
|
|
$ |
(56,098 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(55,969 |
) |
Funds withheld at
interest embedded
derivatives |
|
|
|
|
|
|
(106,797 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(106,797 |
) |
Other invested assets
equity securities |
|
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 |
|
Reinsurance ceded
receivable
embedded derivatives |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10,242 |
) |
|
|
(10,242 |
) |
|
|
|
Total |
|
$ |
137 |
|
|
$ |
(162,895 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
(10,242 |
) |
|
$ |
(173,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest sensitive
contract liabilities
embedded
derivatives |
|
$ |
|
|
|
$ |
(34,209 |
) |
|
$ |
1,351 |
|
|
$ |
41,315 |
|
|
$ |
|
|
|
$ |
8,457 |
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(34,209 |
) |
|
$ |
1,351 |
|
|
$ |
41,315 |
|
|
$ |
|
|
|
$ |
8,457 |
|
|
|
|
13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in Unrealized Gains and Losses |
|
|
Changes in unrealized gains/losses relating to assets and liabilities still held at the reporting |
|
|
date for the nine months ended September 30, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policy |
|
|
|
|
Investment |
|
|
|
|
|
|
|
|
|
|
|
|
|
acquisition |
|
|
|
|
income, net |
|
Investment |
|
Claims & |
|
|
|
|
|
costs and other |
|
|
|
|
of related |
|
related gains |
|
other policy |
|
Interest |
|
insurance |
|
|
|
|
expenses |
|
(losses), net |
|
benefits |
|
Credited |
|
expenses |
|
Total |
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity
securities
available-for-sale |
|
$ |
285 |
|
|
$ |
(58,193 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(57,908 |
) |
Funds withheld at
interest embedded
derivatives |
|
|
|
|
|
|
(266,777 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(266,777 |
) |
Other invested assets
equity securities |
|
|
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
|
Reinsurance ceded
receivable
embedded derivatives |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,745 |
) |
|
|
(2,745 |
) |
|
|
|
Total |
|
$ |
294 |
|
|
$ |
(324,970 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
(2,745 |
) |
|
$ |
(327,421 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest sensitive
contract liabilities
embedded
derivatives |
|
$ |
|
|
|
$ |
(33,268 |
) |
|
$ |
3,841 |
|
|
$ |
(31,775 |
) |
|
$ |
|
|
|
$ |
(61,202 |
) |
|
|
|
Total |
|
$ |
|
|
|
$ |
(33,268 |
) |
|
$ |
3,841 |
|
|
$ |
(31,775 |
) |
|
$ |
|
|
|
$ |
(61,202 |
) |
|
|
|
6. Investment Related Gains and Losses
Investment related gains and losses consisted of the following (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Nine months ended |
|
|
September 30, |
|
September 30, |
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
|
|
|
Investment impairments |
|
$ |
(109,281 |
) |
|
$ |
(2,847 |
) |
|
$ |
(114,982 |
) |
|
$ |
(4,731 |
) |
Investment gains (losses) |
|
|
2,989 |
|
|
|
(1,987 |
) |
|
|
11,557 |
|
|
|
(16,000 |
) |
Derivative losses, net |
|
|
(135,015 |
) |
|
|
(57,279 |
) |
|
|
(300,221 |
) |
|
|
(61,246 |
) |
|
|
|
Net losses |
|
$ |
(241,307 |
) |
|
$ |
(62,113 |
) |
|
$ |
(403,646 |
) |
|
$ |
(81,977 |
) |
|
|
|
The increase in investment impairments in 2008 is due to the recent turmoil in the U.S. and global
financial markets which has resulted in bankruptcies, consolidations and government interventions.
The increase in derivative losses is primarily due to a decline in the fair value of embedded
derivatives associated with modified coinsurance and funds withheld treaties.
The Company monitors its investment securities to determine impairments in value and evaluates
factors such as financial condition of the issuer, payment performance, the length of time and the
extent to which the market value has been below amortized cost, compliance with covenants, general
market conditions and industry sector, current intent and ability to hold securities and various
other subjective factors. Based on managements judgment, securities determined to have an
other-than-temporary impairment in value are written down to fair value. See Note 2 Summary of
Significant Accounting Policies in the Notes to Consolidated Financial Statements of the 2007
Annual Report for additional information on the Companys policy regarding other-than-temporary
impairments.
7. Segment Information
The accounting policies of the segments are the same as those described in the Summary of
Significant Accounting Policies in Note 2 of the consolidated financial statements accompanying the
2007 Annual Report. The Company measures segment performance primarily based on profit or loss
from operations before income taxes. There are no intersegment reinsurance transactions and the
Company does not have any material long-lived assets. Investment income is allocated to the
segments based upon average assets and related capital levels deemed appropriate to support the
segment business volumes.
14
The Company allocates capital to its segments based on an internally developed risk capital model,
the purpose of which is to measure the risk in the business and to provide a basis upon which
capital is deployed. The economic capital model considers the unique and specific nature of the
risks inherent in the Companys businesses. As a result of the economic capital allocation
process, a portion of investment income and investment related gains and losses are credited to the
segments based on the level of allocated equity. In addition, the segments are charged for excess
capital utilized above the allocated economic capital basis. This charge is included in policy
acquisition costs and other insurance expenses.
Information related to total revenues, income (loss) from continuing operations before income
taxes, and total assets of the Company for each reportable segment are summarized below (dollars in
thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Nine months ended |
|
|
September 30, |
|
September 30, |
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
|
|
|
Total revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. |
|
$ |
710,303 |
|
|
$ |
764,724 |
|
|
$ |
2,364,652 |
|
|
$ |
2,531,787 |
|
Canada |
|
|
167,872 |
|
|
|
157,447 |
|
|
|
531,255 |
|
|
|
442,925 |
|
Europe & South Africa |
|
|
180,579 |
|
|
|
175,437 |
|
|
|
572,336 |
|
|
|
520,156 |
|
Asia Pacific |
|
|
265,759 |
|
|
|
251,348 |
|
|
|
811,628 |
|
|
|
658,270 |
|
Corporate & Other |
|
|
(14,218 |
) |
|
|
29,385 |
|
|
|
33,297 |
|
|
|
68,628 |
|
|
|
|
Total |
|
$ |
1,310,295 |
|
|
$ |
1,378,341 |
|
|
$ |
4,313,168 |
|
|
$ |
4,221,766 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Nine months ended |
|
|
September 30, |
|
September 30, |
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
|
|
|
Income (loss) from
continuing operations
before income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. |
|
$ |
(11,289 |
) |
|
$ |
66,152 |
|
|
$ |
113,162 |
|
|
$ |
245,544 |
|
Canada |
|
|
29,733 |
|
|
|
22,798 |
|
|
|
80,182 |
|
|
|
62,034 |
|
Europe & South Africa |
|
|
20,791 |
|
|
|
11,689 |
|
|
|
43,875 |
|
|
|
44,659 |
|
Asia Pacific |
|
|
21,225 |
|
|
|
17,240 |
|
|
|
61,044 |
|
|
|
43,181 |
|
Corporate & Other |
|
|
(27,914 |
) |
|
|
3,851 |
|
|
|
(38,065 |
) |
|
|
(30,745 |
) |
|
|
|
Total |
|
$ |
32,546 |
|
|
$ |
121,730 |
|
|
$ |
260,198 |
|
|
$ |
364,673 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
|
September 30, 2008 |
|
December 31, 2007 |
|
|
|
U.S. |
|
$ |
14,915,865 |
|
|
$ |
13,779,284 |
|
Canada |
|
|
2,838,324 |
|
|
|
2,738,005 |
|
Europe & South Africa |
|
|
1,311,864 |
|
|
|
1,345,900 |
|
Asia Pacific |
|
|
1,414,703 |
|
|
|
1,355,111 |
|
Corporate and Other |
|
|
1,363,591 |
|
|
|
2,379,709 |
|
|
|
|
Total |
|
$ |
21,844,347 |
|
|
$ |
21,598,009 |
|
|
|
|
8. Commitments and Contingent Liabilities
The Company has commitments to fund investments in limited partnerships, private placement
investments and commercial mortgage loans in the amount of $134.3 million, $6.5 million and $4.5
million, respectively, at September 30, 2008. The Company anticipates that the majority of its
commitments to fund investments in limited partnerships will be invested over the next five years;
however, contractually these commitments could become due at the request of the counterparties.
Investments in limited partnerships are carried at cost less any other-than-temporary impairments
and are included in other invested assets in the condensed consolidated balance sheets.
15
In January 2006, the Company was threatened with an arbitration related to its life reinsurance
business. As of June 30, 2008, the ceding company involved in this action had raised a claim in
the amount of $4.9 million. During the third quarter, the Company and the ceding company settled
the matter with no net payment by the Company.
Additionally, the Company is subject to litigation in the normal course of its business. The
Company currently has no material litigation. However, if such material litigation did arise, it
is possible that an adverse outcome on any particular arbitration or litigation situation could
have a material adverse effect on the Companys consolidated net income in a particular reporting
period.
The Company has obtained letters of credit, issued by banks, in favor of various affiliated and
unaffiliated insurance companies from which the Company assumes business. These letters of credit
represent guarantees of performance under the reinsurance agreements and allow ceding companies to
take statutory reserve credits. At September 30, 2008 and December 31, 2007, there were
approximately $24.1 million and $22.6 million, respectively, of outstanding bank letters of credit
in favor of third parties. Additionally, the Company utilizes letters of credit to secure reserve
credits when it retrocedes business to its offshore subsidiaries, including RGA Americas
Reinsurance Company, Ltd. and RGA Reinsurance Company (Barbados) Ltd. The Company cedes business
to its offshore affiliates to help reduce the amount of regulatory capital required in certain
jurisdictions, such as the U.S. and the United Kingdom. The capital required to support the
business in the offshore affiliates reflects more realistic expectations than the original
jurisdiction of the business, where capital requirements are often considered to be quite
conservative. As of September 30, 2008 and December 31, 2007, $493.5 million and $459.6 million,
respectively, in letters of credit from various banks were outstanding between the various
subsidiaries of the Company. The Company maintains a syndicated revolving credit facility with an
overall capacity of $750.0 million, which is scheduled to mature in September 2012. The Company
may borrow cash and may obtain letters of credit in multiple currencies under this facility. As of
September 30, 2008, the Company had $445.4 million in issued, but undrawn, letters of credit under
this facility, which is included in the total above. Applicable letter of credit fees and fees
payable for the credit facility depend upon the Companys senior unsecured long-term debt rating.
Fees associated with the Companys other letters of credit are not fixed for periods in excess of
one year and are based on the Companys ratings and the general availability of these instruments
in the marketplace.
RGA has issued guarantees to third parties on behalf of its subsidiaries performance for the
payment of amounts due under certain credit facilities, reinsurance treaties and office lease
obligations, whereby if a subsidiary fails to meet an obligation, RGA or one of its other
subsidiaries will make a payment to fulfill the obligation. In limited circumstances, treaty
guarantees are granted to ceding companies in order to provide them additional security,
particularly in cases where RGAs subsidiary is relatively new, unrated, or not of a significant
size. Liabilities supported by the treaty guarantees, before consideration for any legally
offsetting amounts due from the guaranteed party, totaled $313.3 million and $325.1 million as of
September 30, 2008 and December 31, 2007, respectively, and are reflected on the Companys
condensed consolidated balance sheets in future policy benefits. Potential guaranteed amounts of
future payments will vary depending on production levels and underwriting results. Guarantees
related to trust preferred securities and credit facilities provide additional security to third
parties should a subsidiary fail to make principal and/or interest payments when due. As of
September 30, 2008, RGAs exposure related to these guarantees was $159.0 million.
In addition, the Company indemnifies its directors and officers as provided in its charters and
by-laws. Since this indemnity generally is not subject to limitation with respect to duration or
amount, the Company does not believe that it is possible to determine the maximum potential amount
due under this indemnity in the future.
9. Employee Benefit Plans
The components of net periodic benefit costs were as follows (dollars in thousands):
16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Nine months ended |
|
|
September 30, |
|
September 30, |
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
|
|
|
Net periodic pension benefit cost: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost |
|
$ |
1,072 |
|
|
$ |
806 |
|
|
$ |
2,552 |
|
|
$ |
2,077 |
|
Interest cost |
|
|
921 |
|
|
|
424 |
|
|
|
2,092 |
|
|
|
1,274 |
|
Expected return on plan assets |
|
|
(705 |
) |
|
|
(469 |
) |
|
|
(1,643 |
) |
|
|
(1,407 |
) |
Amortization of prior service cost |
|
|
78 |
|
|
|
70 |
|
|
|
232 |
|
|
|
244 |
|
Amortization of prior actuarial
(gain) loss |
|
|
238 |
|
|
|
51 |
|
|
|
402 |
|
|
|
120 |
|
|
|
|
Net periodic pension benefit cost |
|
$ |
1,604 |
|
|
$ |
882 |
|
|
$ |
3,635 |
|
|
$ |
2,308 |
|
|
|
|
|
Net periodic other benefits cost: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost |
|
$ |
159 |
|
|
$ |
71 |
|
|
$ |
474 |
|
|
$ |
214 |
|
Interest cost |
|
|
188 |
|
|
|
135 |
|
|
|
478 |
|
|
|
404 |
|
Expected return on plan assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of prior service cost |
|
|
|
|
|
|
7 |
|
|
|
|
|
|
|
19 |
|
Amortization of prior actuarial
(gain) loss |
|
|
(2 |
) |
|
|
40 |
|
|
|
69 |
|
|
|
122 |
|
|
|
|
Net periodic other benefits cost |
|
$ |
345 |
|
|
$ |
253 |
|
|
$ |
1,021 |
|
|
$ |
759 |
|
|
|
|
The Company made pension contributions of $4.0 million during the second quarter of 2008.
10. Stock Transactions
On September 5, 2008, the shareholders of RGA approved a recapitalization and distribution
agreement by and between RGA and MetLife. In the recapitalization, each issued and outstanding
share of RGA common stock was reclassified as RGA class A common stock. The recapitalization was
completed on September 12, 2008. Immediately after the recapitalization, MetLife and its
subsidiaries, which held 32,243,539 shares of RGAs outstanding stock exchanged 29,243,539 shares
of RGA class A common stock for 29,243,539 shares of RGA class B common stock. In turn, MetLife
exchanged all of its RGA class B common stock to MetLife shareholders for shares of MetLife common
stock. Both the RGA class A common stock and RGA class B common stock are entitled to an equal
share of dividend distributions. However, RGA class A common stock carries the right to elect up
to 20% of RGAs directors and RGA Class B common stock carries the right to elect at least 80% of
RGAs directors.
11. Equity Based Compensation
Equity compensation expense was $3.0 million and $3.8 million in the third quarter of 2008 and
2007, respectively, and $10.8 million and $13.3 million in the first nine months of 2008 and 2007,
respectively. In the first quarter of 2008, the Company granted 0.4 million incentive stock
options at $56.03 weighted average per share and 0.2 million performance contingent units to
employees. Additionally, non-employee directors were granted a total of 4,800 shares of common
stock. As of September 30, 2008, 1.7 million share options at $32.40 weighted average per share
vested and exercisable with a remaining weighted average exercise period of 3.8 years. As of
September 30, 2008, the total compensation cost of non-vested awards not yet recognized in the
financial statements was $17.4 million. It is estimated that these costs will vest over a weighted
average period of 1.7 years.
12. New Accounting Standards
In October 2008, the Financial Accounting Standards Board (FASB) issued Staff Position (FSP)
No. FAS 157-3, Determining the Fair Value of a Financial Asset When the Market for That Asset Is
Not Active (FSP 157-3). FSP 157-3 clarifies the application of SFAS 157 in a market that is not
active and provides an example to illustrate key considerations in determining the fair value of a
financial asset when the market for that financial asset is not active. FSP 157-3 was effective
upon issuance on October 10, 2008, including prior periods for which financial
statements had not been issued. The Company did not consider it necessary to change any valuation
techniques as a result of FSP 157-3. The Company also adopted FSP No. FAS 157-2, Effective Date
of FASB Statement No. 157 which delays the effective date of SFAS 157 for certain nonfinancial
assets and liabilities that are recorded at fair value on a nonrecurring basis. The effective date
is delayed until January 1, 2009 and impacts balance sheet items including nonfinancial assets and
liabilities in a business combination and the impairment testing of goodwill and long-lived assets.
17
In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging
Activities An Amendment of FASB Statement No. 133 (SFAS 161). SFAS 161 requires enhanced
qualitative disclosures about objectives and strategies for using derivatives, quantitative
disclosures about fair value amounts of and gains and losses on derivative instruments, and
disclosures about credit-risk-related contingent features in derivative agreements. SFAS 161 is
effective for financial statements issued for fiscal years and interim periods beginning after
November 15, 2008. The Company is currently evaluating the impact of SFAS 161 on its condensed
consolidated financial statements.
In February 2008, the FASB issued FSP No. FAS 140-3, Accounting for Transfers of Financial Assets
and Repurchase Financing Transactions (FSP 140-3). FSP 140-3 provides guidance for evaluating
whether to account for a transfer of a financial asset and repurchase financing as a single
transaction or as two separate transactions. FSP 140-3 is effective prospectively for financial
statements issued for fiscal years beginning after November 15, 2008. The Company is currently
evaluating the impact of FSP 140-3 on its condensed consolidated financial statements.
In December 2007, the FASB issued SFAS No. 141 (revised 2007), Business Combinations A
Replacement of FASB Statement No. 141 (SFAS 141(r)) and SFAS No. 160, Noncontrolling Interests
in Consolidated Financial Statements An Amendment of ARB No. 51 (SFAS 160). SFAS 141(r)
establishes principles and requirements for how an acquirer recognizes and measures certain items
in a business combination, as well as disclosures about the nature and financial effects of a
business combination. SFAS 160 establishes accounting and reporting standards surrounding
noncontrolling interest, or minority interests, which are the portions of equity in a subsidiary
not attributable, directly or indirectly, to a parent. The pronouncements are effective for fiscal
years beginning on or after December 15, 2008 and apply prospectively to business combinations.
Presentation and disclosure requirements related to noncontrolling interests must be
retrospectively applied. The Company is currently evaluating the impact of SFAS 141(r) on its
accounting for future acquisitions and the impact of SFAS 160 on its condensed consolidated
financial statements.
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and
Financial Liabilities (SFAS 159). SFAS 159 permits all entities the option to measure most
financial instruments and certain other items at fair value at specified election dates and to
report related unrealized gains and losses in earnings. The fair value option will generally be
applied on an instrument-by-instrument basis and is generally an irrevocable election. SFAS 159 is
effective for fiscal years beginning after November 15, 2007. The Company did not elect to apply
the fair value option available under SFAS 159 for any of its eligible financial instruments.
13. Subsequent Events
On October 6, 2008, RGA announced that its Board of Directors had authorized and will recommend
that the holders of class A common stock and class B common stock approve a proposal to convert
class B common stock into class A common stock on a one-for-one basis, pursuant to the existing
conversion terms contained in RGAs articles of incorporation. The conversion proposal will require
the affirmative vote of the holders of a majority of class A common stock and the holders of a
majority of class B common stock, represented in person or by proxy at a special meeting of RGA
shareholders.
The Board of Directors established a record date of October 17, 2008 and scheduled the special
meeting of shareholders on November 25, 2008.
On October 30, 2008, the Company announced it priced a public offering of 8,900,000 shares of its
class A common stock at $33.89 per share. The public offering was made in conjunction with the
decision by the Standard & Poors Corporation to include the Company in the S&P MidCap 400 Index.
Additionally, on October 30, 2008, the
Company was notified of the underwriters election to exercise a 30-day option to purchase an
additional 1,335,000 shares at the public offering price. The Company expects to use the estimated
$331.6 million in net proceeds from the offering to pursue reinsurance opportunities and for
general corporate purposes. The offering is scheduled to be completed on November 4, 2008.
18
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-Looking and Cautionary Statements
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995 including, among others, statements relating to
projections of the strategies, earnings, revenues, income or loss, ratios, future financial
performance, and growth potential of the Company. The words intend, expect, project,
estimate, predict, anticipate, should, believe, and other similar expressions also are
intended to identify forward-looking statements. Forward-looking statements are inherently subject
to risks and uncertainties, some of which cannot be predicted or quantified. Future events and
actual results, performance, and achievements could differ materially from those set forth in,
contemplated by, or underlying the forward-looking statements.
Numerous important factors could cause actual results and events to differ materially from those
expressed or implied by forward-looking statements including, without limitation, (1) adverse
capital and credit market conditions and their impact on the Companys liquidity, access to capital
and cost of capital, (2) the impairment of other financial institutions and its effect on the
Companys business, (3) requirements to post collateral or make payments due to declines in market
value of assets subject to the Companys collateral arrangements, (4) the fact that the
determination of allowances and impairments taken on the Companys investments is highly
subjective, (5) adverse changes in mortality, morbidity, lapsation or claims experience, (6)
changes in the Companys financial strength and credit ratings and the effect of such changes on
the Companys future results of operations and financial condition, (7) inadequate risk analysis
and underwriting, (8) general economic conditions or a prolonged economic downturn affecting the
demand for insurance and reinsurance in the Companys current and planned markets, (9) the
availability and cost of collateral necessary for regulatory reserves and capital, (10) market or
economic conditions that adversely affect the value of the Companys investment securities or
result in the impairment of all or a portion of the value of certain of the Companys investment
securities, (11) market or economic conditions that adversely affect the Companys ability to make
timely sales of investment securities, (12) risks inherent in the Companys risk management and
investment strategy, including changes in investment portfolio yields due to interest rate or
credit quality changes, (13) fluctuations in U.S. or foreign currency exchange rates, interest
rates, or securities and real estate markets, (14) adverse litigation or arbitration results, (15)
the adequacy of reserves, resources and accurate information relating to settlements, awards and
terminated and discontinued lines of business, (16) the stability of and actions by governments and
economies in the markets in which the Company operates, (17) competitive factors and competitors
responses to the Companys initiatives, (18) the success of the Companys clients, (19) successful
execution of the Companys entry into new markets, (20) successful development and introduction of
new products and distribution opportunities, (21) the Companys ability to successfully integrate
and operate reinsurance business that the Company acquires, (22) regulatory action that may be
taken by state Departments of Insurance with respect to the Company, (23) the Companys dependence
on third parties, including those insurance companies and reinsurers to which the Company cedes
some reinsurance, third-party investment managers and others, (24) the threat of natural disasters,
catastrophes, terrorist attacks, epidemics or pandemics anywhere in the world where the Company or
its clients do business, (25) changes in laws, regulations, and accounting standards applicable to
the Company, its subsidiaries, or its business, (26) the effect of the Companys status as an
insurance holding company and regulatory restrictions on its ability to pay principal of and
interest on its debt obligations, and (27) other risks and uncertainties described in this document
and in the Companys other filings with the Securities and Exchange Commission (SEC).
Forward-looking statements should be evaluated together with the many risks and uncertainties that
affect the Companys business, including those mentioned in this document and the cautionary
statements described in the periodic reports the Company files with the SEC. These forward-looking
statements speak only as of the date on which they are made. The Company does not undertake any
obligations to update these forward-looking statements, even though the Companys situation may
change in the future. The Company qualifies all of its forward-looking statements by these
cautionary statements. For a discussion of these risks and uncertainties that could cause actual
results to differ materially from those contained in the forward-looking statements, you are
advised to see Item 1A Risk Factors of this quarterly report on Form 10-Q.
19
Overview
Reinsurance Group of America, Incorporated (RGA) is an insurance holding company that was formed
on December 31, 1992. Prior to September 12, 2008, General American Life Insurance Company
(General American), a Missouri life insurance company, directly owned 32,243,539 shares, or
approximately 51.7%, of the outstanding shares of common stock of RGA. General American is a
wholly-owned subsidiary of MetLife, Inc. (MetLife), a New York-based insurance and financial
services holding company. On September 12, 2008 MetLife disposed of the majority of its interest
in RGA by exchanging 29,243,539 of its shares of RGA common stock to MetLife shareholders for
shares of MetLife common stock. See Note 10 Stock Transactions in the Notes to Condensed
Consolidated Financial Statements for further details of this transaction.
RGA and its subsidiaries (collectively, the Company) are primarily engaged in the life
reinsurance business, which involves reinsuring life insurance policies that are often in force for
the remaining lifetime of the underlying individuals insured, with premiums earned typically over a
period of 10 to 30 years. Each year, however, a portion of the business under existing treaties
terminates due to, among other things, lapses or surrenders of underlying policies, deaths of
policyholders, and the exercise of recapture options by ceding companies.
The Company derives revenues primarily from renewal premiums from existing reinsurance treaties,
new business premiums from existing or new reinsurance treaties, income earned on invested assets,
and fees earned from financial reinsurance transactions. The Company believes that industry trends
have not changed materially from those discussed in its 2007 Annual Report.
The Companys profitability primarily depends on the volume and amount of death claims incurred and
its ability to adequately price the risks it assumes. While death claims are reasonably
predictable over a period of years, claims become less predictable over shorter periods and are
subject to significant fluctuation from quarter to quarter and year to year. The maximum amount of
coverage the Company retains per life is $8.0 million. Claims in excess of this retention amount
are retroceded to retrocessionaires; however, the Company remains fully liable to the ceding
company for the entire amount of risk it assumes. The Company believes its sources of liquidity
are sufficient to cover potential claims payments on both a short-term and long-term basis.
The Company measures performance based on income or loss from continuing operations before income
taxes for each of its five segments. The Companys U.S., Canada, Europe & South Africa and Asia
Pacific operations provide traditional life reinsurance to clients. The Companys U.S. operations
also provide asset-intensive and financial reinsurance products. The Company also provides
insurers with critical illness reinsurance in its Canada, Europe & South Africa and Asia Pacific
operations. Asia Pacific operations also provide financial reinsurance. The Corporate and Other
segment results include the corporate investment activity, general corporate expenses, interest
expense of RGA, operations of RGA Technology Partners, Inc., a wholly-owned subsidiary that
develops and markets technology solutions for the insurance industry, Argentine privatized pension
business in run-off, investment income and expense associated with the Companys collateral finance
facility and the provision for income taxes. The Companys discontinued accident and health
operations are not reflected in its results from continuing operations.
The Company allocates capital to its segments based on an internally developed risk capital model,
the purpose of which is to measure the risk in the business and to provide a basis upon which
capital is deployed. The economic capital model considers the unique and specific nature of the
risks inherent in RGAs businesses. As a result of the economic capital allocation process, a
portion of investment income and investment related gains and losses are credited to the segments
based on the level of allocated equity. In addition, the segments are charged for excess capital
utilized above the allocated economic capital basis. This charge is included in policy acquisition
costs and other insurance expenses.
Results of Operations
Consolidated income from continuing operations before income taxes decreased $89.2 million, or
73.3%, and $104.5 million, or 28.6%, for the three and nine months ended September 30, 2008, as
compared to the same periods in 2007. The decrease in the third quarter reflects an increase in
investment related losses due to the recognition of investment impairments and an increase in the
unrealized loss due to an unfavorable change in the value of embedded derivatives within the U.S.
segment due to the impact of widening credit spreads in the U.S. debt markets. Also contributing to
the third quarter income decrease was unfavorable mortality experience in the U.S.
20
segment. Offsetting these negative income items were increases in premium levels in all segments and
favorable mortality
experience in the Canada, Europe & South Africa and Asia Pacific segments. The decrease in income
for the first nine months can be largely attributed to the third quarter recognition of investment
impairments and an increase in the unrealized loss due to an unfavorable change in the value of
embedded derivatives within the U.S. segment due to the impact of widening credit spreads in the
U.S. debt markets. Also contributing to the decrease in income for the first nine months was
unfavorable mortality experience in the U.S. and Europe & South Africa segments. Offsetting these
negative income items for the first nine months were increases in premium levels in all segments.
Foreign currency exchange fluctuations resulted in a decrease to income from continuing operations
before income taxes of approximately $1.4 million and an increase of approximately $11.9 million
for the third quarter and first nine months of 2008, respectively.
The unrealized loss due to an unfavorable change in value of embedded derivatives is primarily
related to reinsurance treaties written on a modified coinsurance or funds withheld basis and
subject to the provisions of Statement of Financial Accounting Standards (SFAS) No. 133
Implementation Issue No. B36, Embedded Derivatives: Modified Coinsurance Arrangements and Debt
Instruments That Incorporate Credit Risk Exposures That Are Unrelated or Only Partially Related to
the Creditworthiness of the Obligor under Those Instruments (Issue B36). Additionally, changes
in risk free rates used in the present value calculations of embedded derivatives associated with
equity-indexed annuity treaties (EIAs) negatively affected income before income taxes in the
first nine months of 2008. Changes in these two types of embedded derivatives, after adjustment
for deferred acquisition costs and retrocession, resulted in a decrease in consolidated income from
continuing operations before income taxes of approximately $8.9 million and $54.8 million for the
three and nine months ended September 30, 2008, as compared to the same periods in 2007,
respectively. These fluctuations do not affect current cash flows, crediting rates or spread
performance on the underlying treaties. Therefore, Company management believes it is helpful to
distinguish between the effects of changes in these embedded derivatives and the primary factors
that drive profitability of the underlying treaties, namely investment income, fee income, and
interest credited. Additionally, over the expected life of the underlying treaties, management
expects the cumulative effect of the embedded derivatives to be immaterial.
Consolidated net premiums increased $75.7 million, or 6.2%, and $399.2 million, or 11.2%, for the
three and nine months ended September 30, 2008, as compared to the same periods in 2007, due to
growth in life reinsurance in force. Consolidated assumed insurance in force increased to $2.2
trillion for the quarter ended September 30, 2008 from $2.1 trillion for quarter ended September
30, 2007. The Company added new business production, measured by face amount of insurance in
force, of $73.8 billion and $81.0 billion during the third quarter, and $221.8 billion and $224.5
billion during the first nine months, of 2008 and 2007, respectively. Management believes industry
consolidation and the established practice of reinsuring mortality risks should continue to provide
opportunities for growth, albeit at rates less than historically experienced. Foreign currency
fluctuations unfavorably affected net premiums by approximately $5.7 million for the third quarter
of 2008 and favorably affected net premiums by $61.4 million for the first nine months of 2008.
Consolidated investment income, net of related expenses, increased $29.8 million, or 15.6%, and
decreased $6.5 million, or 0.9%, for the three and nine months ended September 30, 2008, as
compared to the same periods in 2007, primarily due to market value changes related to the
Companys funds withheld at interest investment related to the reinsurance of certain equity
indexed annuity products, which are substantially offset by a corresponding change in interest
credited to policyholder account balances resulting in a negligible effect on net income.
Contributing to the third quarter increase and largely offsetting the nine month decrease in
investment income was a larger invested asset base and a higher effective investment portfolio
yield. Invested assets as of September 30, 2008 totaled $16.2 billion, a 2.3% increase over
September 30, 2007. The average yield earned on investments, excluding funds withheld, was 6.01%
in the third quarter of 2008 and 6.00% for the third quarter of 2007. The average yield earned on
investments, excluding funds withheld, increased to 6.05% for the first nine months of 2008 from
5.97% for the first nine months of 2007. The average yield will vary from quarter to quarter and
year to year depending on a number of variables, including the prevailing interest rate and credit
spread environment, changes in the mix of the underlying investments, and the timing of dividends
and distributions on certain investments.
Investment related losses, net increased $179.2 million and $321.7 million for the three and nine
months ended September 30, 2008, as compared to the same periods in 2007. The increase in the
third quarter is due to an increase of $106.4 million in investment impairments and an increase of
$53.8 million in the loss of the
21
aforementioned embedded derivatives related to Issue B36. See the
discussion of Investments in the Liquidity and Capital
Resources section of Managements Discussion and Analysis for additional information on the
impairment losses. The increase in the first nine months is primarily due to an increase of $209.5
million in the loss of the embedded derivatives related to Issue B36 and the investment impairments
recognized in the third quarter. Investment income and investment related gains and losses are
allocated to the operating segments based upon average assets and related capital levels deemed
appropriate to support the segment business volumes. Investment income and investment related
gains and losses are allocated to the operating segments based upon average assets and related
capital levels deemed appropriate to support the segment business volumes.
The effective tax rate on a consolidated basis was 22.4% and 33.6% for the third quarter of 2008
and 2007, respectively, and 33.7% and 35.1% for the first nine months of 2008 and 2007,
respectively. These effective tax rates were affected by the ongoing application of FASB issued
Interpretation No. 48, Accounting for Uncertainty in Income Taxes an interpretation of FASB
Statement No. 109 and by the earnings of non-U.S. subsidiaries in which the Company is permanently
reinvested whose statutory tax rates are less than the U.S. statutory tax rate.
Critical Accounting Policies
The Companys accounting policies are described in Note 2 in the 2007 Annual Report. The Company
believes its most critical accounting policies include the capitalization and amortization of
deferred acquisition costs (DAC); the establishment of liabilities for future policy benefits,
other policy claims and benefits, including incurred but not reported claims; the valuation of
investments, derivatives and investment impairments, if any; accounting for income taxes; and the
establishment of arbitration or litigation reserves. The balances of these accounts require
extensive use of assumptions and estimates, particularly related to the future performance of the
underlying business.
Additionally, for each of the Companys reinsurance contracts, it must determine if the contract
provides indemnification against loss or liability relating to insurance risk, in accordance with
applicable accounting standards. The Company must review all contractual features, particularly
those that may limit the amount of insurance risk to which the Company is subject or features that
delay the timely reimbursement of claims. If the Company determines that the possibility of a
significant loss from insurance risk will occur only under remote circumstances, it records the
contract under a deposit method of accounting with the net amount receivable or payable reflected
in premiums receivable and other reinsurance balances or other reinsurance liabilities on the
condensed consolidated balance sheets. Fees earned on the contracts are reflected as other
revenues, as opposed to net premiums, on the condensed consolidated statements of income.
Costs of acquiring new business, which vary with and are primarily related to the production of new
business, have been deferred to the extent that such costs are deemed recoverable from future
premiums or gross profits. Deferred policy acquisition costs reflect the Companys expectations
about the future experience of the business in force and include commissions and allowances as well
as certain costs of policy issuance and underwriting. Some of the factors that can affect the
carrying value of DAC include mortality assumptions, interest spreads and policy lapse rates. The
Company performs periodic tests to determine that DAC remains recoverable, and the cumulative
amortization is re-estimated and, if necessary, adjusted by a cumulative charge or credit to
current operations.
Liabilities for future policy benefits under long-term life insurance policies (policy reserves)
are computed based upon expected investment yields, mortality and withdrawal (lapse) rates, and
other assumptions, including a provision for adverse deviation from expected claim levels. The
Company primarily relies on its own valuation and administration systems to establish policy
reserves. The policy reserves the Company establishes may differ from those established by the
ceding companies due to the use of different mortality and other assumptions. However, the Company
relies upon its clients to provide accurate data, including policy-level information, premiums and
claims, which is the primary information used to establish reserves. The Companys administration
departments work directly with its clients to help ensure information is submitted by them in
accordance with the reinsurance contracts. Additionally, the Company performs periodic audits of
the information provided by ceding companies. The Company establishes reserves for processing
backlogs with a goal of clearing all backlogs within a ninety-day period. The backlogs are usually
due to data errors the Company discovers or computer file compatibility issues, since much of the
data reported to the Company is in electronic format and is uploaded to its computer systems.
The Company periodically reviews actual historical experience and relative anticipated experience
compared to the assumptions used to establish aggregate policy reserves. Further, the Company
establishes premium deficiency
22
reserves if actual and anticipated experience indicates that
existing aggregate policy reserves, together with the present value of future gross premiums, are
not sufficient to cover the present value of future benefits, settlement and
maintenance costs and to recover unamortized acquisition costs. The premium deficiency reserve is
established through a charge to income, as well as a reduction to unamortized acquisition costs
and, to the extent there are no unamortized acquisition costs, an increase to future policy
benefits. Because of the many assumptions and estimates used in establishing reserves and the
long-term nature of the Companys reinsurance contracts, the reserving process, while based on
actuarial science, is inherently uncertain. If the Companys assumptions, particularly on
mortality, are inaccurate, its reserves may be inadequate to pay claims and there could be a
material adverse effect on its results of operations and financial condition.
Other policy claims and benefits include claims payable for incurred but not reported losses, which
are determined using case-basis estimates and lag studies of past experience. These estimates are
periodically reviewed and any adjustments to such estimates, if necessary, are reflected in current
operations. The time lag from the date of the claim or death to the date when the ceding company
reports the claim to the Company can be several months and can vary significantly by ceding company
and business segment. The Company updates its analysis of incurred but not reported claims,
including lag studies, on a periodic basis and adjusts its claim liabilities accordingly. The
adjustments in a given period are generally not significant relative to the overall policy
liabilities.
The Company primarily invests in fixed maturity securities and monitors these fixed maturity
securities to determine potential impairments in value. With the Companys external investment
managers, it evaluates its intent and ability to hold securities, along with factors such as the
financial condition of the issuer, payment performance, the extent to which the market value has
been below amortized cost, compliance with covenants, general market and industry sector
conditions, and various other factors. Securities, based on managements judgments, with an
other-than-temporary impairment in value are written down to managements estimate of fair value.
Assets and liabilities measured at fair value on a recurring basis are summarized below (dollars in
thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2008 |
|
|
|
|
|
|
Fair Value Measurements Using: |
|
|
Total |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities available-for-sale |
|
$ |
9,121,953 |
|
|
$ |
113,479 |
|
|
$ |
7,333,142 |
|
|
$ |
1,675,332 |
|
Funds withheld at interest embedded derivatives |
|
|
(351,867 |
) |
|
|
|
|
|
|
|
|
|
|
(351,867 |
) |
Short-term investments |
|
|
976 |
|
|
|
|
|
|
|
|
|
|
|
976 |
|
Other invested assets equity securities |
|
|
148,593 |
|
|
|
89,280 |
|
|
|
48,493 |
|
|
|
10,820 |
|
Other invested assets derivatives |
|
|
24,747 |
|
|
|
|
|
|
|
24,747 |
|
|
|
|
|
Reinsurance ceded receivable embedded derivatives |
|
|
71,341 |
|
|
|
|
|
|
|
|
|
|
|
71,341 |
|
|
|
|
Total |
|
$ |
9,015,743 |
|
|
$ |
202,759 |
|
|
$ |
7,406,382 |
|
|
$ |
1,406,602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest sensitive contract liabilities embedded derivatives |
|
$ |
(568,337 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
(568,337 |
) |
Other liabilities derivatives |
|
|
(6,856 |
) |
|
|
|
|
|
|
(6,856 |
) |
|
|
|
|
|
|
|
Total |
|
$ |
(575,193 |
) |
|
$ |
|
|
|
$ |
(6,856 |
) |
|
$ |
(568,337 |
) |
|
|
|
The tables below present reconciliations for all assets and liabilities measured at fair value on a
recurring basis using significant unobservable inputs (Level 3) for the three and nine months ended
September 30, 2008 (dollars in thousands).
23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Fair Value Measurements for the three months ended September 30, 2008 |
|
|
|
|
|
|
Total gains/losses |
|
|
|
|
|
|
|
|
|
|
|
|
(realized/unrealized) included in: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases, |
|
Transfers |
|
|
|
|
Balance |
|
|
|
|
|
Other |
|
issuances |
|
in and/or |
|
Balance |
|
|
July 1, |
|
|
|
|
|
comprehensive |
|
and |
|
out of |
|
September |
|
|
2008 |
|
Earnings, net |
|
loss |
|
disposals |
|
Level 3 |
|
30, 2008 |
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity
securities
available-for-sale |
|
$ |
1,502,373 |
|
|
$ |
(56,953 |
) |
|
$ |
(75,744 |
) |
|
$ |
86,606 |
|
|
$ |
219,050 |
|
|
$ |
1,675,332 |
|
Funds withheld at
interest embedded
derivatives |
|
|
(245,070 |
) |
|
|
(106,797 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(351,867 |
) |
Short-term investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
976 |
|
|
|
976 |
|
Other invested assets
equity securities |
|
|
11,339 |
|
|
|
8 |
|
|
|
(1,717 |
) |
|
|
1,370 |
|
|
|
(180 |
) |
|
|
10,820 |
|
Reinsurance ceded
receivable
embedded derivatives |
|
|
81,163 |
|
|
|
(11,552 |
) |
|
|
|
|
|
|
1,730 |
|
|
|
|
|
|
|
71,341 |
|
|
|
|
Total |
|
$ |
1,349,805 |
|
|
$ |
(175,294 |
) |
|
$ |
(77,461 |
) |
|
$ |
89,706 |
|
|
$ |
219,846 |
|
|
$ |
1,406,602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest sensitive
contract liabilities
embedded
derivatives |
|
$ |
(588,870 |
) |
|
$ |
19,544 |
|
|
$ |
|
|
|
$ |
989 |
|
|
$ |
|
|
|
$ |
(568,337 |
) |
|
|
|
Total |
|
$ |
(588,870 |
) |
|
$ |
19,544 |
|
|
$ |
|
|
|
$ |
989 |
|
|
$ |
|
|
|
$ |
(568,337 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Fair Value Measurements for the nine months ended September 30, 2008 |
|
|
|
|
|
|
Total gains/losses |
|
|
|
|
|
|
|
|
|
|
|
|
(realized/unrealized) included in: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases, |
|
Transfers |
|
|
|
|
Balance |
|
|
|
|
|
Other |
|
issuances |
|
in and/or |
|
Balance |
|
|
January 1, |
|
|
|
|
|
comprehensive |
|
and |
|
out of |
|
September |
|
|
2008 |
|
Earnings, net |
|
loss |
|
disposals |
|
Level 3 |
|
30, 2008 |
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity
securities
available-for-sale |
|
$ |
1,500,054 |
|
|
$ |
(64,504 |
) |
|
$ |
(153,528 |
) |
|
$ |
213,694 |
|
|
$ |
179,616 |
|
|
$ |
1,675,332 |
|
Funds withheld at
interest embedded
derivatives |
|
|
(85,090 |
) |
|
|
(266,777 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(351,867 |
) |
Short-term investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
976 |
|
|
|
976 |
|
Other invested assets
equity securities |
|
|
13,950 |
|
|
|
9 |
|
|
|
(3,436 |
) |
|
|
15,100 |
|
|
|
(14,803 |
) |
|
|
10,820 |
|
Reinsurance ceded
receivable
embedded derivatives |
|
|
68,298 |
|
|
|
(6,966 |
) |
|
|
|
|
|
|
10,009 |
|
|
|
|
|
|
|
71,341 |
|
|
|
|
Total |
|
$ |
1,497,212 |
|
|
$ |
(338,238 |
) |
|
$ |
(156,964 |
) |
|
$ |
238,803 |
|
|
$ |
165,789 |
|
|
$ |
1,406,602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest sensitive
contract liabilities
embedded
derivatives |
|
$ |
(531,160 |
) |
|
$ |
(18,152 |
) |
|
$ |
|
|
|
$ |
(19,025 |
) |
|
$ |
|
|
|
$ |
(568,337 |
) |
|
|
|
Total |
|
$ |
(531,160 |
) |
|
$ |
(18,152 |
) |
|
$ |
|
|
|
$ |
(19,025 |
) |
|
$ |
|
|
|
$ |
(568,337 |
) |
|
|
|
Level 3 assets were 15.6% of total assets measured at fair value and Level 3 liabilities were 98.8%
of total liabilities measured at fair value as of September 30, 2008. Transfers in and out of
Level 3 for the period ended September 30, 2008 were not significant.
Asset-backed securities (ABS) represented approximately 16.6% of Level 3 fixed maturity
securities available-for-sale and 19.7% of total Level 3 assets as of September 30, 2008. ABS
primarily represents sub-prime and Alt-A securities which are classified as Level 3 due to the lack
of liquidity in the market along with illiquid bank loan collateralized debt obligations. While
the fair value of these investments, as well as others within the Companys portfolio of fixed
maturity securities available-for-sale, has declined in recent quarters due to increased credit
spreads in the financial markets, the Company believes the investment fundamentals remain sound,
and the ultimate value that will be realized from these investments is greater than that reflected
by their current fair value and therefore not other-than-temporarily impaired.
24
See Note 5 Fair Value Disclosures in the Notes to Condensed Consolidated Financial Statements
and the discussion of Investments in the Liquidity and Capital Resources section of
Managements Discussion and Analysis for additional information on the Companys assets and
liabilities recorded at fair value as of September 30, 2008.
Differences in experience compared with the assumptions and estimates utilized in the justification
of the recoverability of DAC, in establishing reserves for future policy benefits and claim
liabilities, or in the determination of other-than-temporary impairments to investment securities
can have a material effect on the Companys results of operations and financial condition.
Income taxes represent the net amount of income taxes that the Company expects to pay to or receive
from various taxing jurisdictions in connection with its operations. The Company provides for
federal, state and foreign income taxes currently payable, as well as those deferred due to
temporary differences between the financial reporting and tax bases of assets and liabilities. The
Companys accounting for income taxes represents managements best estimate of various events and
transactions.
Deferred tax assets and liabilities resulting from temporary differences between the financial
reporting and tax bases of assets and liabilities are measured at the balance sheet date using
enacted tax rates expected to apply to taxable income in the years the temporary differences are
expected to reverse. The realization of deferred tax assets depends upon the existence of
sufficient taxable income within the carryback or carryforward periods under the tax law in the
applicable tax jurisdiction. Valuation allowances are established when management determines,
based on available information, that it is more likely than not that deferred income tax assets
will not be realized. Significant judgment is required in determining whether valuation allowances
should be established as well as the amount of such allowances. When making such determination,
consideration is given to, among other things, the following:
(i) |
|
future taxable income exclusive of reversing temporary differences and carryforwards; |
|
(ii) |
|
future reversals of existing taxable temporary differences; |
|
(iii) |
|
taxable income in prior carryback years; and |
|
(iv) |
|
tax planning strategies. |
The Company may be required to change its provision for income taxes in certain circumstances.
Examples of such circumstances include when the ultimate deductibility of certain items is
challenged by taxing authorities or when estimates used in determining valuation allowances on
deferred tax assets significantly change or when receipt of new information indicates the need for
adjustment in valuation allowances. Additionally, future events such as changes in tax legislation
could have an impact on the provision for income tax and the effective tax rate. Any such changes
could significantly affect the amounts reported in the condensed consolidated financial statements
in the period these changes occur.
The Company at times is a party to various litigation and arbitrations. The Company cannot predict
or determine the ultimate outcome of any pending litigation or arbitrations or even provide useful
ranges of potential losses. However, it is possible that an adverse outcome on any particular
arbitration or litigation situation could have a material adverse effect on the Companys
consolidated net income in a particular reporting period.
Further discussion and analysis of the results for 2008 compared to 2007 are presented by segment.
References to income before income taxes exclude the effects of discontinued operations.
U.S. OPERATIONS
U.S. operations consist of two major sub-segments: Traditional and Non-Traditional. The
Traditional sub-segment primarily specializes in mortality-risk reinsurance. The Non-Traditional
sub-segment consists of Asset-Intensive and Financial Reinsurance.
25
For the three months ended September 30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(dollars in thousands) |
|
|
|
Non-Traditional |
|
Total |
|
|
|
|
|
|
Asset- |
|
Financial |
|
U.S. |
|
|
Traditional |
|
Intensive |
|
Reinsurance |
|
Operations |
|
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net premiums |
|
$ |
740,502 |
|
|
$ |
1,719 |
|
|
$ |
|
|
|
$ |
742,221 |
|
Investment income, net of related expenses |
|
|
99,991 |
|
|
|
43,727 |
|
|
|
192 |
|
|
|
143,910 |
|
Investment related losses, net |
|
|
(62,065 |
) |
|
|
(132,280 |
) |
|
|
(136 |
) |
|
|
(194,481 |
) |
Other revenues |
|
|
(42 |
) |
|
|
15,051 |
|
|
|
3,644 |
|
|
|
18,653 |
|
|
|
|
Total revenues |
|
|
778,386 |
|
|
|
(71,783 |
) |
|
|
3,700 |
|
|
|
710,303 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Claims and other policy benefits |
|
|
632,258 |
|
|
|
2,040 |
|
|
|
|
|
|
|
634,298 |
|
Interest credited |
|
|
15,221 |
|
|
|
(6,005 |
) |
|
|
|
|
|
|
9,216 |
|
Policy acquisition costs and other insurance expenses |
|
|
107,199 |
|
|
|
(45,043 |
) |
|
|
252 |
|
|
|
62,408 |
|
Other operating expenses |
|
|
12,756 |
|
|
|
2,167 |
|
|
|
747 |
|
|
|
15,670 |
|
|
|
|
Total benefits and expenses |
|
|
767,434 |
|
|
|
(46,841 |
) |
|
|
999 |
|
|
|
721,592 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
$ |
10,952 |
|
|
$ |
(24,942 |
) |
|
$ |
2,701 |
|
|
$ |
(11,289 |
) |
|
|
|
For the three months ended September 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(dollars in thousands) |
|
|
|
Non-Traditional |
|
Total |
|
|
|
|
|
|
Asset- |
|
Financial |
|
U.S. |
|
|
Traditional |
|
Intensive |
|
Reinsurance |
|
Operations |
|
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net premiums |
|
$ |
690,388 |
|
|
$ |
1,555 |
|
|
$ |
|
|
|
$ |
691,943 |
|
Investment income, net of related expenses |
|
|
89,221 |
|
|
|
28,870 |
|
|
|
(9 |
) |
|
|
118,082 |
|
Investment related losses, net |
|
|
(5,457 |
) |
|
|
(58,384 |
) |
|
|
(2 |
) |
|
|
(63,843 |
) |
Other revenues |
|
|
242 |
|
|
|
11,095 |
|
|
|
7,205 |
|
|
|
18,542 |
|
|
|
|
Total revenues |
|
|
774,394 |
|
|
|
(16,864 |
) |
|
|
7,194 |
|
|
|
764,724 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Claims and other policy benefits |
|
|
572,871 |
|
|
|
2,280 |
|
|
|
|
|
|
|
575,151 |
|
Interest credited |
|
|
14,845 |
|
|
|
15,457 |
|
|
|
|
|
|
|
30,302 |
|
Policy acquisition costs and other
insurance expenses |
|
|
99,759 |
|
|
|
(22,880 |
) |
|
|
1,831 |
|
|
|
78,710 |
|
Other operating expenses |
|
|
11,631 |
|
|
|
1,757 |
|
|
|
1,021 |
|
|
|
14,409 |
|
|
|
|
Total benefits and expenses |
|
|
699,106 |
|
|
|
(3,386 |
) |
|
|
2,852 |
|
|
|
698,572 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
$ |
75,288 |
|
|
$ |
(13,478 |
) |
|
$ |
4,342 |
|
|
$ |
66,152 |
|
|
|
|
For the nine months ended September 30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(dollars in thousands) |
|
|
|
Non-Traditional |
|
Total |
|
|
|
|
|
|
Asset- |
|
Financial |
|
U.S. |
|
|
Traditional |
|
Intensive |
|
Reinsurance |
|
Operations |
|
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net premiums |
|
$ |
2,218,726 |
|
|
$ |
4,974 |
|
|
$ |
|
|
|
$ |
2,223,700 |
|
Investment income, net of related expenses |
|
|
294,884 |
|
|
|
149,678 |
|
|
|
588 |
|
|
|
445,150 |
|
Investment related losses, net |
|
|
(65,210 |
) |
|
|
(290,878 |
) |
|
|
(139 |
) |
|
|
(356,227 |
) |
Other revenues |
|
|
570 |
|
|
|
40,757 |
|
|
|
10,702 |
|
|
|
52,029 |
|
|
|
|
Total revenues |
|
|
2,448,970 |
|
|
|
(95,469 |
) |
|
|
11,151 |
|
|
|
2,364,652 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Claims and other policy benefits |
|
|
1,908,418 |
|
|
|
3,090 |
|
|
|
|
|
|
|
1,911,508 |
|
Interest credited |
|
|
44,935 |
|
|
|
100,958 |
|
|
|
|
|
|
|
145,893 |
|
Policy acquisition costs and other
insurance expenses |
|
|
296,480 |
|
|
|
(149,707 |
) |
|
|
700 |
|
|
|
147,473 |
|
Other operating expenses |
|
|
38,115 |
|
|
|
6,341 |
|
|
|
2,160 |
|
|
|
46,616 |
|
|
|
|
Total benefits and expenses |
|
|
2,287,948 |
|
|
|
(39,318 |
) |
|
|
2,860 |
|
|
|
2,251,490 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
$ |
161,022 |
|
|
$ |
(56,151 |
) |
|
$ |
8,291 |
|
|
$ |
113,162 |
|
|
|
|
26
For the nine months ended September 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(dollars in thousands) |
|
|
|
Non-Traditional |
|
Total |
|
|
|
|
|
|
Asset- |
|
Financial |
|
U.S. |
|
|
Traditional |
|
Intensive |
|
Reinsurance |
|
Operations |
|
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net premiums |
|
$ |
2,078,560 |
|
|
$ |
4,779 |
|
|
$ |
|
|
|
$ |
2,083,339 |
|
Investment income, net of related expenses |
|
|
261,300 |
|
|
|
214,141 |
|
|
|
110 |
|
|
|
475,551 |
|
Investment related losses, net |
|
|
(10,292 |
) |
|
|
(64,599 |
) |
|
|
(9 |
) |
|
|
(74,900 |
) |
Other revenues |
|
|
648 |
|
|
|
28,209 |
|
|
|
18,940 |
|
|
|
47,797 |
|
|
|
|
Total revenues |
|
|
2,330,216 |
|
|
|
182,530 |
|
|
|
19,041 |
|
|
|
2,531,787 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Claims and other policy benefits |
|
|
1,710,076 |
|
|
|
6,250 |
|
|
|
1 |
|
|
|
1,716,327 |
|
Interest credited |
|
|
43,694 |
|
|
|
159,939 |
|
|
|
|
|
|
|
203,633 |
|
Policy acquisition costs and other
insurance expenses |
|
|
300,946 |
|
|
|
16,163 |
|
|
|
6,026 |
|
|
|
323,135 |
|
Other operating expenses |
|
|
35,103 |
|
|
|
5,083 |
|
|
|
2,962 |
|
|
|
43,148 |
|
|
|
|
Total benefits and expenses |
|
|
2,089,819 |
|
|
|
187,435 |
|
|
|
8,989 |
|
|
|
2,286,243 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
$ |
240,397 |
|
|
$ |
(4,905 |
) |
|
$ |
10,052 |
|
|
$ |
245,544 |
|
|
|
|
Income (loss) before income taxes for the U.S. operations segment decreased by $77.4 million, or
117.1%, and $132.4 million, or 53.9%, for the three and nine months ended September 30, 2008, as
compared to the same periods in 2007. The decrease for the three and nine month periods can
primarily be attributed to investment related losses associated with investment impairments
recognized in the third quarter of 2008 and the impact of increases in credit spreads on the fair
value of embedded derivatives subject to Issue B36. See the discussion of Investments in the
Liquidity and Capital Resources section of Managements Discussion and Analysis for additional
information on the impairment losses. The decrease in the third quarter was due to an increase in
investment related losses of $76.8 million and the negative effect of Issue B36 of $18.6 million,
after adjustment for deferred acquisition costs. The decrease in the first nine months was due to
an increase in investment related losses of $71.8 million and the negative effect of Issue B36 of
$51.9 million, after adjustment for deferred acquisition costs. Unfavorable mortality experience
in the Traditional sub-segment also contributed to the decrease in income before income taxes for
the three and nine month periods of 2008 compared to 2007. Offsetting these decreases in income
was an increase in net premiums due to growth in total business in force.
Traditional Reinsurance
The U.S. Traditional sub-segment provides life reinsurance to domestic clients for a variety of
life products through yearly renewable term, coinsurance and modified coinsurance agreements.
These reinsurance arrangements may involve either facultative or automatic agreements. This
sub-segment added new business production, measured by face amount of insurance in force, of $30.4
billion and $36.5 billion during the third quarter, and $100.7 billion and $120.9 billion during
the first nine months, of 2008 and 2007, respectively. Management believes industry consolidation
and the established practice of reinsuring mortality risks should continue to provide opportunities
for growth, albeit at rates less than historically experienced.
Income before income taxes for the U.S. Traditional sub-segment decreased by $64.3 million, or
85.5%, and $79.4 million, or 33.0% for the three and nine months ended September 30, 2008, as
compared to the same periods in 2007. The decrease in the third quarter was due to an increase in
investment related losses of $56.6 million and adverse mortality experience compared to the prior
year. The decrease in the first nine months was due to an increase in investment related losses of
$54.9 million and adverse mortality experience compared to the prior year. The increase in
investment related losses for the third quarter and first nine months was due to the aforementioned
investment impairments recognized in the third quarter of 2008.
Net premiums for the U.S. Traditional sub-segment grew $50.1 million, or 7.3%, and $140.2 million,
or 6.7% for the three and nine months ended September 30, 2008, as compared to the same periods in
2007. These increases in net premiums were driven primarily by the growth of total U.S.
Traditional business in force, which totaled $1.3 trillion of face amount as of September 30, 2008.
This represents a 4.3% increase over the amount in force on September 30, 2007.
27
Net investment income increased $10.8 million, or 12.1%, and $33.6 million, or 12.9%, for the three
and nine months ended September 30, 2008, as compared to the same periods in 2007. These increases
can be attributed to growth in the invested asset base and an increase in the average yield earned
on investments. Investment related losses increased $56.6 million and $54.9 million for the three
and nine months ended September 30, 2008, as compared to the same periods in 2007. The increase in
investment related losses for the third quarter and first nine months was due to the aforementioned
investment impairments recognized in the third quarter of 2008.
Investment income and investment related gains and losses are allocated to the various operating
segments based on average assets and related capital levels deemed appropriate to support the
segment business volumes. Investment performance varies with the composition of investments and
the relative allocation of capital to the operating segments.
Claims and other policy benefits as a percentage of net premiums (loss ratios) were 85.4% and
83.0% for the third quarter of 2008 and 2007, respectively, and 86.0% and 82.3% for the nine months
ended September 30, 2008 and 2007, respectively. The increase in these loss ratios is due to an
increase in the total number of claims, including large claims. Claims were approximately $50.0
million higher than expected in the first quarter and approximately $20.0 million higher than
expected in the third quarter of 2008. Although reasonably predictable over a period of years,
death claims can be volatile over shorter periods. Management views recent experience as normal
volatility that is inherent in the business.
Interest credited expense increased $0.4 million, or 2.5%, and $1.2 million, or 2.8%, for the three
and nine months ended September 30, 2008, as compared to the same periods in 2007. These increases
are the result of one treaty that had a slight increase in its asset base with a credited loan rate
remaining constant at 5.6% for 2007 and 2008. Interest credited in this case relates to amounts
credited on cash value products which also have a significant mortality component. The amount of
interest credited fluctuates in step with changes in deposit levels, cash surrender values and
investment performance. Income before income taxes is affected by the spread between the
investment income and the interest credited on the underlying products.
Policy acquisition costs and other insurance expenses as a percentage of net premiums were 14.5%
and 14.4% for the third quarter of 2008 and 2007, respectively, and 13.4% and 14.5% for the nine
months ended September 30, 2008 and 2007, respectively. Overall, while these ratios are expected
to remain in a predictable range, they may fluctuate from period to period due to varying allowance
levels within coinsurance-type arrangements. In addition, the amortization pattern of previously
capitalized amounts, which are subject to the form of the reinsurance agreement and the underlying
insurance policies, may vary. Finally, the mix of first year coinsurance business versus yearly
renewable term business can cause the percentage to fluctuate from period to period.
Other operating expenses increased $1.1 million, or 9.7%, and $3.0 million, or 8.6% for the three
and nine months ended September 30, 2008, as compared to the same periods in 2007. Other operating
expenses, as a percentage of net premiums, remained relatively constant at 1.7%, for the third
quarter and nine months ended September 30, 2008 and 2007. The expense ratio can fluctuate from
period to period.
Asset-Intensive Reinsurance
The U.S. Asset-Intensive sub-segment assumes investment risk within underlying annuities and
corporate-owned life insurance policies. Most of these agreements are coinsurance, coinsurance
with funds withheld or modified coinsurance of non-mortality risks whereby the Company recognizes
profits or losses primarily from the spread between the investment income earned and the interest
credited on the underlying deposit liabilities.
Income (loss) before income taxes for this sub-segment decreased by $11.5 million, and $51.2
million for the three and nine months ended September 30, 2008, as compared to the same periods in
2007. The decrease for the three and nine month period can be primarily attributed to the
unfavorable change in the value of embedded derivatives, after adjustment for deferred acquisition
costs under Issue B36. The decrease in income before income taxes related to Issue B36 was $18.6
million and $51.9 million for the three and nine months ended September 30, 2008, as compared to
the same periods in 2007. Largely offsetting the decrease in income in the third quarter was a
$9.7 million decrease in the present value calculations of embedded derivatives associated with
EIAs, after adjustment for related deferred acquisition costs and retrocession.
In accordance with the provisions of Issue B36, the Company recorded a gross change in value of
embedded derivatives of $(106.8) million and $(266.8) million for the three and nine months ended
September 30 2008, within
28
investment related losses, net. The amount represents a non-cash, unrealized change in value,
offset in part by a reduction in policy acquisition costs and other insurance expenses associated
with an adjustment of related deferred acquisition costs totaling $74.4 million and $200.2 million,
respectively, for a total net contribution quarter-to-date of $32.4 million and year-to-date of
$66.6 million to the loss before income taxes. Significant fluctuations may occur as the fair
value of the embedded derivatives is tied primarily to the movements in credit spreads. For the
three and nine months, ended September 30, 2008, weighted average asset credit spreads widened by
approximately 0.47% and 1.16%, respectively. Additionally, the Company uses risk free rates, in
accordance with FAS 157, to discount the fair value of estimated future equity option purchases
associated with its reinsurance of EIAs (a component of the embedded derivative), which affects the
fair value of the embedded derivative liability. In the third quarter of 2008, the Company recorded
a decrease in the fair value of the embedded liability of $43.9 million, which was recorded as a
reduction of interest credited, offset by related deferred acquisition costs and retrocession of
$(34.2) million for a net gain before income taxes of $9.7 million. For the nine months ended
September 30, 2008, the Company recorded an increase in the fair value of the embedded liability of
$11.4 million, which was recorded as expense within interest credited, offset by related deferred
acquisition costs and retrocession of $(8.4) million for a net loss before income taxes of $3.0
million. These fluctuations do not affect current cash flows, crediting rates or spread
performance on the underlying treaties. Therefore, Company management believes it is helpful to
distinguish between the effects of changes in these embedded derivatives and the primary factors
that drive profitability of the underlying treaties, namely investment income, fee income, and
interest credited. Additionally, over the expected life of the underlying treaties, management
expects the cumulative effect of the impact of changes in risk free rates used in the present value
calculations of embedded derivatives associated with EIAs and Issue B36 to be immaterial.
Excluding the impact of changes in risk free rates and credit spreads used in the present value
calculations of embedded derivatives associated with EIAs and Issue B36, income before income taxes
decreased $2.5 million and increased $3.6 million for the three and nine months ended September 30,
2008, as compared to the same periods in 2007. The decrease quarter over quarter can be primarily
attributed to an increase in investment related losses, net of related deferred acquisition costs,
of $6.0 million primarily related to guaranteed minimum living benefits riders associated with the
Companys variable annuity products. The increase for the nine month period can be attributed to
continued growth in business and improved mortality experience in a single universal life treaty
for the comparable periods. These gains were partially offset by poor performance in equity
markets and higher investment related losses, net of deferred acquisition costs associated with
guaranteed minimum benefits riders.
Total revenues, which are comprised primarily of investment income and investment related losses,
net, decreased $54.9 million and $278.0 million for the three and nine months ended September 30,
2008, as compared to the same periods in 2007. The losses associated with embedded derivatives
subject to Issue B36, which are included in investment related losses, net, represented $53.8
million and $209.5 million of the decreases for the third quarter and nine month periods,
respectively. Excluding the losses associated with embedded derivatives subject to Issue B36,
revenue decreased $(1.1) million and $(68.5) million for the third quarter and nine month periods,
respectively. The decrease for the third quarter can be largely attributed to an increase in
investment related losses of $20.1 million almost entirely related to guaranteed minimum living
benefits riders. These losses were partially offset by related deferred acquisition costs. The
decrease in the first nine months can be primarily attributed to a drop in investment income
related to option income on a funds withheld treaty. The decrease in investment income related to
options is mostly offset by a corresponding decrease in interest credited. Investment related
losses associated with guaranteed minimum death benefits also increased in the first nine months.
The average invested asset base supporting this sub-segment grew to $5.3 billion in the third
quarter of 2008 from $4.8 billion in the third quarter of 2007. The growth in the asset base is
driven by new business written on existing equity indexed and variable annuity treaties. In
addition, a new fixed annuity transaction was executed in the second quarter of 2008 and a new
guaranteed investment contract was executed in the third quarter of 2008, together adding
approximately $700.0 million to the asset base of this sub-segment. Invested assets outstanding
were $5.4 billion as of September 30, 2008 compared to $4.8 billion in 2007. As of September 30,
2008, $3.6 billion of the invested assets were funds withheld at interest, of which 90.1% is
associated with one client. As of September 30, 2007, $3.5 billion of the invested assets were
funds withheld at interest, of which 91.1% of the balance was associated with one client.
29
Total benefits and expenses, which are comprised primarily of interest credited and policy
acquisition costs, decreased $43.5 million and $226.8 million for the three and nine months ended
September 30, 2008, as compared to the same periods in 2007. Contributing to these decreases was a
reduction in expenses related to embedded
derivatives subject to Issue B36 of $35.2 million and $157.6 million, coupled with decrease in
interest credited of $21.5 million and $59.0 million for the three and nine month periods,
respectively. As mentioned above, a large part of the decrease in interest credited relates to
market value changes in certain equity indexed annuity products and is offset in investment income.
Financial Reinsurance
The U.S. Financial Reinsurance sub-segment income consists primarily of net fees earned on
financial reinsurance transactions. The majority of the financial reinsurance risks are assumed by
the U.S. segment and retroceded to other insurance companies or brokered business in which the
Company does not participate in the assumption of risk. The fees earned from financial reinsurance
contracts are reflected in other revenues, and the fees paid to retrocessionaires are reflected in
policy acquisition costs and other insurance expenses. Fees earned on brokered business are
reflected in other revenues.
Income before income taxes decreased by $1.6 million, or 37.8%, and $1.8 million, or 17.5%, for the
three and nine months ended September 30, 2008, as compared to the same periods in 2007. The
decrease in the three and nine month periods can be primarily attributed to one treaty which was
recaptured in the third quarter of 2007. At September 30, 2008 and 2007, the amount of reinsurance
provided, as measured by pre-tax statutory surplus, was $0.5 billion and $0.5 billion,
respectively. The pre-tax statutory surplus amounts indicated include all business assumed or
brokered by the Company in the U.S. Fees earned from this business can vary significantly
depending on the size of the transactions and the timing of their completion and therefore can
fluctuate from period to period.
CANADA OPERATIONS
The Company conducts reinsurance business in Canada through RGA Life Reinsurance Company of Canada
(RGA Canada), a wholly-owned subsidiary. RGA Canada assists clients with capital management
activity and mortality and morbidity risk management, and is primarily engaged in traditional
individual life reinsurance, as well as creditor, critical illness, and group life and health
reinsurance. Creditor insurance covers the outstanding balance on personal, mortgage or commercial
loans in the event of death, disability or critical illness and is generally shorter in duration
than traditional life insurance.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(dollars in thousands) |
|
For the three months ended |
|
For the nine months ended |
|
|
September 30, |
|
September 30, |
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
|
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net premiums |
|
$ |
128,930 |
|
|
$ |
123,676 |
|
|
$ |
407,452 |
|
|
$ |
345,748 |
|
Investment income, net of related expenses |
|
|
35,836 |
|
|
|
31,057 |
|
|
|
107,561 |
|
|
|
89,852 |
|
Investment related gains (losses), net |
|
|
(1,183 |
) |
|
|
2,713 |
|
|
|
(1,264 |
) |
|
|
7,145 |
|
Other revenues |
|
|
4,289 |
|
|
|
1 |
|
|
|
17,506 |
|
|
|
180 |
|
|
|
|
Total revenues |
|
|
167,872 |
|
|
|
157,447 |
|
|
|
531,255 |
|
|
|
442,925 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Claims and other policy benefits |
|
|
104,339 |
|
|
|
106,416 |
|
|
|
353,756 |
|
|
|
303,231 |
|
Interest credited |
|
|
77 |
|
|
|
170 |
|
|
|
297 |
|
|
|
541 |
|
Policy acquisition costs and other
insurance expenses |
|
|
27,591 |
|
|
|
23,118 |
|
|
|
79,543 |
|
|
|
62,937 |
|
Other operating expenses |
|
|
6,132 |
|
|
|
4,945 |
|
|
|
17,477 |
|
|
|
14,182 |
|
|
|
|
Total benefits and expenses |
|
|
138,139 |
|
|
|
134,649 |
|
|
|
451,073 |
|
|
|
380,891 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
$ |
29,733 |
|
|
$ |
22,798 |
|
|
$ |
80,182 |
|
|
$ |
62,034 |
|
|
|
|
Income before income taxes increased by $6.9 million, or 30.4%, and $18.1 million or 29.3%, for the
three and nine months ended September 30 2008, as compared to the same periods in 2007. The
increase in the third quarter of 2008 was primarily due to income of $4.3 million from the
recapture of a previously assumed block of individual life business as well as higher premium
volume and favorable mortality experience, offset by a decrease of $3.9 million in investment
related gains and losses, net. In the first nine months of 2008, strength in the Canadian dollar
resulted in an increase in income before income taxes of $6.8 million. The remaining increase in
the first nine
30
months of 2008 was due to the $4.3 million from the third quarter recapture and $2.5
million from the recapture of a previously retroceded block of creditor business, in addition to
higher premium volume and favorable mortality experience. This increase was largely offset by a
decrease of $8.4 million in investment related gains and losses, net.
Net premiums grew by $5.3 million, or 4.2%, and $61.7 million, or 17.8%, for the three and nine
months ended September 30, 2008, as compared to the same periods in 2007. A stronger Canadian
dollar resulted in an increase in net premiums of approximately $0.6 million and $31.8 million in
the third quarter and first nine months of 2008, respectively. The remaining increases are
primarily due to new business from both new and existing treaties. In addition, increases in
premiums from creditor treaties contributed $0.4 million and $11.8 million in the third quarter and
first nine months of 2008, respectively. Creditor and group life and health premiums represented
19.7% and 19.7% of net premiums in the third quarter and first nine months of 2008, respectively.
Premium levels can be significantly influenced by large transactions, mix of business and reporting
practices of ceding companies and therefore may fluctuate from period to period.
Net investment income increased $4.8 million, or 15.4%, and $17.7 million, or 19.7%, for the three
and nine months ended September 30, 2008, as compared to the same periods in 2007. A stronger
Canadian dollar resulted in an increase in net investment income of approximately $0.1 million and
$8.3 million in the third quarter and first nine months of 2008, respectively. Investment income
and investment related gains and losses are allocated to the segments based upon average assets and
related capital levels deemed appropriate to support the segment business volumes. Investment
performance varies with the composition of investments and the relative allocation of capital to
the operating segments. The increase in investment income was mainly the result of an increase in
the allocated asset base due to growth in the underlying business volume.
Other revenues increased by $4.3 million, and $17.3 million, for the three and nine months ended
September 30, 2008, as compared to the same periods in 2007. The increase in the third quarter of
2008 was primarily due to a fee earned of $3.3 million from the recapture of a previously assumed
block of individual life business. The increase in the first nine months of 2008 was due to the
$3.3 million from the third quarter recapture and $12.9 million from the recapture of a previously
retroceded block of creditor business.
Loss ratios for this segment were 80.9% and 86.0% for the third quarter of 2008 and 2007,
respectively, and 86.8% and 87.7% for the nine months ended September 30, 2008 and 2007,
respectively. The loss ratios on creditor reinsurance business are normally lower than traditional
reinsurance, while allowances are normally higher as a percentage of premiums. Excluding creditor
business and the aforementioned recaptures, the loss ratios for this segment were 89.1% and 96.2%
for the third quarter of 2008 and 2007, respectively, and 93.3% and 97.1% for the nine months ended
September 30, 2008 and 2007. The decrease in the loss ratio in the third quarter of 2008 is
primarily the result of favorable mortality and the release of assumed claims incurred and reserves
of $6.0 million related to the recapture of a previously assumed block of individual life business.
The decrease in the first nine months of 2008 is primarily the result of favorable mortality and
the release of assumed claims incurred and reserves of $6.0 million related to the recapture of a
previously assumed block of individual life business, offset by the release of retroceded reserves
of $10.4 million from the recapture of a previously retroceded block of creditor business.
Historically, the loss ratio increased primarily as the result of several large permanent level
premium in force blocks assumed in 1997 and 1998. These blocks are mature blocks of permanent
level premium business in which mortality as a percentage of net premiums is expected to be higher
than historical ratios. The nature of permanent level premium policies requires the Company to set
up actuarial liabilities and invest the amounts received in excess of early-year mortality costs to
fund claims in the later years when premiums, by design, continue to be level as compared to
expected increasing mortality or claim costs. Claims and other policy benefits, as a percentage of
net premiums and investment income were 63.3% and 68.8% in the third quarter of 2008 and 2007,
respectively, and 68.7% and 69.6% for the nine months ended September 30, 2008 and 2007,
respectively.
Policy acquisition costs and other insurance expenses as a percentage of net premiums were 21.4%
and 18.7% for the third quarter of 2008 and 2007, respectively, and 19.5% and 18.2% for the nine
months ended September 30, 2008 and 2007, respectively. Excluding foreign exchange and creditor
business, policy acquisition costs and other insurance expenses as a percentage of net premiums
were 14.2% and 11.4% for the third quarter of 2008 and 2007, respectively, and 12.6% and 12.4% for
the nine months ended September 30, 2008 and 2007, respectively. Overall, while these ratios are
expected to remain in a predictable range, they may fluctuate from period to period due to varying
allowance levels, significantly caused by the mix of first year coinsurance business versus yearly
renewable
31
term business. In addition, the amortization pattern of previously capitalized amounts,
which are subject to the form of the reinsurance agreement and the underlying insurance policies,
may vary.
Other operating expenses increased $1.2 million, or 24.0%, and $3.3 million, or 23.2%, for the
three and nine months ended September 30, 2008, as compared to the same periods in 2007. A
stronger Canadian dollar
contributed approximately $1.1 million to the increase in other operating expenses in the first
nine months of 2008. Other operating expenses as a percentage of net premiums were 4.8% and 4.0%
for the third quarter of 2008 and 2007, respectively, and 4.3% and 4.1% for the nine months ended
September 30, 2008 and 2007, respectively.
EUROPE & SOUTH AFRICA OPERATIONS
The Europe & South Africa segment has operations in France, Germany, India, Italy, Mexico, Poland,
Spain, South Africa and the United Kingdom (UK). The segment provides life reinsurance for a
variety of products through yearly renewable term and coinsurance agreements, and reinsurance of
critical illness coverage. Reinsurance agreements may be either facultative or automatic
agreements covering primarily individual risks and in some markets, group risks.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(dollars in thousands) |
|
For the three months ended |
|
For the nine months ended |
|
|
September 30, |
|
September 30, |
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
|
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net premiums |
|
$ |
176,184 |
|
|
$ |
170,774 |
|
|
$ |
550,870 |
|
|
$ |
503,366 |
|
Investment income, net of related expenses |
|
|
9,065 |
|
|
|
5,569 |
|
|
|
25,394 |
|
|
|
18,446 |
|
Investment related losses, net |
|
|
(4,703 |
) |
|
|
(863 |
) |
|
|
(4,089 |
) |
|
|
(1,717 |
) |
Other revenues |
|
|
33 |
|
|
|
(43 |
) |
|
|
161 |
|
|
|
61 |
|
|
|
|
Total revenues |
|
|
180,579 |
|
|
|
175,437 |
|
|
|
572,336 |
|
|
|
520,156 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Claims and other policy benefits |
|
|
122,521 |
|
|
|
127,281 |
|
|
|
425,516 |
|
|
|
370,263 |
|
Interest credited |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
1,019 |
|
Policy acquisition costs and other
insurance expenses |
|
|
21,559 |
|
|
|
22,592 |
|
|
|
54,815 |
|
|
|
65,781 |
|
Other operating expenses |
|
|
15,708 |
|
|
|
13,872 |
|
|
|
48,130 |
|
|
|
38,434 |
|
|
|
|
Total benefits and expenses |
|
|
159,788 |
|
|
|
163,748 |
|
|
|
528,461 |
|
|
|
475,497 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
$ |
20,791 |
|
|
$ |
11,689 |
|
|
$ |
43,875 |
|
|
$ |
44,659 |
|
|
|
|
Income before income taxes increased by $9.1 million, or 77.9%, and decreased by $0.8 million, or
1.8%, for the three and nine months ended September 30, 2008, as compared to the same periods in
2007. The increase for the third quarter was primarily due to an increase in net premiums as well
as a decrease to claims and other policy benefits and a decrease to policy acquisition costs and
other insurance expenses. During the third quarter ended September 30, 2008 and the nine months
ended September 30, 2008, a block of business was recaptured that increased income before income
taxes by $8.7 million in these periods. The decrease in the first nine months of 2008 compared to
2007 was primarily due to adverse claims experience in the first quarter of 2008, partially offset
by increased net premiums and decreased policy acquisition costs and other insurance expenses in
the third quarter of 2008. Unfavorable foreign currency exchange fluctuations resulted in a
decrease to income before income taxes totaling approximately $2.0 million and $0.7 million for the
third quarter and first nine months of 2008, respectively.
Net premiums grew $5.4 million, or 3.2%, and $47.5 million, or 9.4%, for the three and nine months
ended September 30, 2008, as compared to the same periods in 2007. These increases were primarily
the result of new business from both new and existing treaties. During the third quarter ended
September 30, 2008 and the nine months ended September 30, 2008, a block of business was recaptured
that decreased net premiums by $3.2 million and $0.4 million, respectively. During 2008, there was
an unfavorable foreign currency exchange fluctuation, particularly from the British pound and the
South African rand weakening against the U.S. dollar, which decreased net premiums by approximately
$9.4 million in the third quarter of 2008, and $4.5 million for the nine months ended September 30,
2008, as compared to the same periods in 2007.
32
A significant portion of the net premiums for the segment, in each period presented, relates to
reinsurance of critical illness coverage, primarily in the UK. This coverage provides a benefit in
the event of the diagnosis of a pre-defined critical illness. Net premiums earned from this
coverage totaled $59.2 million and $59.6 million in the third quarter of 2008 and 2007,
respectively, and $187.0 million and $174.5 million for the nine months ended September 30, 2008
and 2007, respectively. Premium levels are significantly influenced by large transactions and
reporting practices of ceding companies and therefore can fluctuate from period to period.
Net investment income increased $3.5 million, or 62.8%, and $6.9 million, or 37.7%, for the three
and nine months ended September 30, 2008, as compared to the same periods in 2007. These increases
can be attributed to growth in the invested asset base and increased portfolio return. Investment
income and investment related gains and losses are allocated to the various operating segments
based on average assets and related capital levels deemed appropriate to support the segment
business volumes. Investment performance varies with the composition of investments and the
relative allocation of capital to the operating segments.
Loss ratios for this segment were 69.5% and 74.5% for the third quarter of 2008 and 2007,
respectively, and 77.2% and 73.6% for the nine months ended September 30, 2008 and 2007,
respectively. During the third quarter ended September 30, 2008 and the nine months ended
September 30, 2008 a block of business was recaptured. Excluding this recapture, loss ratios for
this segment were 79.3% and 79.6% for the third quarter and first nine months of 2008,
respectively. The increase in the loss ratio for the nine months ended September 30, 2008 was
primarily due to unfavorable claims experience in the UK and South Africa during the first quarter,
while the prior year reflected favorable mortality experience.
Policy acquisition costs and other insurance expenses as a percentage of net premiums were 12.2%
and 13.2% for the third quarter of 2008 and 2007, respectively, and 10.0% and 13.1% for the nine
months ended September 30, 2008 and 2007, respectively. During the third quarter ended September
30, 2008 and the nine months ended September 30, 2008 a block of business was recaptured.
Excluding this recapture, policy acquisition costs and other insurance expenses as a percentage of
net premiums were 9.1% and 8.8% for the third quarter and first nine months of 2008, respectively.
These percentages fluctuate due to timing of client company reporting, variations in the mixture of
business being reinsured and the relative maturity of the business. In addition, as the segment
grows, renewal premiums, which have lower allowances than first-year premiums, represent a greater
percentage of the total net premiums.
Other operating expenses increased $1.8 million, or 13.2%, and $9.7 million, or 25.2%, for the
three and nine months ended September 30, 2008, as compared to the same periods in 2007. Other
operating expenses as a percentage of net premiums totaled 8.9% and 8.1% for the third quarter of
2008 and 2007, respectively, and 8.7% and 7.6% for the nine months ended September 30, 2008 and
2007, respectively. These increases were due to higher costs associated with maintaining and
supporting the segments increase in business over the past several years and the Companys recent
expansion into central Europe. The Company believes that sustained growth in net premiums should
lessen the burden of start-up expenses and expansion costs over time.
ASIA PACIFIC OPERATIONS
The Asia Pacific segment has operations in Australia, Hong Kong, Japan, Malaysia, Singapore, New
Zealand, South Korea, Taiwan and mainland China. The principal types of reinsurance for this
segment include life, critical illness, disability income, superannuation, and financial
reinsurance. Superannuation is the Australian government mandated compulsory retirement savings
program. Superannuation funds accumulate retirement funds for employees, and in addition, offer
life and disability insurance coverage. Reinsurance agreements may be either facultative or
automatic agreements covering primarily individual risks and in some markets, group risks.
33
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(dollars in thousands) |
|
For the three months ended |
|
For the nine months ended |
|
|
September 30, |
|
September 30, |
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
|
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net premiums |
|
$ |
254,497 |
|
|
$ |
240,476 |
|
|
$ |
773,148 |
|
|
$ |
626,285 |
|
Investment income, net of related expenses |
|
|
12,272 |
|
|
|
9,134 |
|
|
|
36,083 |
|
|
|
26,407 |
|
Investment related losses, net |
|
|
(3,821 |
) |
|
|
(367 |
) |
|
|
(4,817 |
) |
|
|
(937 |
) |
Other revenues |
|
|
2,811 |
|
|
|
2,105 |
|
|
|
7,214 |
|
|
|
6,515 |
|
|
|
|
Total revenues |
|
|
265,759 |
|
|
|
251,348 |
|
|
|
811,628 |
|
|
|
658,270 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Claims and other policy benefits |
|
|
201,707 |
|
|
|
197,827 |
|
|
|
620,387 |
|
|
|
499,974 |
|
Policy acquisition costs and other insurance expenses |
|
|
25,053 |
|
|
|
22,833 |
|
|
|
81,520 |
|
|
|
75,620 |
|
Other operating expenses |
|
|
17,774 |
|
|
|
13,448 |
|
|
|
48,677 |
|
|
|
39,495 |
|
|
|
|
Total benefits and expenses |
|
|
244,534 |
|
|
|
234,108 |
|
|
|
750,584 |
|
|
|
615,089 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
$ |
21,225 |
|
|
$ |
17,240 |
|
|
$ |
61,044 |
|
|
$ |
43,181 |
|
|
|
|
Income before income taxes increased by $4.0 million, or 23.1%, and $17.9 million, or 41.4%, for
the three and nine months ended September 30, 2008, as compared to the same periods in 2007.
Favorable results from operations throughout the segment, primarily due to increased net premiums,
contributed to the increase in income before income taxes for the third quarter and first nine
months of 2008, as compared to the same periods in 2007. Favorable foreign currency exchange
fluctuations resulted in an increase to income before income taxes totaling approximately $1.0
million and $5.4 million for the third quarter and first nine months of 2008, respectively.
Net premiums grew $14.0 million, or 5.8%, and $146.9 million, or 23.4%, for the three and nine
months ended September 30, 2008, as compared to the same periods in 2007. This premium growth was
primarily the result of increases in the volume of business in Australia, Taiwan and Japan.
Premiums in Australia increased by $37.7 million in the third quarter of 2008, and $72.7 million
for the nine months ended September 30, 2008, as compared to the same periods in 2007. Premiums in
Taiwan increased by $6.8 million in the third quarter of 2008, and $23.5 million for the nine
months ended September 30, 2008, as compared to the same periods in 2007. Premiums in Japan
increased by $4.0 million in the third quarter of 2008, and $6.8 million for the nine months ended
September 30, 2008, as compared to the same periods in 2007. Premium levels are significantly
influenced by large transactions and reporting practices of ceding companies and can fluctuate from
period to period.
Foreign currencies in certain significant markets, particularly the Australian dollar, Taiwanese
dollar and the Japanese yen, have strengthened against the U.S. dollar during 2008 compared to
2007. The overall effect of changes in local Asia Pacific segment currencies was an increase in
net premiums of approximately $3.0 million and $34.0 million for the third quarter and first nine
months of 2008, respectively.
A portion of the net premiums for the segment, in each period presented, relates to reinsurance of
critical illness coverage. This coverage provides a benefit in the event of the diagnosis of a
pre-defined critical illness. Reinsurance of critical illness in the Asia Pacific operations is
offered primarily in South Korea, Australia and Hong Kong. Net premiums earned from this coverage
totaled $52.0 million and $58.3 million in the third quarter of 2008 and 2007, respectively, and
$165.2 million and $140.9 million for the first nine months of 2008 and 2007, respectively.
Net investment income increased $3.1 million, or 34.4%, and $9.7 million, or 36.6%, for the three
and nine months ended September 30, 2008, as compared to the same periods in 2007. These increases
can be attributed to growth in the invested asset base and increased portfolio return. Investment
income and investment related gains and losses are allocated to the various operating segments
based on average assets and related capital levels deemed appropriate to support the segment
business volumes. Investment performance varies with the composition of investments and the
relative allocation of capital to the operating segments.
Other revenues increased by $0.7 million, or 33.5%, and $0.7 million, or 10.7%, for the three and
nine months ended September 30, 2008, as compared to the same periods in 2007. The primary source
of other revenues is fees from financial reinsurance treaties in Japan. At September 30, 2008 and
2007, the amount of reinsurance assumed from client companies, as measured by pre-tax statutory
surplus, was $0.6 billion and $0.7 billion, respectively.
34
Fees earned from this business can vary
significantly depending on the size of the transactions and the timing of their completion and
therefore can fluctuate from period to period.
Loss ratios for this segment were 79.3% and 82.3% for the third quarter of 2008 and 2007,
respectively, and 80.2% and 79.8% for the nine months ended September 30, 2008 and 2007,
respectively. The decrease in the loss ratio for the third quarter of 2008 when compared to 2007
was largely due to more favorable mortality experience in 2008 compared to 2007. The increase in
the loss ratio for the first nine months of 2008 when compared with prior year is
also related to mortality experience. While the 2007 ratio was slightly better than in 2008, there
were no material claims or benefit movements when comparing the two years results. Loss ratios
will fluctuate due to timing of client company reporting, variations in the mixture of business
being reinsured and the relative maturity of the business.
Policy acquisition costs and other insurance expenses as a percentage of net premiums were 9.8% and
9.5% for the third quarter of 2008 and 2007, respectively, and 10.5% and 12.1% for the nine months
ended September 30, 2008 and 2007, respectively. The ratio of policy acquisition costs and other
insurance expenses as a percentage of net premiums should generally decline as the business
matures; however, the percentage does fluctuate periodically due to timing of client company
reporting and variations in the mixture of business being reinsured.
Other operating expenses increased $4.3 million, or 32.2%, and $9.2 million, or 23.2%, for the
three and nine months ended September 30, 2008, as compared to the same periods in 2007. Other
operating expenses as a percentage of net premiums totaled 7.0% and 5.6% for the third quarter of
2008 and 2007, respectively, and 6.3% for the nine months ended September 30, 2008 and 2007. The
timing of premium flows and the level of costs associated with the entrance into and development of
new markets in the growing Asia Pacific segment may cause other operating expenses as a percentage
of net premiums to fluctuate over periods of time.
CORPORATE AND OTHER
Corporate and Other revenues include investment income from invested assets not allocated to
support segment operations and undeployed proceeds from the Companys capital raising efforts, in
addition to unallocated investment related gains and losses. Corporate expenses consist of the
offset to capital charges allocated to the operating segments within the policy acquisition costs
and other insurance expenses line item, unallocated overhead and executive costs, and interest
expense related to debt and the $225.0 million of 5.75% Company-obligated mandatorily redeemable
trust preferred securities. Additionally, Corporate and Other includes results from RGA Technology
Partners, Inc., a wholly-owned subsidiary that develops and markets technology solutions for the
insurance industry, the Companys Argentine privatized pension business, which is currently in
run-off, the investment income and expense associated with the Companys collateral finance
facility and an insignificant amount of direct insurance operations in Argentina.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(dollars in thousands) |
|
For the three months ended |
|
For the nine months ended |
|
|
September 30, |
|
September 30, |
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
|
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net premiums |
|
$ |
1,758 |
|
|
$ |
1,038 |
|
|
$ |
5,040 |
|
|
$ |
2,265 |
|
Investment income, net of related expenses |
|
|
19,165 |
|
|
|
26,616 |
|
|
|
60,454 |
|
|
|
70,847 |
|
Investment related gains (losses), net |
|
|
(37,119 |
) |
|
|
247 |
|
|
|
(37,249 |
) |
|
|
(11,568 |
) |
Other revenues |
|
|
1,978 |
|
|
|
1,484 |
|
|
|
5,052 |
|
|
|
7,084 |
|
|
|
|
Total revenues |
|
|
(14,218 |
) |
|
|
29,385 |
|
|
|
33,297 |
|
|
|
68,628 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Claims and other policy benefits |
|
|
83 |
|
|
|
189 |
|
|
|
120 |
|
|
|
217 |
|
Policy acquisition costs and other insurance expenses |
|
|
(11,775 |
) |
|
|
(8,172 |
) |
|
|
(32,981 |
) |
|
|
(27,395 |
) |
Other operating expenses |
|
|
8,602 |
|
|
|
10,610 |
|
|
|
28,323 |
|
|
|
34,066 |
|
Interest expense |
|
|
9,935 |
|
|
|
9,860 |
|
|
|
54,609 |
|
|
|
53,545 |
|
Collateral finance facility expense |
|
|
6,851 |
|
|
|
13,047 |
|
|
|
21,291 |
|
|
|
38,940 |
|
|
|
|
Total benefits and expenses |
|
|
13,696 |
|
|
|
25,534 |
|
|
|
71,362 |
|
|
|
99,373 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
$ |
(27,914 |
) |
|
$ |
3,851 |
|
|
$ |
(38,065 |
) |
|
$ |
(30,745 |
) |
|
|
|
35
Loss before income taxes increased by $31.8 million and $7.3 million for the three and nine months
ended September 30, 2008, as compared to the same periods in 2007. The increase for the third
quarter is primarily due to a $37.4 million increase in investment related losses, due to
investment impairments, a $7.5 million decrease in investment income, offset in large part by a
$6.2 million decrease in collateral finance facility expense, a $3.6 million decrease in policy
acquisition costs and other insurance expenses and a $2.0 million decrease in other operating
expenses. The increase for the first nine months is primarily due to a $25.7 million increase in
investment related losses, a $10.4 million decrease in investment income, largely offset by a $17.6
million decrease in collateral
finance facility expense, a $5.6 million decrease in policy acquisition costs and other insurance
expenses and a $5.7 million decrease in other operating expenses.
Total revenues decreased by $43.6 million and $35.3 million for the three and nine months ended
September 30, 2008, as compared to the same periods in 2007. The decrease for the third quarter
was due to a $7.5 million decrease in net investment income largely due to lower investment returns
on variable investments used to fund the Companys collateral finance facility and a $37.4 million
increase in investment related losses due to investment impairments. The decrease for the nine
month period was due to a $10.4 million decrease in net investment income largely due to lower
investment returns on variable investments used to fund the Companys collateral finance facility
and a $25.7 million increase in investment related losses due to investment impairments as compared
to the recognition of a $10.5 million currency translation loss in the first quarter of 2007
related to the Companys decision to sell its direct insurance operations in Argentina.
Total benefits and expenses decreased by $11.8 million and $28.0 million for the three and nine
months ended September 30, 2008, as compared to the same periods in 2007. The decrease for the
third quarter was primarily due to a $6.2 million decrease in collateral finance facility expense
due to substantially reduced variable interest rates in the current year. Policy acquisition costs
and other insurance expenses also decreased $3.6 million in the third quarter, primarily due to
increased charges to the operating segments for the use of capital and decreased other operating
expenses of $2.0 million, primarily related to a decrease in equity based compensation. The
decrease for the nine month period was primarily due to a $17.6 million decrease in collateral
finance facility expense due to substantially reduced variable interest rates in the current year.
Additionally, other operating expenses decreased $5.7 million in 2008 primarily related to a
decrease in equity based compensation; policy acquisition costs and other insurance expenses
decreased $5.6 million, primarily due to increased charges to the operating segments for the use of
capital; and interest expense increased $1.1 million, primarily due to lower interest provisions
for income taxes related to FIN 48.
Discontinued Operations
The discontinued accident and health operations reported losses, net of taxes, of less than $0.1
million and $4.3 million in the third quarter of 2008 and 2007, respectively, and $5.2 million and
$6.5 million for the first nine months of 2008 and 2007, respectively. The loss for the first nine
months of 2008 was due to the settlement of a disputed claim in which the Company paid $5.8 million
in excess of the amount held in reserve in the first quarter of 2008. The calculation of the claim
reserve liability for the entire portfolio of accident and health business requires management to
make estimates and assumptions that affect the reported claim reserve levels. As of September 30,
2008, there are no arbitrations or claims disputes associated with the Companys discontinued
accident and health operations, and the remaining runoff activity of this business is not
significant.
Liquidity and Capital Resources
The Holding Company
RGA is a holding company whose primary uses of liquidity include, but are not limited to, the
immediate capital needs of its operating companies associated with the Companys primary
businesses, dividends paid by RGA to its shareholders, interest payments on its indebtedness, and
repurchases of RGA common stock under a plan approved by the board of directors. The primary
sources of RGAs liquidity include proceeds from its capital raising efforts, interest income on
undeployed corporate investments, interest income received on surplus notes with two operating
subsidiaries, and dividends from operating subsidiaries. As the Company continues its expansion
efforts, RGA will continue to be dependent on these sources of liquidity.
The Company believes that it has sufficient liquidity to fund its cash needs under various
scenarios that include the potential risk of the early recapture of a reinsurance treaty by the
ceding company and significantly higher than
36
expected death claims. Historically, the Company has
generated positive net cash flows from operations. However, in the event of significant
unanticipated cash requirements beyond normal liquidity, the Company has multiple liquidity
alternatives available based on market conditions and the amount and timing of the liquidity need.
These options include borrowings under committed credit facilities, secured borrowings, the ability
to issue long-term debt, capital securities or common equity and, if necessary, the sale of
invested assets.
On October 30, 2008, the Company announced it priced a public offering of 8,900,000 shares of its
class A common stock at $33.89 per share. The public offering was made in conjunction with the
decision by the Standard & Poors Corporation to include the Company in the S&P MidCap 400 Index.
Additionally, on October 30, 2008, the
Company was notified of the underwriters election to exercise a 30-day option to purchase an
additional 1,335,000 shares at the public offering price. The Company expects to use the estimated
$331.6 million in net proceeds from the offering to pursue reinsurance opportunities and for
general corporate purposes. The offering is scheduled to be completed on November 4, 2008.
Cash Flows
The Companys net cash flows provided by operating activities for the periods ended September 30,
2008 and 2007 were $465.1 million and $658.4 million, respectively. Cash flows from operating
activities are affected by the timing of premiums received, claims paid, and working capital
changes. The $193.3 million net decrease in operating cash flows during the nine months of 2008
compared to the same period in 2007 was primarily a result of cash outflows related to claims,
acquisition costs, income taxes and other operating expenses increasing more than cash inflows
related to premiums and investment income. Cash from premiums and investment income increased
$372.8 million and decreased $16.1 million, respectively, but was more than offset in total by
higher operating cash outlays of $550.0 million for the current nine month period. The Company
believes the short-term cash requirements of its business operations will be sufficiently met by
the positive cash flows generated. Additionally, the Company believes it maintains a high quality
fixed maturity portfolio that can be sold, if necessary, to meet the Companys short- and long-term
obligations.
Net cash used in investing activities was $845.3 million and $543.5 million in the first nine
months of 2008 and the comparable prior-year period, respectively. This increase is largely
related to the investment of two large deposits of approximately $540.2 million received on
investment type contracts in 2008 largely offset by the investment in 2007 of $295.3 million of the
net proceeds from the Companys issuance of senior notes. The sales and purchases of fixed
maturity securities are related to the management of the Companys investment portfolios and the
investment of excess cash generated by operating and financing activities.
Net cash provided by financing activities was $399.0 million and $169.4 million in the first nine
months of 2008 and 2007, respectively. Changes in cash provided by financing activities primarily
relate to the issuance of equity or debt securities, borrowings or payments under the Companys
existing credit agreements, treasury stock activity and excess deposits (payments) under
investment-type contracts.
Debt and Preferred Securities
As of September 30, 2008 and December 31, 2007, the Company had $1,018.0 million and $925.8
million, respectively, in outstanding borrowings under its debt agreements and was in compliance
with all covenants under those agreements.
The Company maintains three revolving credit facilities. The largest is a syndicated credit
facility with an overall capacity of $750.0 million that expires in September 2012. The Company
may borrow cash and may obtain letters of credit in multiple currencies under this facility. As of
September 30, 2008, the Company had no cash borrowings outstanding and $445.4 million in issued,
but undrawn, letters of credit under this facility. The Companys other credit facilities consist
of a £15.0 million credit facility that expires in May 2010, with an outstanding balance of $26.7
million as of September 30, 2008, and an A$50.0 million Australian credit facility that expires in
March 2011, with no outstanding balance as of September 30, 2008.
As of September 30, 2008, the average interest rate on all long-term and short-term debt
outstanding, excluding the Company-obligated mandatorily redeemable preferred securities of
subsidiary trust holding solely junior subordinated debentures of the Company (Trust Preferred
Securities), was 6.37%. Interest is expensed on the face amount, or $225 million, of the Trust
Preferred Securities at a rate of 5.75%.
Collateral Finance Facility
In June 2006, RGAs subsidiary, Timberlake Financial, L.L.C. (Timberlake Financial), issued
$850.0 million of Series A Floating Rate Insured Notes due September 2036 in a private placement.
The notes were issued to fund the collateral requirements for statutory reserves required by the
U.S. Valuation of Life Policies Model Regulation (commonly referred to as Regulation XXX) on
specified term life insurance policies reinsured by RGA Reinsurance Company (RGA Reinsurance).
Proceeds from the notes, along with a $112.8 million direct investment by the Company, have been
deposited into a series of trust accounts that collateralize the notes and are not available to
37
satisfy the general obligations of the Company. Interest on the notes will accrue at an annual
rate of 1-month LIBOR plus a base rate margin, payable monthly. The payment of interest and
principal on the notes is insured by a monoline insurance company through a financial guaranty
insurance policy. The notes represent senior, secured indebtedness of Timberlake Financial without
legal recourse to RGA or its other subsidiaries. Timberlake Financial will rely primarily upon the
receipt of interest and principal payments on a surplus note and dividend payments from its
wholly-owned subsidiary, Timberlake Reinsurance Company II (Timberlake Re), a South Carolina
captive insurance company, to make payments of interest and principal on the notes. The ability of
Timberlake Re to make interest and principal payments on the surplus note and dividend payments to
Timberlake Financial is contingent
upon South Carolina regulatory approval and the performance of specified term life insurance
policies with guaranteed level premiums retroceded by RGAs subsidiary, RGA Reinsurance, to
Timberlake Re.
Asset / Liability Management
The Company actively manages its cash and invested assets using an approach that is intended to
balance quality, diversification, asset/liability matching, liquidity and investment return. The
goals of the investment process are to optimize after-tax, risk-adjusted investment income and
after-tax, risk-adjusted total return while managing the assets and liabilities on a cash flow and
duration basis.
The Company has established target asset portfolios for each major insurance product, which
represent the investment strategies intended to profitably fund its liabilities within acceptable
risk parameters. These strategies include objectives for effective duration, yield curve
sensitivity and convexity, liquidity, asset sector concentration and credit quality.
The Companys liquidity position (cash and cash equivalents and short-term investments) was $444.8
million and $479.4 million at September 30, 2008 and December 31, 2007, respectively. The decrease
in the Companys liquidity position from December 31, 2007 is primarily due to the timing of
investment activity. Liquidity needs are determined from valuation analyses conducted by
operational units and are driven by product portfolios. Periodic evaluations of demand liabilities
and short-term liquid assets are designed to adjust specific portfolios, as well as their durations
and maturities, in response to anticipated liquidity needs.
The Company has entered into sales of investment securities under agreements to repurchase the same
securities. These arrangements are used for purposes of short-term financing. There were no
securities subject to these agreements outstanding at September 30, 2008. At December 31, 2007,
the book value of securities subject to these agreements, and included in fixed maturity securities
was $30.1 million, while the repurchase obligations of $30.1 million were reported in other
liabilities in the consolidated statement of financial position. The Company also occasionally
enters into arrangements to purchase securities under agreements to resell the same securities.
Amounts outstanding, if any, are reported in cash and cash equivalents. These agreements are
primarily used as yield enhancement alternatives to other cash equivalent investments. There were
no agreements outstanding at September 30, 2008 and December 31, 2007. Further, the Company often
enters into securities lending agreements whereby certain securities are loaned to third parties,
primarily major brokerage firms, in order to earn additional yield. The Company requires a minimum
of 102% of the fair value of the loaned securities as collateral in the form of either cash or
securities held by the Company or a trust. The cash collateral is reported in cash and the
offsetting collateral repayment obligation is reported in other liabilities. The Company had
securities lending agreements outstanding of $17.1 million at September 30, 2008. There were no
securities lending agreements outstanding at December 31, 2007.
RGA Reinsurance is a member of the Federal Home Loan Bank of Des Moines (FHLB) and holds $23.5
million of common stock of the FHLB, which is included in other invested assets on the Companys
condensed consolidated balance sheets. RGA Reinsurance occasionally enters into traditional
funding agreements with the FHLB and had $95.0 million outstanding in traditional funding
agreements with the FHLB at September 30, 2008, which is included in short-term debt. The Company
had no outstanding traditional funding agreements with the FHLB at December 31, 2007.
In addition, RGA Reinsurance has also entered into a funding agreement with the FHLB under a
guaranteed investment contract whereby RGA Reinsurance has issued the funding agreement in exchange
for cash and for which the FHLB has been granted a blanket lien on RGA Reinsurances commercial
mortgage-backed securities used to collateralize RGA Reinsurances obligations under the funding
agreement. RGA Reinsurance maintains control over these pledged assets, and may use, commingle,
encumber or dispose of any portion of the collateral as
38
long as there is no event of default and
the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. The
funding agreement and the related security agreement represented by this blanket lien provide that
upon any event of default by RGA Reinsurance, the FHLBs recovery is limited to the amount of RGA
Reinsurances liability under the outstanding funding agreement. The amount of the Companys
liability for the funding agreements with the FHLB under guaranteed investment contracts was $199.3
million at September 30, 2008, which is included in interest sensitive contract liabilities. The
advance on this agreement is collateralized by commercial mortgage-backed securities with a fair
value of $187.8 million at September 30, 2008. The Company had no outstanding funding agreements
with the FHLB under guaranteed investment contracts at December 31, 2007.
Future Liquidity and Capital Needs
Based on the historic cash flows and the current financial results of the Company, subject to any
dividend limitations which may be imposed by various insurance regulations, management believes
RGAs cash flows from operating activities, together with undeployed proceeds from its capital
raising efforts, including interest and investment income on those proceeds, interest income
received on surplus notes with two operating subsidiaries, and its ability to raise funds in the
capital markets, will be sufficient to enable RGA to make dividend payments to its shareholders, to
make interest payments on its senior indebtedness, Trust Preferred Securities and junior
subordinated notes, repurchase RGA common stock under the board of director approved plan and meet
its other obligations.
A sustained general economic downturn or a downturn in the equity and other capital markets could
adversely affect the market for many annuity and life insurance products. Because the Company
obtains substantially all of its revenues through reinsurance arrangements that cover a portfolio
of life insurance products, as well as annuities, its business could be harmed if the market for
annuities or life insurance were adversely affected for an extended period of time.
Investments
The Company had total cash and invested assets of $16.6 billion and $16.8 billion at September 30,
2008 and December 31, 2007, respectively, as illustrated below (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
September 30, 2008 |
|
December 31, 2007 |
Fixed maturity securities, available-for-sale |
|
$ |
9,121,953 |
|
|
$ |
9,397,916 |
|
Mortgage loans on real estate |
|
|
782,282 |
|
|
|
831,557 |
|
Policy loans |
|
|
1,048,517 |
|
|
|
1,059,439 |
|
Funds withheld at interest |
|
|
4,806,642 |
|
|
|
4,749,496 |
|
Short-term investments |
|
|
32,520 |
|
|
|
75,062 |
|
Other invested assets |
|
|
432,982 |
|
|
|
284,220 |
|
Cash and cash equivalents |
|
|
412,255 |
|
|
|
404,351 |
|
|
|
|
Total cash and invested assets |
|
$ |
16,637,151 |
|
|
$ |
16,802,041 |
|
|
|
|
The following table presents consolidated invested assets, net investment income and investment
yield, excluding funds withheld. Funds withheld assets are primarily associated with the
reinsurance of annuity contracts on which the Company earns a spread. Fluctuations in the yield on
funds withheld assets are generally offset by a corresponding adjustment to the interest credited
on the liabilities (dollars in thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, |
|
Nine months ended September 30, |
|
|
2008 |
|
2007 |
|
Increase |
|
2008 |
|
2007 |
|
Increase |
Average invested
assets at amortized
cost |
|
$ |
12,185,216 |
|
|
$ |
10,996,941 |
|
|
|
10.8 |
% |
|
$ |
11,632,451 |
|
|
$ |
10,497,605 |
|
|
|
10.8 |
% |
Net investment income |
|
|
179,193 |
|
|
|
161,311 |
|
|
|
11.1 |
% |
|
|
523,681 |
|
|
|
466,449 |
|
|
|
12.3 |
% |
Investment yield
(ratio of net
investment income to
average invested
assets) |
|
|
6.01 |
% |
|
|
6.00 |
% |
|
1 bp |
|
|
6.05 |
% |
|
|
5.97 |
% |
|
8 bps |
39
Investment yield increased for the three months and nine months ended September 30, 2008, as the
current economic environment allowed the Company to invest in securities with higher spreads than
those already held in the portfolio. In addition, new mandates with longer duration targets
allowed the Company to invest in securities with longer maturities than what was held in the
portfolio, which, in a positively-sloped yield curve environment, has also contributed to the
increase in the average yield of the portfolio.
All investments held by RGA and its subsidiaries are monitored for conformance to the qualitative
and quantitative limits prescribed by the applicable jurisdictions insurance laws and regulations.
In addition, the operating companies boards of directors periodically review their respective
investment portfolios. The Companys investment strategy is to maintain a predominantly
investment-grade, fixed maturity portfolio, to provide adequate
liquidity for expected reinsurance obligations, and to maximize total return through prudent asset
management. The Companys asset/liability duration matching differs between operating segments.
Based on Canadian reserve requirements, the Canadian liabilities are matched with long-duration
Canadian assets. The duration of the Canadian portfolio exceeds twenty years. The duration for
all the Companys portfolios, when consolidated, ranges between eight and ten years. See Note 4
Investments in the Notes to Consolidated Financial Statements of the 2007 Annual Report for
additional information regarding the Companys investments.
The amortized cost, gross unrealized gains and losses, and estimated fair values of investments in
fixed maturity securities and equity securities, the percentage that each sector represents by the
total fixed maturity securities holdings and by the total equity securities holdings at September
30, 2008 and December 31, 2007 are as follows (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated |
|
|
|
|
Amortized |
|
Unrealized |
|
Unrealized |
|
Fair |
|
% of |
|
|
Cost |
|
Gains |
|
Losses |
|
Value |
|
Total |
Available-for-sale: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities |
|
$ |
3,565,074 |
|
|
$ |
5,682 |
|
|
$ |
469,436 |
|
|
$ |
3,101,320 |
|
|
|
34.0 |
% |
Canadian and Canadian provincial
governments |
|
|
1,678,671 |
|
|
|
330,369 |
|
|
|
40,926 |
|
|
|
1,968,114 |
|
|
|
21.6 |
% |
Residential mortgage-backed
securities |
|
|
1,302,991 |
|
|
|
6,776 |
|
|
|
47,052 |
|
|
|
1,262,715 |
|
|
|
13.9 |
% |
Foreign corporate securities |
|
|
1,185,038 |
|
|
|
11,588 |
|
|
|
108,371 |
|
|
|
1,088,255 |
|
|
|
11.9 |
% |
Asset-backed securities |
|
|
483,308 |
|
|
|
1,316 |
|
|
|
88,717 |
|
|
|
395,907 |
|
|
|
4.3 |
% |
Commercial mortgage-backed
securities |
|
|
1,029,457 |
|
|
|
891 |
|
|
|
124,917 |
|
|
|
905,431 |
|
|
|
9.9 |
% |
U.S. government and agencies |
|
|
8,250 |
|
|
|
298 |
|
|
|
|
|
|
|
8,548 |
|
|
|
0.1 |
% |
State and political subdivisions |
|
|
46,630 |
|
|
|
25 |
|
|
|
4,587 |
|
|
|
42,068 |
|
|
|
0.5 |
% |
Other foreign government
securities |
|
|
343,905 |
|
|
|
7,032 |
|
|
|
1,342 |
|
|
|
349,595 |
|
|
|
3.8 |
% |
|
|
|
Total fixed maturity securities |
|
$ |
9,643,324 |
|
|
$ |
363,977 |
|
|
$ |
885,348 |
|
|
$ |
9,121,953 |
|
|
|
100.0 |
% |
|
|
|
Non-redeemable preferred stock |
|
$ |
187,966 |
|
|
$ |
14 |
|
|
$ |
72,830 |
|
|
$ |
115,150 |
|
|
|
77.5 |
% |
Common stock |
|
|
35,571 |
|
|
|
336 |
|
|
|
2,464 |
|
|
|
33,443 |
|
|
|
22.5 |
% |
|
|
|
Total equity securities |
|
$ |
223,537 |
|
|
$ |
350 |
|
|
$ |
75,294 |
|
|
$ |
148,593 |
|
|
|
100.0 |
% |
|
|
|
40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated |
|
|
|
|
Amortized |
|
Unrealized |
|
Unrealized |
|
Fair |
|
% of |
|
|
Cost |
|
Gains |
|
Losses |
|
Value |
|
Total |
Available-for-sale: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities |
|
$ |
3,382,944 |
|
|
$ |
27,350 |
|
|
$ |
96,679 |
|
|
$ |
3,313,615 |
|
|
|
35.3 |
% |
Canadian and Canadian provincial
governments |
|
|
1,561,700 |
|
|
|
570,691 |
|
|
|
1,163 |
|
|
|
2,131,228 |
|
|
|
22.7 |
% |
Residential mortgage-backed
securities |
|
|
1,414,187 |
|
|
|
12,306 |
|
|
|
12,216 |
|
|
|
1,414,277 |
|
|
|
15.0 |
% |
Foreign corporate securities |
|
|
1,040,817 |
|
|
|
35,159 |
|
|
|
25,971 |
|
|
|
1,050,005 |
|
|
|
11.2 |
% |
Asset-backed securities |
|
|
494,458 |
|
|
|
1,252 |
|
|
|
31,456 |
|
|
|
464,254 |
|
|
|
4.9 |
% |
Commercial mortgage-backed
securities |
|
|
641,479 |
|
|
|
8,835 |
|
|
|
5,087 |
|
|
|
645,227 |
|
|
|
6.9 |
% |
U.S. government and agencies |
|
|
3,244 |
|
|
|
209 |
|
|
|
1 |
|
|
|
3,452 |
|
|
|
|
% |
State and political subdivisions |
|
|
52,254 |
|
|
|
152 |
|
|
|
945 |
|
|
|
51,461 |
|
|
|
0.5 |
% |
Other foreign government
securities |
|
|
325,609 |
|
|
|
3,300 |
|
|
|
4,512 |
|
|
|
324,397 |
|
|
|
3.5 |
% |
|
|
|
Total fixed maturity securities |
|
$ |
8,916,692 |
|
|
$ |
659,254 |
|
|
$ |
178,030 |
|
|
$ |
9,397,916 |
|
|
|
100.0 |
% |
|
|
|
Non-redeemable preferred stock |
|
$ |
144,942 |
|
|
$ |
986 |
|
|
$ |
19,953 |
|
|
$ |
125,975 |
|
|
|
91.8 |
% |
Common stock |
|
|
11,483 |
|
|
|
2 |
|
|
|
232 |
|
|
|
11,253 |
|
|
|
8.2 |
% |
|
|
|
Total equity securities |
|
$ |
156,425 |
|
|
$ |
988 |
|
|
$ |
20,185 |
|
|
$ |
137,228 |
|
|
|
100.0 |
% |
|
|
|
The Companys fixed maturity securities are invested primarily in commercial and industrial bonds,
public utilities, U.S. and Canadian government securities, as well as mortgage- and asset-backed
securities. As of September 30, 2008 and December 31, 2007, approximately 96.7% and 97.2%,
respectively, of the Companys consolidated investment portfolio of fixed maturity securities was
investment grade. Important factors in the selection of investments include diversification,
quality, yield, total rate of return potential and call protection. The relative importance of
these factors is determined by market conditions and the underlying product or portfolio
characteristics. Cash equivalents are invested in high-grade money market instruments. The largest
asset class in which fixed maturities were invested was in corporate securities, including
commercial, industrial, finance and utility bonds, which represented approximately 45.9% of fixed
maturity securities as of September 30, 2008, compared to 46.5% at December 31, 2007. The table
below shows the major industry types and weighted average credit ratings, which comprise the U.S.
and foreign corporate fixed maturity holdings at (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2008 |
|
|
Amortized |
|
Estimated |
|
|
|
|
|
Average Credit |
|
|
Cost |
|
Fair Value |
|
% of Total |
|
Ratings |
|
|
|
Finance |
|
$ |
1,433,689 |
|
|
$ |
1,176,929 |
|
|
|
28.1 |
% |
|
|
A- |
|
Industrial |
|
|
1,161,833 |
|
|
|
1,043,016 |
|
|
|
24.9 |
% |
|
BBB |
Foreign (1) |
|
|
1,185,038 |
|
|
|
1,088,255 |
|
|
|
26.0 |
% |
|
|
A |
|
Utility |
|
|
531,564 |
|
|
|
487,337 |
|
|
|
11.6 |
% |
|
BBB |
Other |
|
|
437,988 |
|
|
|
394,038 |
|
|
|
9.4 |
% |
|
BBB+ |
|
|
|
Total |
|
$ |
4,750,112 |
|
|
$ |
4,189,575 |
|
|
|
100.0 |
% |
|
|
A- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007 |
|
|
Amortized |
|
Estimated |
|
|
|
|
|
Average |
|
|
Cost |
|
Fair Value |
|
% of Total |
|
Credit Ratings |
|
|
|
Finance |
|
$ |
1,394,562 |
|
|
$ |
1,343,539 |
|
|
|
30.8 |
% |
|
|
A |
|
Industrial |
|
|
1,069,727 |
|
|
|
1,060,236 |
|
|
|
24.3 |
% |
|
BBB+ |
Foreign (1) |
|
|
1,040,817 |
|
|
|
1,050,005 |
|
|
|
24.1 |
% |
|
|
A |
|
Utility |
|
|
504,678 |
|
|
|
503,969 |
|
|
|
11.5 |
% |
|
BBB |
Other |
|
|
413,977 |
|
|
|
405,871 |
|
|
|
9.3 |
% |
|
BBB+ |
|
|
|
Total |
|
$ |
4,423,761 |
|
|
$ |
4,363,620 |
|
|
|
100.0 |
% |
|
|
A- |
|
|
|
|
41
(1) Includes U.S. dollar-denominated debt obligations of foreign obligors and other foreign
investments.
The National Association of Insurance Commissioners (NAIC) assigns securities quality ratings and
uniform valuations called NAIC Designations which are used by insurers when preparing their
annual statements. The NAIC assigns designations to publicly traded as well as privately placed
securities. The designations assigned by the NAIC range from class 1 to class 6, with designations
in classes 1 and 2 generally considered investment grade (BBB or higher rating agency designation).
NAIC designations in classes 3 through 6 are generally considered below investment grade (BB or
lower rating agency designation).
As of September 30, 2008, the Company classified approximately 18.4% of its fixed maturity
securities in the Level 3 category in accordance with SFAS 157 (refer to Note 5 Fair Value
Disclosures in the Notes to Condensed Consolidated Financial Statements for additional
information). These securities primarily consist of private placement corporate securities with an
inactive trading market. Additionally, the Company has included asset-backed securities with
subprime exposure in the Level 3 category due to the current market uncertainty associated with
these securities and the Companys utilization of information from third parties.
The quality of the Companys available-for-sale fixed maturity securities portfolio, as measured at
fair value and by the percentage of fixed maturity securities invested in various ratings
categories, relative to the entire available-for-sale fixed maturity security portfolio, at
September 30, 2008 and December 31, 2007 was as follows (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2008 |
|
December 31, 2007 |
NAIC |
|
Rating Agency |
|
Amortized |
|
Estimated |
|
% of |
|
Amortized |
|
Estimated |
|
% of |
Designation |
|
Designation |
|
Cost |
|
Fair Value |
|
Total |
|
Cost |
|
Fair Value |
|
Total |
|
1 |
|
|
AAA/AA/A |
|
$ |
7,479,538 |
|
|
$ |
7,183,940 |
|
|
|
78.8 |
% |
|
$ |
7,022,497 |
|
|
$ |
7,521,177 |
|
|
|
80.0 |
% |
|
2 |
|
|
BBB |
|
|
1,817,281 |
|
|
|
1,632,806 |
|
|
|
17.9 |
% |
|
|
1,628,431 |
|
|
|
1,617,983 |
|
|
|
17.2 |
% |
|
3 |
|
|
BB |
|
|
253,665 |
|
|
|
231,706 |
|
|
|
2.5 |
% |
|
|
201,868 |
|
|
|
198,487 |
|
|
|
2.1 |
% |
|
4 |
|
|
B |
|
|
58,868 |
|
|
|
43,503 |
|
|
|
0.5 |
% |
|
|
47,013 |
|
|
|
43,680 |
|
|
|
0.5 |
% |
|
5 |
|
|
CCC and lower |
|
|
31,336 |
|
|
|
27,361 |
|
|
|
0.3 |
% |
|
|
16,800 |
|
|
|
16,502 |
|
|
|
0.2 |
% |
|
6 |
|
|
In or near default |
|
|
2,636 |
|
|
|
2,637 |
|
|
|
|
% |
|
|
83 |
|
|
|
87 |
|
|
|
|
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
9,643,324 |
|
|
$ |
9,121,953 |
|
|
|
100.0 |
% |
|
$ |
8,916,692 |
|
|
$ |
9,397,916 |
|
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
The Companys fixed maturity portfolio includes structured securities. The following table shows
the types of structured securities the Company held at (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2008 |
|
December 31, 2007 |
|
|
Amortized |
|
Estimated |
|
Amortized |
|
Estimated |
|
|
Cost |
|
Fair Value |
|
Cost |
|
Fair Value |
Residential mortgage-backed securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Collateralized mortgage obligations |
|
$ |
932,046 |
|
|
$ |
892,959 |
|
|
$ |
1,018,597 |
|
|
$ |
1,016,195 |
|
Pass-through securities |
|
|
370,945 |
|
|
|
369,756 |
|
|
|
395,590 |
|
|
|
398,081 |
|
|
|
|
Total residential mortgage-backed securities |
|
|
1,302,991 |
|
|
|
1,262,715 |
|
|
|
1,414,187 |
|
|
|
1,414,276 |
|
Commercial mortgage-backed securities |
|
|
1,029,457 |
|
|
|
905,431 |
|
|
|
641,479 |
|
|
|
645,227 |
|
Asset-backed securities |
|
|
483,308 |
|
|
|
395,907 |
|
|
|
494,458 |
|
|
|
464,254 |
|
|
|
|
Total |
|
$ |
2,815,756 |
|
|
$ |
2,564,053 |
|
|
$ |
2,550,124 |
|
|
$ |
2,523,757 |
|
|
|
|
The residential mortgage backed securities include agency-issued pass-through securities,
collateralized mortgage obligations, a majority of which are guaranteed or otherwise supported by
the Federal Home Loan Mortgage Corporation, Federal National Mortgage Association, or the
Government National Mortgage Association. As of September 30, 2008 and December 31, 2007, the
weighted average credit rating was AA+. At September 30, 2008 and December 31, 2007, $905.4
million and $645.2 million, respectively, or 83.7% and 81.0%, respectively, of the commercial
mortgage-backed securities were rated AAA by S&P. The principal risks inherent in holding
mortgage-backed securities are prepayment and extension risks, which will affect the timing of when
cash will be received and are dependent on the level of mortgage interest rates. Prepayment risk
is the unexpected increase in principal payments, primarily as a result of owner refinancing.
Extension risk relates to the unexpected slowdown in principal payments. In addition,
mortgage-backed securities face default risk should the borrower be unable to pay the contractual
interest or principal on their obligation. The Company monitors its mortgage-backed securities
42
to
mitigate exposure to the cash flow uncertainties associated with
these risks.
Asset-backed securities include credit card and automobile receivables, subprime and Alt-A
securities, home equity loans, manufactured housing bonds and collateralized debt obligations. The
Companys asset-backed securities are diversified by issuer and contain both floating and fixed
rate securities and had a weighted average credit rating of AA at September 30, 2008 and December
31, 2007. The Company owns floating rate securities that represent approximately 20.4% and 19.2%
of the total fixed maturity securities at September 30, 2008 and December 31, 2007, respectively.
These investments have a higher degree of income variability than the other fixed income holdings
in the portfolio due to the floating rate nature of the interest payments. The Company holds these
investments to match specific floating rate liabilities primarily reflected in the condensed
consolidated balance sheets as collateral finance facility. In addition to the risks associated
with floating rate securities, principal risks in holding asset-backed securities are structural,
credit and capital market risks. Structural risks include the securities priority in the issuers
capital structure, the adequacy of and ability to realize proceeds from collateral, and the
potential for prepayments. Credit risks include consumer or corporate credits such as credit card
holders, equipment lessees, and corporate obligors. Capital market risks include general level of
interest rates and the liquidity for these securities in the marketplace.
As of September 30, 2008 and December 31, 2007, the Company held investments in securities with
subprime mortgage exposure with amortized costs totaling $239.6 million and $267.7 million, and
estimated fair values of $177.4 million and $246.8 million, respectively. Those amounts include
exposure to subprime mortgages through securities held directly in the Companys investment
portfolios within asset-backed securities, as well as securities backing the Companys funds
withheld at interest investment. The securities are highly rated with weighted average S&P credit
ratings of approximately AA- at September 30, 2008 and AA+ at December 31, 2007. Additionally,
the Company has largely avoided investing in securities originated since the second half of 2005,
which management believes was a period of lessened underwriting quality. During the three months
ended September 30, 2008, the Company recorded $11.6 million of other-than-temporary write-downs in
its subprime portfolio due primarily to the increased likelihood that some or all of the remaining
scheduled principal and interest payments on select securities will not be received. The following
tables summarize the securities by rating and underwriting year at September 30, 2008 and December
31, 2007 (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2008 |
|
|
AAA |
|
AA |
|
A |
|
|
|
|
|
|
Estimated |
|
|
|
|
|
Estimated Fair |
|
|
|
|
|
Estimated |
Underwriting Year |
|
Amortized Cost |
|
Fair Value |
|
Amortized Cost |
|
Value |
|
Amortized Cost |
|
Fair Value |
2003 & Prior |
|
$ |
11,419 |
|
|
$ |
10,586 |
|
|
$ |
6,580 |
|
|
$ |
4,746 |
|
|
$ |
1,868 |
|
|
$ |
1,337 |
|
2004 |
|
|
|
|
|
|
|
|
|
|
39,335 |
|
|
|
30,741 |
|
|
|
13,560 |
|
|
|
10,791 |
|
2005 |
|
|
48,481 |
|
|
|
40,885 |
|
|
|
57,019 |
|
|
|
38,337 |
|
|
|
6,516 |
|
|
|
3,362 |
|
2006 |
|
|
5,018 |
|
|
|
3,135 |
|
|
|
9,498 |
|
|
|
5,480 |
|
|
|
|
|
|
|
|
|
2007 |
|
|
2,250 |
|
|
|
1,820 |
|
|
|
888 |
|
|
|
615 |
|
|
|
10,490 |
|
|
|
5,175 |
|
|
|
|
Total |
|
$ |
67,168 |
|
|
$ |
56,426 |
|
|
$ |
113,320 |
|
|
$ |
79,919 |
|
|
$ |
32,434 |
|
|
$ |
20,665 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BBB |
|
Below Investment Grade |
|
Total |
|
|
|
|
|
|
Estimated |
|
|
|
|
|
Estimated |
|
|
|
|
|
Estimated |
Underwriting Year |
|
Amortized Cost |
|
Fair Value |
|
Amortized Cost |
|
Fair Value |
|
Amortized Cost |
|
Fair Value |
2003 & Prior |
|
$ |
1,221 |
|
|
$ |
217 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
21,088 |
|
|
$ |
16,886 |
|
2004 |
|
|
|
|
|
|
|
|
|
|
9,071 |
|
|
|
6,610 |
|
|
|
61,966 |
|
|
|
48,142 |
|
2005 |
|
|
1,323 |
|
|
|
1,323 |
|
|
|
4,173 |
|
|
|
4,168 |
|
|
|
117,512 |
|
|
|
88,075 |
|
2006 |
|
|
3,223 |
|
|
|
1,823 |
|
|
|
|
|
|
|
|
|
|
|
17,739 |
|
|
|
10,438 |
|
2007 |
|
|
|
|
|
|
|
|
|
|
7,639 |
|
|
|
6,288 |
|
|
|
21,267 |
|
|
|
13,898 |
|
|
|
|
Total |
|
$ |
5,767 |
|
|
$ |
3,363 |
|
|
$ |
20,883 |
|
|
$ |
17,066 |
|
|
$ |
239,572 |
|
|
$ |
177,439 |
|
|
|
|
43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007 |
|
|
AAA |
|
AA |
|
A |
|
|
|
|
|
|
Estimated |
|
|
|
|
|
Estimated |
|
|
|
|
|
Estimated |
Underwriting Year |
|
Amortized Cost |
|
Fair Value |
|
Amortized Cost |
|
Fair Value |
|
Amortized Cost |
|
Fair Value |
2003 & Prior |
|
$ |
16,520 |
|
|
$ |
16,531 |
|
|
$ |
2,111 |
|
|
$ |
1,910 |
|
|
$ |
3,749 |
|
|
$ |
3,246 |
|
2004 |
|
|
26,520 |
|
|
|
26,286 |
|
|
|
33,757 |
|
|
|
31,465 |
|
|
|
16,151 |
|
|
|
14,614 |
|
2005 |
|
|
41,638 |
|
|
|
40,190 |
|
|
|
60,233 |
|
|
|
55,041 |
|
|
|
21,593 |
|
|
|
18,140 |
|
2006 |
|
|
13,964 |
|
|
|
11,957 |
|
|
|
5,002 |
|
|
|
3,763 |
|
|
|
|
|
|
|
|
|
2007 |
|
|
20,274 |
|
|
|
18,351 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
118,916 |
|
|
$ |
113,315 |
|
|
$ |
101,103 |
|
|
$ |
92,179 |
|
|
$ |
41,493 |
|
|
$ |
36,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BBB |
|
Below Investment Grade |
|
Total |
|
|
|
|
|
|
Estimated |
|
|
|
|
|
Estimated |
|
|
|
|
|
Estimated |
Underwriting Year |
|
Amortized Cost |
|
Fair Value |
|
Amortized Cost |
|
Fair Value |
|
Amortized Cost |
|
Fair Value |
2003 & Prior |
|
$ |
1,186 |
|
|
$ |
1,046 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
23,566 |
|
|
$ |
22,733 |
|
2004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
76,428 |
|
|
|
72,365 |
|
2005 |
|
|
5,026 |
|
|
|
4,250 |
|
|
|
|
|
|
|
|
|
|
|
128,490 |
|
|
|
117,621 |
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,966 |
|
|
|
15,720 |
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,274 |
|
|
|
18,351 |
|
|
|
|
Total |
|
$ |
6,212 |
|
|
$ |
5,296 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
267,724 |
|
|
$ |
246,790 |
|
|
|
|
Alternative residential mortgage loans (Alt-A) are a classification of mortgage loans where the
risk profile of the borrower falls between prime and sub-prime. At September 30, 2008 and December
31, 2007, the Companys Alt-A residential mortgage-backed securities exposure was $106.5 million
and $102.4 million, respectively, with an unrealized loss of $21.1 million and $3.2 million,
respectively. 83.2% of the Alt-A securities were rated AA or better as of September 30, 2008.
This amount includes securities directly held by the Company and securities backing the Companys
funds withheld at interest investment. For the three months ended September 30, 2008, the Company
recorded other-than-temporary impairments of $13.3 million in its Alt-A portfolio due primarily to
the increased likelihood that some or all of the remaining scheduled principal and interest
payments on select securities will not be received.
The Companys fixed maturity and funds withheld portfolios include approximately $564.9 million in
estimated fair value of securities that are insured by various financial guarantors, or less than
five percent of consolidated investments. The securities are diversified between municipal bonds
and asset-backed securities with well diversified collateral pools. The Company invests in insured
collateralized debt obligation (CDO) structures backing subprime investments of approximately
$0.2 million at September 30, 2008. The insured securities are primarily investment grade without
the benefit of the insurance provided by the financial guarantor and therefore the Company does not
expect to incur significant realized losses as a result of the recent financial difficulties
encountered by several of the financial guarantors. In addition to the insured securities, the
Company held investment-grade securities issued by four of the financial guarantors totaling $13.7
million in amortized cost.
The Company does not invest in the common equity securities of Fannie Mae and Freddie Mac, both
government sponsored entities; however, as of September 30, 2008, the Company holds in its general
portfolio a book value of $6.0 million in direct exposure in the form of senior unsecured and
preferred securities. Additionally, as of September 30, 2008, the portfolios held by the Companys
ceding companies that support its funds withheld asset contain about $354.3 million in amortized
cost of direct unsecured holdings and no equity exposure. As of September 30, 2008, indirect
exposure in the form of secured, structured mortgaged securities issued by Fannie Mae and Freddie
Mac totals about $1.1 billion in amortized cost across the Companys general and funds withheld
portfolios. Including the funds withheld portfolios, the Companys direct holdings in the form of
preferred securities total a book value of $0.9 million. As a result of the U.S. government
intervention and cessation of dividend payments, the Company recorded an other-than-temporary
impairment of its preferred holdings of Fannie Mae and Freddie Mac totaling $11.9 million for the
three and nine months ended September 30, 2008.
The Company monitors its fixed maturity securities and equity securities to determine impairments
in value and evaluates factors such as financial condition of the issuer, payment performance, the
length of time and the extent to
44
which the market value has been below amortized cost, compliance with covenants, general market
conditions and industry sector, current intent and ability to hold securities and various other
subjective factors. Based on managements judgment, securities determined to have an
other-than-temporary impairment in value are written down to fair value. The Company recorded
$115.0 million in other-than-temporary write-downs on fixed maturity securities and equity
securities for the nine months ended September 30, 2008. The Company recorded $4.7 million in
other-than-temporary write-downs on fixed maturity securities and equity securities for the nine
months ended September 30, 2007. The write-downs are due primarily to the recent turmoil in the
U.S. and global financial markets which has resulted in bankruptcies, consolidations and government
interventions. The table below summarizes impairment write-downs for the three-month period ended
September 30, 2008 (dollars in thousands).
|
|
|
|
|
Asset Class / Institution |
|
Impairment |
|
Subprime / Alt-A / Other Structured Securities |
|
$ |
25,727 |
|
Lehman Brothers Holdings |
|
|
24,232 |
|
Washington Mutual |
|
|
22,075 |
|
Morgan Stanley |
|
|
8,214 |
|
American International Group |
|
|
7,500 |
|
Fannie Mae |
|
|
7,231 |
|
Freddie Mac |
|
|
4,680 |
|
Bell Canada Enterprises |
|
|
3,499 |
|
Other |
|
|
6,123 |
|
|
|
|
|
Total |
|
$ |
109,281 |
|
|
|
|
|
During the three months ended September 30, 2008 and 2007, the Company sold fixed maturity
securities and equity securities with fair values of $97.3 million and $281.2 million at losses of
$12.1 million and $13.7 million, respectively, or at 89.0% and 95.4% of book value, respectively.
During the nine months ended September 30, 2008 and 2007, the Company sold fixed maturity
securities and equity securities with fair values of $489.2 million and $910.1 million at losses of
$26.4 million and $32.1 million, respectively, or at 94.9% and 96.6% of book value, respectively.
Generally, such losses are insignificant in relation to the cost basis of the investment and are
largely due to changes in interest rates from the time the security was purchased. The securities
are classified as available-for-sale in order to meet the Companys operational and other cash flow
requirements. The Company does not engage in short-term buying and selling of securities to
generate gains or losses.
At September 30, 2008 and December 31, 2007, the Company had $960.6 million and $198.2 million,
respectively, of gross unrealized losses related to its fixed maturity and equity securities. These
securities are concentrated, calculated as a percentage of gross unrealized losses, as follows:
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
December 31, |
|
|
2008 |
|
2007 |
Sector: |
|
|
|
|
|
|
|
|
U.S. corporate securities |
|
|
58 |
% |
|
|
59 |
% |
Canadian and Canada provincial governments |
|
|
4 |
% |
|
|
1 |
% |
Residential mortgage-backed securities |
|
|
5 |
% |
|
|
6 |
% |
Foreign corporate securities |
|
|
11 |
% |
|
|
13 |
% |
Asset-backed securities |
|
|
9 |
% |
|
|
16 |
% |
Commercial mortgage-backed securities |
|
|
13 |
% |
|
|
3 |
% |
State and political subdivisions |
|
|
|
% |
|
|
|
% |
Other foreign government securities |
|
|
|
% |
|
|
2 |
% |
|
|
|
Total |
|
|
100 |
% |
|
|
100 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
Industry: |
|
|
|
|
|
|
|
|
Finance |
|
|
40 |
% |
|
|
49 |
% |
Asset-backed |
|
|
9 |
% |
|
|
16 |
% |
Industrial |
|
|
17 |
% |
|
|
12 |
% |
Mortgage-backed |
|
|
18 |
% |
|
|
9 |
% |
Government |
|
|
5 |
% |
|
|
3 |
% |
Utility |
|
|
6 |
% |
|
|
4 |
% |
Other |
|
|
5 |
% |
|
|
7 |
% |
|
|
|
Total |
|
|
100 |
% |
|
|
100 |
% |
|
|
|
45
The following table presents the total gross unrealized losses for 1,976 and 1,105 fixed maturity
securities and equity securities as of September 30, 2008 and December 31, 2007, respectively,
where the estimated fair value had declined and remained below amortized cost by the indicated
amount (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2008 |
|
December 31, 2007 |
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
|
|
|
Gross |
|
|
|
|
Number of |
|
Unrealized |
|
|
|
|
|
Number of |
|
Unrealized |
|
|
|
|
Securities |
|
Losses |
|
% of Total |
|
Securities |
|
Losses |
|
% of Total |
|
|
|
Less than 20% |
|
|
1,583 |
|
|
$ |
472,148 |
|
|
|
49.1 |
% |
|
|
1,039 |
|
|
$ |
159,563 |
|
|
|
80.5 |
% |
20% or more for
less than six
months |
|
|
324 |
|
|
|
381,221 |
|
|
|
39.7 |
% |
|
|
59 |
|
|
|
35,671 |
|
|
|
18.0 |
|
20% or more for six
months or greater |
|
|
69 |
|
|
|
107,273 |
|
|
|
11.2 |
% |
|
|
7 |
|
|
|
2,981 |
|
|
|
1.5 |
|
|
|
|
Total |
|
|
1,976 |
|
|
$ |
960,642 |
|
|
|
100.0 |
% |
|
|
1,105 |
|
|
$ |
198,215 |
|
|
|
100.0 |
% |
|
|
|
The investment securities in an unrealized loss position as of September 30, 2008 consisted of
1,976 securities accounting for unrealized losses of $960.6 million. Of these unrealized losses
94.7% were investment grade and 49.1% were less than 20% below cost. The amount of the unrealized
loss on these securities was primarily attributable to increases in interest rates, including a
widening of credit default spreads.
While all of these securities are monitored for potential impairment, the Companys experience
indicates that the first two categories do not present as great a risk of impairment, and often,
fair values recover over time. These securities have generally been adversely affected by overall
economic conditions, primarily an increase in the interest rate environment, including a widening
of credit default spreads.
The following tables present the estimated fair values and gross unrealized losses for the 1,976
and 1,105 fixed maturity securities and equity securities that have estimated fair values below
amortized cost as of September 30, 2008 and December 31, 2007, respectively. These investments are
presented by class and grade of security, as well as the length of time the related market value
has remained below amortized cost.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2008 |
|
|
|
|
|
|
|
|
|
|
Equal to or greater than |
|
|
(dollars in thousands) |
|
Less than 12 months |
|
12 months |
|
Total |
|
|
|
|
|
|
Gross |
|
|
|
|
|
Gross |
|
|
|
|
|
Gross |
|
|
Estimated |
|
Unrealized |
|
Estimated |
|
Unrealized |
|
Estimated |
|
Unrealized |
|
|
Fair Value |
|
Losses |
|
Fair Value |
|
Losses |
|
Fair Value |
|
Losses |
Investment grade securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities |
|
$ |
2,136,005 |
|
|
$ |
289,078 |
|
|
$ |
481,672 |
|
|
$ |
139,996 |
|
|
$ |
2,617,677 |
|
|
$ |
429,074 |
|
Canadian and Canadian
provincial governments |
|
|
483,226 |
|
|
|
33,670 |
|
|
|
55,046 |
|
|
|
7,256 |
|
|
|
538,272 |
|
|
|
40,926 |
|
Residential mortgage-backed
securities |
|
|
497,433 |
|
|
|
26,121 |
|
|
|
253,224 |
|
|
|
20,931 |
|
|
|
750,657 |
|
|
|
47,052 |
|
Foreign corporate securities |
|
|
573,499 |
|
|
|
72,645 |
|
|
|
191,346 |
|
|
|
31,944 |
|
|
|
764,845 |
|
|
|
104,589 |
|
Asset-backed securities |
|
|
159,077 |
|
|
|
20,269 |
|
|
|
201,503 |
|
|
|
66,944 |
|
|
|
360,580 |
|
|
|
87,213 |
|
Commercial mortgage-backed
securities |
|
|
801,793 |
|
|
|
105,354 |
|
|
|
59,865 |
|
|
|
19,563 |
|
|
|
861,658 |
|
|
|
124,917 |
|
State and political subdivisions |
|
|
27,468 |
|
|
|
4,587 |
|
|
|
8,000 |
|
|
|
|
|
|
|
35,468 |
|
|
|
4,587 |
|
Other foreign government
securities |
|
|
45,207 |
|
|
|
534 |
|
|
|
47,494 |
|
|
|
808 |
|
|
|
92,701 |
|
|
|
1,342 |
|
|
|
|
|
|
|
|
Investment grade securities |
|
|
4,723,708 |
|
|
|
552,258 |
|
|
|
1,298,150 |
|
|
|
287,442 |
|
|
|
6,021,858 |
|
|
|
839,700 |
|
|
|
|
|
|
|
|
46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continued |
|
As of September 30, 2008 |
|
|
|
|
|
|
|
|
|
|
Equal to or greater than |
|
|
(dollars in thousands) |
|
Less than 12 months |
|
12 months |
|
Total |
|
|
|
|
|
|
Gross |
|
|
|
|
|
Gross |
|
|
|
|
|
Gross |
|
|
Estimated |
|
Unrealized |
|
Estimated |
|
Unrealized |
|
Estimated |
|
Unrealized |
|
|
Fair Value |
|
Losses |
|
Fair Value |
|
Losses |
|
Fair Value |
|
Losses |
Non-investment grade securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities |
|
|
193,333 |
|
|
|
31,385 |
|
|
|
42,473 |
|
|
|
8,977 |
|
|
|
235,806 |
|
|
|
40,362 |
|
Asset-backed securities |
|
|
1,226 |
|
|
|
79 |
|
|
|
5,126 |
|
|
|
1,425 |
|
|
|
6,352 |
|
|
|
1,504 |
|
Foreign corporate securities |
|
|
16,964 |
|
|
|
2,455 |
|
|
|
3,164 |
|
|
|
1,327 |
|
|
|
20,128 |
|
|
|
3,782 |
|
|
|
|
|
|
|
|
Non-investment grade securities |
|
|
211,523 |
|
|
|
33,919 |
|
|
|
50,763 |
|
|
|
11,729 |
|
|
|
262,286 |
|
|
|
45,648 |
|
|
|
|
|
|
|
|
Total fixed maturity securities |
|
$ |
4,935,231 |
|
|
$ |
586,177 |
|
|
$ |
1,348,913 |
|
|
$ |
299,171 |
|
|
$ |
6,284,144 |
|
|
$ |
885,348 |
|
|
|
|
|
|
|
|
Equity securities |
|
$ |
95,030 |
|
|
$ |
60,555 |
|
|
$ |
21,226 |
|
|
$ |
14,739 |
|
|
$ |
116,256 |
|
|
$ |
75,294 |
|
|
|
|
|
|
|
|
Total number of securities in
an unrealized loss position |
|
|
1,426 |
|
|
|
|
|
|
|
550 |
|
|
|
|
|
|
|
1,976 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2007 |
|
|
|
|
|
|
|
|
|
|
Equal to or greater than |
|
|
(dollars in thousands) |
|
Less than 12 months |
|
12 months |
|
Total |
|
|
|
|
|
|
Gross |
|
|
|
|
|
Gross |
|
|
|
|
|
Gross |
|
|
Estimated |
|
Unrealized |
|
Estimated |
|
Unrealized |
|
Estimated |
|
Unrealized |
|
|
Fair Value |
|
Losses |
|
Fair Value |
|
Losses |
|
Fair Value |
|
Losses |
Investment grade securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities |
|
$ |
1,185,664 |
|
|
$ |
63,368 |
|
|
$ |
487,626 |
|
|
$ |
25,541 |
|
|
$ |
1,673,290 |
|
|
$ |
88,909 |
|
Canadian and Canadian provincial
governments |
|
|
78,045 |
|
|
|
1,077 |
|
|
|
4,313 |
|
|
|
86 |
|
|
|
82,358 |
|
|
|
1,163 |
|
Residential mortgage-backed
securities |
|
|
299,655 |
|
|
|
5,473 |
|
|
|
348,632 |
|
|
|
6,743 |
|
|
|
648,287 |
|
|
|
12,216 |
|
Foreign corporate securities |
|
|
293,783 |
|
|
|
17,880 |
|
|
|
155,445 |
|
|
|
5,995 |
|
|
|
449,228 |
|
|
|
23,875 |
|
Asset-backed securities |
|
|
341,337 |
|
|
|
24,958 |
|
|
|
72,445 |
|
|
|
5,722 |
|
|
|
413,782 |
|
|
|
30,680 |
|
Commercial mortgage-backed
securities |
|
|
110,097 |
|
|
|
4,499 |
|
|
|
46,647 |
|
|
|
588 |
|
|
|
156,744 |
|
|
|
5,087 |
|
U.S. government and agencies |
|
|
700 |
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
700 |
|
|
|
1 |
|
State and political subdivisions |
|
|
27,265 |
|
|
|
605 |
|
|
|
14,518 |
|
|
|
339 |
|
|
|
41,783 |
|
|
|
944 |
|
Other foreign government securities |
|
|
127,397 |
|
|
|
1,635 |
|
|
|
75,354 |
|
|
|
2,878 |
|
|
|
202,751 |
|
|
|
4,513 |
|
|
|
|
|
|
|
|
Investment grade securities |
|
|
2,463,943 |
|
|
|
119,496 |
|
|
|
1,204,980 |
|
|
|
47,892 |
|
|
|
3,668,923 |
|
|
|
167,388 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-investment grade securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities |
|
|
106,842 |
|
|
|
6,044 |
|
|
|
30,105 |
|
|
|
1,727 |
|
|
|
136,947 |
|
|
|
7,771 |
|
Asset-backed securities |
|
|
1,996 |
|
|
|
776 |
|
|
|
|
|
|
|
|
|
|
|
1,996 |
|
|
|
776 |
|
Foreign corporate securities |
|
|
9,692 |
|
|
|
1,930 |
|
|
|
3,524 |
|
|
|
165 |
|
|
|
13,216 |
|
|
|
2,095 |
|
|
|
|
|
|
|
|
Non-investment grade securities |
|
|
118,530 |
|
|
|
8,750 |
|
|
|
33,629 |
|
|
|
1,892 |
|
|
|
152,159 |
|
|
|
10,642 |
|
|
|
|
|
|
|
|
Total fixed maturity securities |
|
$ |
2,582,473 |
|
|
$ |
128,246 |
|
|
$ |
1,238,609 |
|
|
$ |
49,784 |
|
|
$ |
3,821,082 |
|
|
$ |
178,030 |
|
|
|
|
|
|
|
|
Equity securities |
|
$ |
83,166 |
|
|
$ |
16,764 |
|
|
$ |
19,073 |
|
|
$ |
3,421 |
|
|
$ |
102,239 |
|
|
$ |
20,185 |
|
|
|
|
|
|
|
|
Total number of securities in
an unrealized loss position |
|
|
691 |
|
|
|
|
|
|
|
414 |
|
|
|
|
|
|
|
1,105 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The table below presents the Companys top twenty corporate exposures held directly in its
investment portfolio as of September 30, 2008. Securities backing the Companys funds withheld
portfolios are not included (dollars in thousands).
47
|
|
|
|
|
|
|
|
|
|
|
Amortized |
|
Estimated |
Corporate Exposures |
|
Cost |
|
Fair Value |
JP Morgan |
|
$ |
85,305 |
|
|
$ |
74,614 |
|
Bank of America |
|
|
82,708 |
|
|
|
71,376 |
|
Citigroup |
|
|
78,036 |
|
|
|
61,825 |
|
General Electric Co. |
|
|
67,940 |
|
|
|
58,011 |
|
AT&T, Inc. |
|
|
64,293 |
|
|
|
57,605 |
|
Toronto Dominion |
|
|
48,816 |
|
|
|
46,577 |
|
Verizon |
|
|
41,480 |
|
|
|
37,208 |
|
American International Group |
|
|
48,367 |
|
|
|
32,760 |
|
HSBC |
|
|
36,755 |
|
|
|
32,102 |
|
Wells Fargo |
|
|
35,330 |
|
|
|
31,887 |
|
Deutsche Telekom |
|
|
30,380 |
|
|
|
27,786 |
|
Merrill Lynch |
|
|
34,418 |
|
|
|
27,506 |
|
Power Corp of Canada |
|
|
25,314 |
|
|
|
27,299 |
|
Morgan Stanley |
|
|
36,957 |
|
|
|
27,041 |
|
Time Warner Cable |
|
|
30,245 |
|
|
|
26,539 |
|
Kraft Foods, Inc. |
|
|
27,943 |
|
|
|
25,976 |
|
Wachovia |
|
|
42,957 |
|
|
|
24,909 |
|
Goldman Sachs |
|
|
36,304 |
|
|
|
24,866 |
|
Enbridge, Inc. |
|
|
20,718 |
|
|
|
23,841 |
|
Banco Santander |
|
|
35,805 |
|
|
|
23,460 |
|
|
|
|
Total |
|
$ |
910,071 |
|
|
$ |
763,188 |
|
|
|
|
As of September 30, 2008, the Company has the ability and intent to hold these investment
securities until the recovery of the fair value up to the current cost of the investment, which may
be maturity. However, from time to time when facts and circumstances arise, the Company may sell
securities in the ordinary course of managing its portfolio to meet diversification, credit
quality, yield enhancement, asset-liability management and liquidity requirements.
The Companys mortgage loan portfolio consists principally of investments in U.S.-based commercial
offices, light industrial properties and retail locations. The mortgage loan portfolio is
diversified by geographic region and property type. Substantially all mortgage loans are
performing and no valuation allowance has been established as of September 30, 2008 or December 31,
2007.
Policy loans present no credit risk because the amount of the loan cannot exceed the obligation due
the ceding company upon the death of the insured or surrender of the underlying policy. The
provisions of the treaties in force and the underlying policies determine the policy loan interest
rates. Because policy loans represent premature distributions of policy liabilities, they have the
effect of reducing future disintermediation risk. In addition, the Company earns a spread between
the interest rate earned on policy loans and the interest rate credited to corresponding
liabilities.
Funds withheld at interest comprised approximately 28.9% and 28.3% of the Companys cash and
invested assets as of September 30, 2008 and December 31, 2007, respectively. For agreements
written on a modified coinsurance basis and certain agreements written on a coinsurance basis,
assets equal to the net statutory reserves are withheld and legally owned and managed by the ceding
company, and are reflected as funds withheld at interest on the Companys condensed consolidated
balance sheet. In the event of a ceding companys insolvency, the Company would need to assert a
claim on the assets supporting its reserve liabilities. However, the risk of loss to the Company
is mitigated by its ability to offset amounts it owes the ceding company for claims or allowances
with amounts owed to the Company from the ceding company. Interest accrues to these assets at
rates defined by the treaty terms. The Company is subject to the investment performance on the
withheld assets, although it does not directly control them. These assets are primarily fixed
maturity investment securities and pose risks similar to the fixed maturity securities the Company
owns. The underlying portfolios also include options related to equity indexed annuity products.
The market value changes associated with these investments have caused some volatility in reported
investment income. This is largely offset by a corresponding change in interest credited, with
minimal impact on income before taxes. To mitigate risk, the Company helps set the investment
guidelines followed by the
48
ceding company and monitors
compliance. Ceding companies with funds withheld at interest had an average rating of A+ at
September 30, 2008 and December 31, 2007. Certain ceding companies maintain segregated portfolios
for the benefit of the Company.
Other invested assets represented approximately 2.6% and 1.7% of the Companys cash and invested
assets as of September 30, 2008 and December 31, 2007, respectively. Other invested assets include
derivative contracts, equity securities, preferred stocks, structured loans and limited partnership
interests. The Company recorded $16.9 million in other-than-temporary write-downs on preferred
stock investments in the first nine months of 2008. The Company did not record any
other-than-temporary write-downs on its preferred stock investments in the first nine months of
2007. The Company may be exposed to credit-related losses in the event of non-performance by
counterparties to derivative financial instruments. Generally, the current credit exposure of the
Companys derivative contracts is limited to contracts with a net positive fair value position at
the reporting date. At September 30, 2008, the Company had credit exposure of $24.7 million
related to its derivative contracts.
Contractual Obligations
From December 31, 2007 to September 30, 2008, the value of the Companys obligation for collateral
finance facility, including interest, decreased by $141.2 million due to substantially reduced
variable interest rates in the current quarter as previously discussed. There were no other
material changes in the Companys contractual obligations from those reported in the 2007 Annual
Report.
Mortality Risk Management
In the event that mortality or morbidity experience develops in excess of expectations, some
reinsurance treaties allow for increases to future premium rates. Other treaties include
experience refund provisions, which may also help reduce RGAs mortality risk. In the normal
course of business, the Company seeks to limit its exposure to loss on any single insured and to
recover a portion of claims paid by ceding reinsurance to other insurance enterprises or
retrocessionaires under excess coverage and coinsurance contracts. In the U.S., the Company
retains a maximum of $8.0 million of coverage per individual life. In certain limited situations,
due to the acquisition of in force blocks of business, the Company has retained more than $8.0
million per individual policy. In total, there are 14 such cases of over-retained policies, for
amounts averaging $2.5 million over the Companys normal retention limit. The largest amount
over-retained on any one life is $10.1 million. The Company enters into agreements with other
reinsurers to mitigate the risk related to the over-retained policies, which renew annually in
September and October. For other countries, particularly those with higher risk factors or smaller
books of business, the Company systematically reduces its retention. The Company has a number of
retrocession arrangements whereby certain business in force is retroceded on an automatic or
facultative basis.
The Company maintains a catastrophe insurance program (Program) that renews on September 7th of
each year. The current Program began September 7, 2008, and covers events involving 10 or more
insured deaths from a single occurrence. The Company retains the first $10 million in claims, the
Program covers the next $50 million in claims, and the Company retains all claims in excess of $60
million. The Program covers reinsurance programs worldwide and includes losses due to acts of
terrorism, including terrorism losses due to nuclear, chemical and/or biological events. The
Program excludes losses from earthquakes occurring in California and also excludes losses from
pandemics. The Program is insured by eleven insurance companies and Lloyds Syndicates, with no
single entity providing more than $10 million of coverage.
Counterparty
Risk - Reinsurance
In the normal course of business, the Company seeks to limit its exposure to reinsurance contracts
by ceding a portion of the reinsurance to other insurance companies or reinsurers. Should a
counterparty not be able to fulfill its obligation to the Company under a reinsurance agreement,
the impact could be material to the Companys financial condition and results of operations.
Generally, RGAs insurance subsidiaries retrocede amounts in excess of their retention to RGA
Reinsurance, RGA Reinsurance Company (Barbados) Ltd., RGA Americas Reinsurance Company, Ltd., RGA
Worldwide Reinsurance Company, Ltd. or RGA Atlantic Reinsurance Company, Ltd. External
retrocessions are arranged through the Companys retrocession pools for amounts in excess of its
retention. As of September 30, 2008, all retrocession pool members in this excess retention pool
reviewed by the A.M. Best Company were rated A-, the fourth highest rating out of fifteen
possible ratings, or better. The Company also retrocedes most of its financial reinsurance
49
business to other insurance companies to alleviate the strain on statutory surplus created by this
business. For a
majority of the retrocessionaires that are not rated, letters of credit or trust assets have been
given as additional security in favor of RGA Reinsurance. In addition, the Company performs annual
financial and in force reviews of its retrocessionaires to evaluate financial stability and
performance.
The Company has never experienced a material default in connection with retrocession arrangements,
nor has it experienced any material difficulty in collecting claims recoverable from
retrocessionaires; however, no assurance can be given as to the future performance of such
retrocessionaires or as to the recoverability of any such claims.
The Company relies upon its clients to provide timely, accurate information. The Company may
experience volatility in its earnings as a result of erroneous or untimely reporting from its
clients. The Company works closely with its clients and monitors this risk in an effort to
minimize its exposure.
Market Risk
Market risk is the risk of loss that may occur when fluctuations in interest and currency exchange
rates and equity and commodity prices change the value of a financial instrument. Since both
derivative and nonderivative financial instruments have market risk, the Companys risk management
extends beyond derivatives to encompass all financial instruments held. The Company is primarily
exposed to interest rate risk and foreign currency risk.
Interest rate risk arises from many of the Companys primary activities, as the Company invests
substantial funds in interest-sensitive assets and also has certain interest-sensitive contract
liabilities. The Company manages interest rate risk and credit risk to maximize the return on the
Companys capital effectively and to preserve the value created by its business operations. As
such, certain management monitoring processes are designed to minimize the impact of sudden and
sustained changes in interest rates on fair value, cash flows, and interest income.
The Company is subject to foreign currency translation, transaction, and net income exposure. The
Company manages its exposure to currency principally by matching invested assets with the
underlying reinsurance liabilities to the extent possible. The Company has in place a net
investment hedge of a portion of its investment in Canada operations. Translation differences
resulting from translating foreign subsidiary balances to U.S. dollars are reflected in
stockholders equity on the condensed consolidated balance sheets. The Company generally does not
hedge the foreign currency exposure of its subsidiaries transacting business in currencies other
than their functional currency (transaction exposure). The majority of the Companys foreign
currency transactions are denominated in Australian dollars, British pounds, Canadian dollars,
Japanese yen, Korean won, the South African rand and euros.
There has been no significant change in the Companys quantitative or qualitative aspects of market
risk during the quarter ended September 30, 2008 from that disclosed in the 2007 Annual Report.
New Accounting Standards
In October 2008, the Financial Accounting Standards Board (FASB) issued Staff Position (FSP)
No. FAS 157-3, Determining the Fair Value of a Financial Asset When the Market for That Asset Is
Not Active (FSP 157-3). FSP 157-3 clarifies the application of SFAS 157 in a market that is not
active and provides an example to illustrate key considerations in determining the fair value of a
financial asset when the market for that financial asset is not active. FSP 157-3 was effective
upon issuance on October 10, 2008, including prior periods for which financial statements had not
been issued. The Company did not consider it necessary to change any valuation techniques as a
result of FSP 157-3. The Company also adopted FSP No. FAS 157-2, Effective Date of FASB Statement
No. 157 which delays the effective date of SFAS 157 for certain nonfinancial assets and
liabilities that are recorded at fair value on a nonrecurring basis. The effective date is delayed
until January 1, 2009 and impacts balance sheet items including nonfinancial assets and liabilities
in a business combination and the impairment testing of goodwill and long-lived assets.
In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging
Activities An Amendment of FASB Statement No. 133 (SFAS 161). SFAS 161 requires enhanced
qualitative disclosures about objectives and strategies for using derivatives, quantitative
disclosures about fair value amounts of and gains and losses on derivative instruments, and
disclosures about credit-risk-related contingent features in derivative agreements. SFAS 161 is
effective for financial statements issued for fiscal years and interim periods beginning after
November 15, 2008. The Company is currently evaluating the impact of SFAS 161 on its condensed
consolidated financial statements.
50
In February 2008, the FASB issued FSP No. FAS 140-3, Accounting for Transfers of Financial Assets
and Repurchase Financing Transactions (FSP 140-3). FSP 140-3 provides guidance for evaluating
whether to account for a transfer of a financial asset and repurchase financing as a single
transaction or as two separate transactions. FSP 140-3 is effective prospectively for financial
statements issued for fiscal years beginning after November 15, 2008. The Company is currently
evaluating the impact of FSP 140-3 on its condensed consolidated financial statements.
Effective January 1, 2008, the Company adopted SFAS No. 157. SFAS 157 defines fair value,
establishes a framework for measuring fair value in GAAP and requires enhanced disclosures about
fair value measurements. SFAS 157 does not require any new fair value measurements. The adoption
of SFAS 157 resulted in a pre-tax gain of approximately $3.9 million, included in interest
credited, related primarily to the decrease in the fair value of liability embedded derivatives
associated with equity-indexed annuity products primarily from the incorporation of nonperformance
risk, also referred to as the Companys own credit risk, into the fair value calculation.
In December 2007, the FASB issued SFAS No. 141 (revised 2007), Business Combinations A
Replacement of FASB Statement No. 141 (SFAS 141(r)) and SFAS No. 160, Noncontrolling Interests
in Consolidated Financial Statements An Amendment of ARB No. 51 (SFAS 160). SFAS 141(r)
establishes principles and requirements for how an acquirer recognizes and measures certain items
in a business combination, as well as disclosures about the nature and financial effects of a
business combination. SFAS 160 establishes accounting and reporting standards surrounding
noncontrolling interest, or minority interests, which are the portions of equity in a subsidiary
not attributable, directly or indirectly, to a parent. The pronouncements are effective for fiscal
years beginning on or after December 15, 2008 and apply prospectively to business combinations.
Presentation and disclosure requirements related to noncontrolling interests must be
retrospectively applied. The Company is currently evaluating the impact of SFAS 141(r) on its
accounting for future acquisitions and the impact of SFAS 160 on its condensed consolidated
financial statements.
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and
Financial Liabilities (SFAS 159). SFAS 159 permits all entities the option to measure most
financial instruments and certain other items at fair value at specified election dates and to
report related unrealized gains and losses in earnings. The fair value option will generally be
applied on an instrument-by-instrument basis and is generally an irrevocable election. SFAS 159 is
effective for fiscal years beginning after November 15, 2007. The Company did not elect to apply
the fair value option available under SFAS 159 for any of its eligible financial instruments.
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk
See Item 2 Managements Discussion and Analysis of Financial Condition and Results of Operations
- Market Risk which is included herein.
ITEM 4. Controls and Procedures
The Chief Executive Officer and the Chief Financial Officer have evaluated the effectiveness of the
design and operation of the Companys disclosure controls and procedures as defined in Exchange Act
Rule 13a-15(e) as of the end of the period covered by this report. Based on that evaluation, the
Chief Executive Officer and the Chief Financial Officer concluded that these disclosure controls
and procedures were effective.
There was no change in the Companys internal control over financial reporting as defined in
Exchange Act Rule 13a-15(f) during the quarter ended September 30, 2008, that has materially
affected, or is reasonably likely to materially affect, the Companys internal control over
financial reporting.
PART
II - OTHER INFORMATION
ITEM 1. Legal Proceedings
In January 2006, the Company was threatened with an arbitration related to its life reinsurance
business. As of June 30, 2008, the ceding company involved in this action had raised a claim in
the amount of $4.9 million. During the third quarter, the Company and the ceding company settled
the matter with no net payment by the Company.
Additionally, the Company is subject to litigation in the normal course of its business. The
Company currently has no material litigation. However, if such material litigation did arise, it
is possible that an adverse outcome on any
51
particular arbitration or litigation situation could have a material adverse effect on the
Companys consolidated net income in a particular reporting period.
ITEM 1A. Risk Factors
In the risk factors below, we refer to the Company as we, us, or our. The following list of
risk factors supercedes the risk factors previously disclosed in the Companys 2007 Annual Report
and the Companys Form 10-Q for the period ending June 30, 2008. For a discussion of additional
uncertainties associated with (1) RGAs businesses and (2) forward-looking statements in this
document, see Forward-Looking and Cautionary Statements.
Risks Related to Our Business
Adverse capital and credit market conditions may significantly affect our ability to meet liquidity
needs, access to capital and cost of capital.
The capital and credit markets have been experiencing extreme volatility and disruption for more
than twelve months. In recent weeks, the volatility and disruption have reached unprecedented
levels. In some cases, the markets have exerted downward pressure on availability of liquidity and
credit capacity for certain issuers.
We need liquidity to pay our operating expenses, interest on our debt and dividends on our capital
stock and replace certain maturing liabilities. Without sufficient liquidity, we will be forced to
curtail our operations, and our business will suffer. The principal sources of our liquidity are
reinsurance premiums, annuity considerations under reinsurance treaties and cash flow from our
investment portfolio and assets, consisting mainly of cash or assets that are readily convertible
into cash. Sources of liquidity in normal markets also include a variety of short- and long-term
instruments, including medium- and long-term debt, junior subordinated debt securities, capital
securities and shareholders equity.
In the event current resources do not satisfy our needs, we may have to seek additional financing.
The availability of additional financing will depend on a variety of factors such as market
conditions, the general availability of credit, the volume of trading activities, the overall
availability of credit to the financial services industry, our credit ratings and credit capacity,
as well as the possibility that customers or lenders could develop a negative perception of our
long- or short-term financial prospects if we incur large investment losses or if the level of our
business activity decreased due to a market downturn. Similarly, our access to funds may be
impaired if regulatory authorities or rating agencies take negative actions against us. Our
internal sources of liquidity may prove to be insufficient, and in such case, we may not be able to
successfully obtain additional financing on favorable terms, or at all.
Disruptions, uncertainty or volatility in the capital and credit markets may also limit our access
to capital required to operate our business, most significantly our reinsurance operations. Such
market conditions may limit our ability to replace, in a timely manner, maturing liabilities;
satisfy statutory capital requirements; generate fee income and market-related revenue to meet
liquidity needs; and access the capital necessary to grow our business. As such, we may be forced
to delay raising capital, issue shorter tenor securities than we prefer, or bear an unattractive
cost of capital which could decrease our profitability and significantly reduce our financial
flexibility. Recently our credit spreads have widened considerably. Further, our ability to
finance our statutory reserve requirements is limited in the current marketplace. If capacity
continues to be limited for a prolonged period of time, our ability to obtain new funding for such
purposes may be hindered and, as a result, our ability to write additional business in a
cost-effective manner may be impacted. Our results of operations, financial condition, cash flows
and statutory capital position could be materially adversely affected by disruptions in the
financial markets.
Difficult conditions in the global capital markets and the economy generally may materially
adversely affect our business and results of operations and we do not expect these conditions to
improve in the near future.
Our results of operations are materially affected by conditions in the global capital markets and
the economy generally, both in the United States and elsewhere around the world. The stress
experienced by global capital markets that began in the second half of 2007 continued and
substantially increased during the third quarter of 2008. Recently, concerns over inflation, energy
costs, geopolitical issues, the availability and cost of credit, the U.S. mortgage market and a
declining real estate market in the United States have contributed to increased volatility and
diminished expectations for the economy and the markets going forward. These factors, combined
with volatile oil
52
prices, declining business and consumer confidence and increased unemployment, have precipitated an
economic slowdown and fears of a possible recession. In addition, the fixed-income markets are
experiencing a period of extreme volatility which has negatively impacted market liquidity
conditions. Initially, the concerns on the part of market participants were focused on the
subprime segment of the mortgage-backed securities market. However, these concerns have since
expanded to include a broad range of mortgage-and asset-backed and other fixed income securities,
including those rated investment grade, the U.S. and international credit and interbank money
markets generally, and a wide range of financial institutions and markets, asset classes and
sectors. As a result, the market for fixed income instruments has experienced decreased liquidity,
increased price volatility, credit downgrade events, and increased probability of default.
Securities that are less liquid are more difficult to value and may be hard to dispose of.
Domestic and international equity markets have also been experiencing heightened volatility and
turmoil, with issuers (such as our company) that have exposure to the mortgage and credit markets
particularly affected. These events and the continuing market upheavals may have an adverse effect
on us, in part because we have a large investment portfolio and are also dependent upon customer
behavior. Our revenues may decline in such circumstances and our profit margins may erode. In
addition, in the event of extreme prolonged market events, such as the global credit crisis, we
could incur significant losses. Even in the absence of a market downturn, we are exposed to
substantial risk of loss due to market volatility.
Factors such as consumer spending, business investment, government spending, the volatility and
strength of the capital markets, and inflation all affect the business and economic environment
and, indirectly, the amount and profitability of our business. In an economic downturn
characterized by higher unemployment, lower family income, lower corporate earnings, lower business
investment and lower consumer spending, the demand for financial and insurance products could be
adversely affected. Adverse changes in the economy could affect earnings negatively and could have
a material adverse effect on our business, results of operations and financial condition. The
current mortgage crisis has also raised the possibility of future legislative and regulatory
actions in addition to the recent enactment of the Emergency Economic Stabilization Act of 2008
(the EESA) that could further impact our business. We cannot predict whether or when such
actions may occur, or what impact, if any, such actions could have on our business, results of
operations and financial condition.
There can be no assurance that actions of the U.S. Government, Federal Reserve and other
governmental and regulatory bodies for the purpose of stabilizing the financial markets will
achieve the intended effect.
In response to the financial crises affecting the banking system and financial markets and going
concern threats to investment banks and other financial institutions, on October 3, 2008, President
Bush signed the EESA into law. Pursuant to the EESA, the U.S. Treasury has the authority to, among
other things, purchase up to $700 billion of mortgage-backed and other securities from financial
institutions in order to make direct investments in financial institutions for the purpose of
stabilizing the financial markets. The Federal Government, Federal Reserve and other governmental
and regulatory bodies have taken or are considering taking other actions to address the financial
crisis. There can be no assurance as to what impact such actions will have on the financial
markets, including the extreme levels of volatility currently being experienced. Such continued
volatility could materially and adversely affect our business, financial condition and results of
operations, or the trading price of our common stock.
The impairment of other financial institutions could adversely affect us.
We have exposure to many different industries and counterparties, and routinely execute
transactions with counterparties in the financial services industry, including brokers and dealers,
insurance companies, commercial banks, investment banks, investment funds and other institutions.
Many of these transactions expose us to credit risk in the event of default of our counterparty. In
addition, with respect to secured transactions, our credit risk may be exacerbated when the
collateral held by us cannot be realized upon or is liquidated at prices not sufficient to recover
the full amount of the loan or derivative exposure due to it. We also have exposure to these
financial institutions in the form of unsecured debt instruments, derivative transactions and
equity investments. There can be no assurance that any such losses or impairments to the carrying
value of these assets would not materially and adversely affect our business and results of
operations.
Our requirements to post collateral or make payments related to declines in market value of
specified assets may adversely affect our liquidity and expose us to counterparty credit risk.
Some of our transactions with financial and other institutions specify the circumstances under
which the parties are required to post collateral. The amount of collateral we may be required to
post under these agreements may
53
increase under certain circumstances, which could adversely affect our liquidity. In addition,
under the terms of some of our transactions we may be required to make payment to our
counterparties related to any decline in the market value of the specified assets.
Defaults on our mortgage loans and volatility in performance may adversely affect our
profitability.
Our mortgage loans face default risk and are principally collateralized by commercial properties.
Mortgage loans are stated on our balance sheet at unpaid principal balance, adjusted for any
unamortized premium or discount, deferred fees or expenses, and are net of valuation allowances.
We establish valuation allowances for estimated impairments as of the balance sheet date. Such
valuation allowances are based on the excess carrying value of the loan over the present value of
expected future cash flows discounted at the loans original effective interest rate, the value of
the loans collateral if the loan is in the process of foreclosure or otherwise collateral
dependent, or the loans market value if the loan is being sold. We also establish allowances for
loan losses when a loss contingency exists for pools of loans with similar characteristics, such as
mortgage loans based on similar property types or loan to value risk factors. At September 30,
2008, we had not established any valuation allowances and no loans were in process of foreclosure.
The performance of our mortgage loan investments, however, may fluctuate in the future. An increase
in the default rate of our mortgage loan investments could have a material adverse effect on our
business, results of operations and financial condition.
Further, any geographic or sector concentration of our mortgage loans may have adverse effects on
our investment portfolios and consequently on our consolidated results of operations or financial
condition. While we seek to mitigate this risk by having a broadly diversified portfolio, events
or developments that have a negative effect on any particular geographic region or sector may have
a greater adverse effect on the investment portfolios to the extent that the portfolios are
concentrated. Moreover, our ability to sell assets relating to such particular groups of related
assets may be limited if other market participants are seeking to sell at the same time.
Our investments are reflected within the consolidated financial statements utilizing different
accounting basis and accordingly we may not have recognized differences, which may be significant,
between cost and fair value in our consolidated financial statements.
Our principal investments are in fixed maturity and equity securities, short-term investments,
mortgage loans, policy loans, funds withheld at interest, and other invested assets. The carrying
value of such investments is as follows:
|
|
|
Fixed maturity and equity securities are classified as available-for-sale and are
reported at their estimated fair value. Unrealized investment gains and losses on these
securities are recorded as a separate component of other comprehensive income or loss, net
of related deferred acquisition costs and deferred income taxes. |
|
|
|
|
Short-term investments include investments with remaining maturities of one year or
less, but greater than three months, at the time of acquisition and are stated at amortized
cost, which approximates fair value. |
|
|
|
|
Mortgage and policy loans are stated at unpaid principal balance. Additionally,
mortgage loans are adjusted for any unamortized premium or discount, deferred fees or
expenses, net of valuation allowances. |
|
|
|
|
Funds withheld at interest represent amounts contractually withheld by ceding companies
in accordance with reinsurance agreements. The value of the assets withheld and interest
income are recorded in accordance with specific treaty terms. We use the cost method of
accounting for investments in real estate joint ventures and other limited partnership
interests since we have a minor equity investment and virtually no influence over the joint
ventures or the partnerships operations. These investments are reflected in other
invested assets on the balance sheet. |
Investments not carried at fair value in our consolidated financial statements principally,
mortgage loans, policy loans, real estate joint ventures, and other limited partnerships may have
fair values which are substantially higher or lower than the carrying value reflected in our
consolidated financial statements. Each of such asset classes is regularly evaluated for
impairment under the accounting guidance appropriate to the respective asset class.
Our valuation of fixed maturity and equity securities may include methodologies, estimations and
assumptions which are subject to differing interpretations and could result in changes to
investment valuations that may materially adversely affect our results of operations or financial
condition.
Fixed maturity, equity securities and short-term investments which are reported at fair value on
the consolidated balance sheet represented the majority of our total cash and invested assets. We
have categorized these securities into a three-level hierarchy, based on the priority of the inputs
to the respective valuation technique. The fair value
54
hierarchy gives the highest priority to quoted prices in active markets for identical assets or
liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). An asset or
liabilitys classification within the fair value hierarchy is based of the lowest level of
significant input to its valuation. SFAS 157 defines the input levels as follows:
|
|
|
Level 1
|
|
Quoted prices in active markets for identical assets or
liabilities. Our Level 1 assets and liabilities include investment
securities and derivative contracts that are traded in exchange
markets. |
|
|
|
Level 2
|
|
Observable inputs other than Level 1 prices such as quoted prices
for similar assets or liabilities; quoted prices in markets that
are not active; or market standard valuation methodologies and
assumptions with significant inputs that are observable or can be
corroborated by observable market data for substantially the full
term of the assets or liabilities. Our Level 2 assets and
liabilities include investment securities with quoted prices that
are traded less frequently than exchange-traded instruments and
derivative contracts whose values are determined using market
standard valuation methodologies. This category primarily
includes U.S. and foreign corporate securities, Canadian and
Canadian provincial government securities, and residential and
commercial mortgage-backed securities, among others. We value
most of these securities using inputs that are market observable |
|
|
|
Level 3
|
|
Unobservable inputs that are supported by little or no market
activity and that are significant to the fair value of the related
assets or liabilities. Level 3 assets and liabilities include
financial instruments whose value is determined using market
standard valuation methodologies described above. When observable
inputs are not available, the market standard methodologies for
determining the estimated fair value of certain securities that
trade infrequently, and therefore have little transparency, rely
on inputs that are significant to the estimated fair value and
that are not observable in the market or cannot be derived
principally from or corroborated by observable market data. These
unobservable inputs can be based in large part on management
judgment or estimation and cannot be supported by reference to
market activity. Even though unobservable, management believes
these inputs are based on assumptions deemed appropriate given the
circumstances and consistent with what other market participants
would use when pricing similar assets and liabilities. For our
invested assets, this category generally includes U.S. and foreign
corporate securities (primarily private placements), asset-backed
securities (including those with exposure to subprime mortgages),
and to a lesser extent, certain residential and commercial
mortgage-backed securities, among others. Additionally, our
embedded derivatives, all of which are associated with reinsurance
treaties, are classified in Level 3 since their values include
significant unobservable inputs associated with actuarial
assumptions regarding policyholder behavior. Embedded derivatives
are reported with the host instruments on the condensed
consolidated balance sheet. |
As required by SFAS 157, when inputs used to measure fair value fall within different levels of the
hierarchy, the level within which the fair value measurement is categorized is based on the lowest
priority level input that is significant to the fair value measurement in its entirety. For
example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2)
and unobservable (Level 3). Therefore, gains and losses for such assets and liabilities
categorized within Level 3 may include changes in fair value that are attributable to both
observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
Prices provided by independent pricing services and independent broker quotes can vary widely even
for the same security.
The determination of fair values in the absence of quoted market prices is based on: (i) valuation
methodologies; (ii) securities we deem to be comparable; and (iii) assumptions deemed appropriate
given the circumstances. The fair value estimates are made at a specific point in time, based on
available market information and judgments about financial instruments, including estimates of the
timing and amounts of expected future cash flows and the credit standing of the issuer or
counterparty. Factors considered in estimating fair value include: coupon rate, maturity,
estimated duration, call provisions, sinking fund requirements, credit rating, industry sector of
the issuer, and quoted market prices of comparable securities. The use of different methodologies
and assumptions may have a material effect on the estimated fair value amounts.
During periods of market disruption including periods of significantly rising or high interest
rates, rapidly widening credit spreads or illiquidity, it may be difficult to value certain of our
securities, for example Alt-A and subprime
55
mortgage backed securities, if trading becomes less frequent and/or market data becomes less
observable. There may be certain asset classes that were in active markets with significant
observable data that become illiquid due to the current financial environment. In such cases, more
securities may fall to Level 3 and thus require more subjectivity and management judgment. As
such, valuations may include inputs and assumptions that are less observable or require greater
estimation as well as valuation methods which are more sophisticated or require greater estimation
thereby resulting in values which may be less than the value at which the investments may be
ultimately sold. Further, rapidly changing and unprecedented credit and equity market conditions
could materially impact the valuation of securities as reported within our consolidated financial
statements and the period-to-period changes in value could vary significantly. Decreases in value
may have a material adverse effect on our results of operations or financial condition.
Some of our investments are relatively illiquid and are in asset classes that have been
experiencing significant market valuation fluctuations.
We hold certain investments that may lack liquidity, such as privately placed fixed maturity
securities; mortgage loans; policy loans and equity real estate, including real estate joint
venture; and other limited partnership interests. Even some of our very high quality assets have
been more illiquid as a result of the recent challenging market conditions.
If we require significant amounts of cash on short notice in excess of normal cash requirements or
are required to post or return collateral in connection with our investment portfolio, derivatives
transactions or securities lending activities, we may have difficulty selling these investments in
a timely manner, be forced to sell them for less than we otherwise would have been able to realize,
or both.
The reported value of our relatively illiquid types of investments, our investments in the asset
classes described in the paragraph above and, at times, our high quality, generally liquid asset
classes, do not necessarily reflect the lowest current market price for the asset. If we were
forced to sell certain of our assets in the current market, there can be no assurance that we will
be able to sell them for the prices at which we have recorded them and we may be forced to sell
them at significantly lower prices.
The determination of the amount of allowances and impairments taken on our investments is highly
subjective and could materially impact our results of operations or financial position.
The determination of the amount of allowances and impairments vary by investment type and is based
upon our periodic evaluation and assessment of known and inherent risks associated with the
respective asset class. Such evaluations and assessments are revised as conditions change and new
information becomes available. Management updates its evaluations regularly and reflects changes
in allowances and impairments in operations as such evaluations are revised. There can be no
assurance that our management has accurately assessed the level of impairments taken and allowances
reflected in our financial statements. Furthermore, additional impairments may need to be taken or
allowances provided for in the future. Historical trends may not be indicative of future
impairments or allowances.
For example, the cost of our fixed maturity and equity securities is adjusted for impairments in
value deemed to be other-than-temporary in the period in which the determination is made. The
assessment of whether impairments have occurred is based on managements case-by-case evaluation of
the underlying reasons for the decline in fair value. The review of our fixed maturity and equity
securities for impairments includes an analysis of the total gross unrealized losses by three
categories of securities: (i) securities where the estimated fair value had declined and remained
below cost or amortized cost by less than 20%; (ii) securities where the estimated fair value had
declined and remained below cost or amortized cost by 20% or more for less than six months; and
(iii) securities where the estimated fair value had declined and remained below cost or amortized
cost by 20% or more for six months or greater.
Additionally, our management considers a wide range of factors about the security issuer and uses
their best judgment in evaluating the cause of the decline in the estimated fair value of the
security and in assessing the prospects for near-term recovery. Inherent in managements
evaluation of the security are assumptions and estimates about the operations of the issuer and its
future earnings potential. Considerations in the impairment evaluation process include, but are
not limited to: (i) the length of time and the extent to which the market value has been below cost
or amortized cost; (ii) the potential for impairments of securities when the issuer is experiencing
56
significant financial difficulties; (iii) the potential for impairments in an entire industry
sector or sub-sector; (iv) the potential for impairments in certain economically depressed
geographic locations; (v) the potential for impairments of securities where the issuer, series of
issuers or industry has suffered a catastrophic type of loss or has exhausted natural resources;
(vi) our ability and intent to hold the security for a period of time sufficient to allow for the
recovery of its value to an amount equal to or greater than cost or amortized cost;
(vii) unfavorable changes in forecasted cash flows on mortgage-backed and asset-backed securities;
and (viii) other subjective factors, including concentrations and information obtained from
regulators and rating agencies.
Gross unrealized losses may be realized or result in future impairments.
Our gross unrealized losses on fixed maturity securities at September 30, 2008 are $960.6 million
pre-tax. Since September 30, 2008, the bond and equity markets have continued to deteriorate. As of October 29, 2008, the
Company estimates that the market value of RGAs investment portfolios, excluding funds withheld,
has declined by approximately $300 million, pre-tax since September 30, 2008, primarily due to
continued spread widening in credit markets. Realized losses or impairments may have a material
adverse impact on our results of operation and financial position.
Defaults, downgrades or other events impairing the value of our fixed maturity securities portfolio
may reduce our earnings.
We are subject to the risk that the issuers, or guarantors, of fixed maturity securities we own may
default on principal and interest payments they owe us. At September 30, 2008, the fixed maturity
securities of $9.1 billion in our investment portfolio represented 55% of our total cash and
invested assets. The occurrence of a major economic downturn (such as the current downturn in the
economy), acts of corporate malfeasance, widening risk spreads, or other events that adversely
affect the issuers or guarantors of these securities could cause the value of our fixed maturity
securities portfolio and our net income to decline and the default rate of the fixed maturity
securities in our investment portfolio to increase. A ratings downgrade affecting issuers or
guarantors of particular securities, or similar trends that could worsen the credit quality of
issuers, such as the corporate issuers of securities in our investment portfolio, could also have a
similar effect. With economic uncertainty, credit quality of issuers or guarantors could be
adversely affected. Any event reducing the value of these securities other than on a temporary
basis could have a material adverse effect on our business, results of operations and financial
condition. Levels of write down or impairment are impacted by our assessment of the intent and
ability to hold securities which have declined in value until recovery. If we determine to
reposition or realign portions of the portfolio where we determine not to hold certain securities
in an unrealized loss position to recovery, then we will incur an other than temporary impairment.
A downgrade in our ratings or in the ratings of our reinsurance subsidiaries could adversely affect
our ability to compete.
Ratings are an important factor in our competitive position. Rating organizations periodically
review the financial performance and condition of insurers, including our reinsurance subsidiaries.
These ratings are based on an insurance companys ability to pay its obligations and are not
directed toward the protection of investors. Rating organizations assign ratings based upon
several factors. While most of the factors considered relate to the rated company, some of the
factors relate to general economic conditions and circumstances outside the rated companys
control. There were no changes to our solicited ratings during 2008. The various rating agencies
periodically review and evaluate our capital adequacy in accordance with their established
guidelines and capital models. In order to maintain our existing ratings, we may commit from time
to time to manage our capital at levels commensurate with such guidelines and models. If our
capital levels are insufficient to fulfill any such commitments, we could be required to reduce our
risk profile by, for example, retroceding some of our business or by raising additional capital by
issuing debt, hybrid, or equity securities. Any such actions could have a material adverse impact
on our earnings or materially dilute our shareholders equity ownership interests.
Any downgrade in the ratings of our reinsurance subsidiaries could adversely affect their ability
to sell products, retain existing business, and compete for attractive acquisition opportunities.
Ratings are subject to revision or withdrawal at any time by the assigning rating organization. A
rating is not a recommendation to buy, sell or hold securities, and each rating should be evaluated
independently of any other rating. We believe that the rating agencies consider the ratings of a
parent company when assigning a rating to a subsidiary of that company. The ability of our
subsidiaries to write reinsurance partially depends on their financial condition and is influenced
by
57
their ratings. In addition, a significant downgrade in the rating or outlook of RGA, among other
factors, could adversely affect our ability to raise and then contribute capital to our
subsidiaries for the purpose of facilitating their operations as well as the cost of capital. For
example, the facility fee and interest rate for our credit facilities are based on our senior
long-term debt ratings. A decrease in those ratings could result in an increase in costs for the
credit facilities. Accordingly, we believe a ratings downgrade of RGA, or of our affiliates, could
have a negative effect on our ability to conduct business.
We cannot assure you that any action taken by our ratings agencies would not result in a material
adverse effect on our business and results of operations. In addition, it is unclear what effect,
if any, a ratings change would have on the price of our securities in the secondary market.
The recent tax-free distribution of our capital stock by our former majority shareholder, MetLife,
could result in potentially significant limitations on the ability of RGA to execute certain
aspects of its business plan and could potentially result in significant tax-related liabilities to
RGA.
In connection with the recent distribution, or split-off, of our capital stock by our former
majority shareholder, MetLife, Inc., or MetLife, MetLife and RGA have agreed to certain
tax-related restrictions and indemnities set forth in a recapitalization and distribution agreement
dated as of June 1, 2008. Under that agreement, we may be restricted or deterred from
(i) redeeming or purchasing our stock in excess of certain agreed-upon amounts, (ii) issuing any
equity securities in excess of certain agreed upon amounts, or (iii) taking any other action that
would be inconsistent with the representations and warranties made in connection with the IRS
ruling and the tax opinion (as those terms are defined in the agreement). Except in specified
circumstances, we have agreed to indemnify MetLife for taxes and tax-related losses it incurs as a
result of the divestiture failing to qualify as tax-free, if the taxes and related losses are
attributable solely to any breach of, or inaccuracy in, any representation, covenant or obligation
of RGA under the recapitalization and distribution agreement or that will be made in connection
with the tax opinion. This indemnity could result in significant liabilities to RGA.
The acquisition restrictions contained in our articles of incorporation and our
Section 382 shareholder rights plan, which are intended to help preserve RGA and its subsidiaries
NOLs and other tax attributes, may not be effective or may have unintended negative effects.
We have recognized and may continue to recognize substantial net operating losses, or NOLs, and
other tax attributes, for U.S. federal income tax purposes, and under the Internal Revenue Code, we
may carry forward these NOLs, in certain circumstances to offset any current and future taxable
income and thus reduce our federal income tax liability, subject to certain requirements and
restrictions. To the extent that the NOLs do not otherwise become limited, we believe that we will
be able to carry forward a substantial amount of NOLs and, therefore, these NOLs are a substantial
asset to RGA. However, if RGA and its subsidiaries experience an ownership change, as defined in
Section 382 of the Internal Revenue Code and related Treasury regulations, their ability to use the
NOLs could be substantially limited, and the timing of the usage of the NOLs could be substantially
delayed, which consequently could significantly impair the value of that asset.
To reduce the likelihood of an ownership change, in light of MetLifes recent divestiture of most
of its RGA stock, we have established acquisition restrictions in our articles of incorporation and
our board of directors adopted a Section 382 shareholder rights plan. The Section 382 shareholder
rights plan is designed to protect shareholder value by attempting to protect against a limitation
on the ability of RGA and its subsidiaries to use their existing NOLs and other tax attributes.
The acquisition restrictions in our articles of incorporation are also intended to restrict certain
acquisitions of RGA stock to help preserve the ability of RGA and its subsidiaries to utilize their
NOLs and other tax attributes by avoiding the limitations imposed by Section 382 of the Internal
Revenue Code and the related Treasury regulations. The acquisition restrictions and the
Section 382 shareholder rights plan are generally designed to restrict or deter direct and indirect
acquisitions of RGA stock if such acquisition would result in an RGA shareholder becoming a
5-percent shareholder or increase the percentage ownership of RGA stock that is treated as owned by
an existing 5-percent shareholder.
Although the acquisition restrictions and the Section 382 shareholder rights plan are intended to
reduce the likelihood of an ownership change that could adversely affect RGA and its subsidiaries,
we can give no assurance that such restrictions would prevent all transfers that could result in
such an ownership change. In particular, we have been advised by our counsel that, absent a court
determination, there can be no assurance that the acquisition restrictions will be enforceable
against all of the RGA shareholders, and that they may be subject to challenge on
58
equitable grounds. In particular, it is possible that the acquisition restrictions may not be
enforceable against the RGA shareholders who voted against or abstained from voting on the
restrictions at our recent special meeting of shareholders or who do not have notice of the
restrictions at the time when they subsequently acquire their shares.
Further, the acquisition restrictions and Section 382 shareholder rights plan did not apply to,
among others, any Class B common stock acquired by any person in the split-off. Accordingly, the
acquisition restrictions and Section 382 shareholder rights plan may not prevent an ownership
change in connection with the divestiture.
Moreover, under certain circumstances, our board of directors may determine it is in the best
interest of RGA and its shareholders to exempt certain 5-percent shareholders from the operation of
the Section 382 shareholder rights plan, in light of the provisions of the recapitalization and
distribution agreement. After the split-off by MetLife, we may, under certain circumstances, incur
significant indemnification obligations under the recapitalization and distribution agreement in
the event that the Section 382 shareholder rights plan is triggered following the split-off in a
manner that would result in MetLifes divestiture failing to qualify as tax-free. Accordingly, our
board of directors may determine that the consequences of enforcing the Section 382 shareholder
rights plan and enhancing its deterrent effect by not exempting a 5-percent shareholder in order to
provide protection to RGAs and its subsidiaries NOLs and other tax attributes, are more adverse
to RGA and its shareholders.
The acquisition restrictions and Section 382 shareholder rights plan also require any person
attempting to become a holder of 5% or more (by value) of RGA stock, as determined under the
Internal Revenue Code, to seek the approval of our board of directors. This may have an unintended
anti-takeover effect because our board of directors may be able to prevent any future takeover.
Similarly, any limits on the amount of stock that a shareholder may own could have the effect of
making it more difficult for shareholders to replace current management. Additionally, because the
acquisition restrictions and Section 382 shareholder rights plan have the effect of restricting a
shareholders ability to dispose of or acquire RGA stock, the liquidity and market value of RGA
stock might suffer. The acquisition restrictions and the Section 382 shareholder rights plan will
remain in effect for the restriction period, which is until the earlier of (a) September 13,
2011, or (b) such other date as our board of directors in good faith determines that the
acquisition restrictions are no longer in the best interests of RGA and its shareholders. The
acquisition restrictions may be waived by our board of directors. Shareholders are advised to
monitor carefully their ownership of RGA stock and consult their own legal advisors and/or RGA to
determine whether their ownership of RGA stock approaches the proscribed level.
We make assumptions when pricing our products relating to mortality, morbidity, lapsation and
expenses, and significant deviations in actual experience could negatively affect our financial
results.
Our reinsurance contracts expose us to mortality risk, which is the risk that the level of
death claims may differ from that which we assumed in pricing our life, critical illness and
annuity reinsurance contracts. Some of our reinsurance contracts expose us to morbidity risk,
which is the risk that an insured person will become critically ill or disabled. Our risk analysis
and underwriting processes are designed with the objective of controlling the quality of the
business and establishing appropriate pricing for the risks we assume. Among other things, these
processes rely heavily on our underwriting, our analysis of mortality and morbidity trends, lapse
rates, expenses and our understanding of medical impairments and their effect on mortality or
morbidity.
We expect mortality, morbidity and lapse experience to fluctuate somewhat from period to
period, but believe they should remain fairly constant over the long term. Mortality, morbidity or
lapse experience that is less favorable than the mortality, morbidity or lapse rates that we used
in pricing a reinsurance agreement will negatively affect our net income because the premiums we
receive for the risks we assume may not be sufficient to cover the claims and profit margin.
Furthermore, even if the total benefits paid over the life of the contract do not exceed the
expected amount, unexpected increases in the incidence of deaths or illness can cause us to pay
more benefits in a given reporting period than expected, adversely affecting our net income in any
particular reporting period. Likewise, adverse experience could impair our ability to offset
certain unamortized deferred acquisition costs and adversely affect our net income in any
particular reporting period.
RGA is an insurance holding company, and our ability to pay principal, interest and/or dividends on
securities is limited.
RGA is an insurance holding company, with our principal assets consisting of the stock of our
insurance company subsidiaries, and substantially all of our income is derived from those
subsidiaries. Our ability to pay principal and
59
interest on any debt securities or dividends on any preferred or common stock depends in part on
the ability of our insurance company subsidiaries, our principal sources of cash flow, to declare
and distribute dividends or to advance money to RGA. We are not permitted to pay common stock
dividends or make payments of interest or principal on securities which rank equal or junior to our
subordinated debentures, until we pay any accrued and unpaid interest on our subordinated
debentures. Our insurance company subsidiaries are subject to various statutory and regulatory
restrictions, applicable to insurance companies generally, that limit the amount of cash dividends,
loans and advances that those subsidiaries may pay to us. As of December 31, 2007, the amount of
dividends that may be paid to us by those subsidiaries, without prior approval from regulators, was
estimated at $270.3 million. Covenants contained in some of our debt agreements and regulations
relating to capital requirements affecting some of our more significant subsidiaries also restrict
the ability of certain subsidiaries to pay dividends and other distributions and make loans to us.
In addition, we cannot assure you that more stringent dividend restrictions will not be adopted, as
discussed below under Our insurance subsidiaries are highly regulated, and changes in these
regulations could negatively affect our business.
As a result of our insurance holding company structure, in the event of the insolvency,
liquidation, reorganization, dissolution or other winding-up of one of our reinsurance
subsidiaries, all creditors of that subsidiary would be entitled to payment in full out of the
assets of such subsidiary before we, as shareholder, would be entitled to any payment. Our
subsidiaries would have to pay their direct creditors in full before our creditors, including
holders of any class of common stock, preferred stock or debt securities of RGA, could receive any
payment from the assets of such subsidiaries.
If our investment strategy is not successful, we could suffer unexpected losses.
The success of our investment strategy is crucial to the success of our business. In particular, we
structure our investments to match our anticipated liabilities under reinsurance treaties to the
extent we believe necessary. If our calculations with respect to these reinsurance liabilities are
incorrect, or if we improperly structure our investments to match such liabilities, we could be
forced to liquidate investments prior to maturity at a significant loss.
Our investment guidelines also permit us to invest up to 5% of our investment portfolio in
non-investment grade fixed maturity securities. While any investment carries some risk, the risks
associated with lower-rated securities are greater than the risks associated with investment grade
securities. The risk of loss of principal or interest through default is greater because
lower-rated securities are usually unsecured and are often subordinated to an issuers other
obligations. Additionally, the issuers of these securities frequently have high debt levels and
are thus more sensitive to difficult economic conditions, individual corporate developments and
rising interest rates which could impair an issuers capacity or willingness to meet its financial
commitment on such lower-rated securities. As a result, the market price of these securities may
be quite volatile, and the risk of loss is greater.
The success of any investment activity is affected by general economic conditions, which may
adversely affect the markets for interest-rate-sensitive securities and equity securities,
including the level and volatility of interest rates and the extent and timing of investor
participation in such markets. Unexpected volatility or illiquidity in the markets in which we
directly or indirectly hold positions could adversely affect us.
The occurrence of various events may adversely affect the ability of RGA and its subsidiaries to
fully utilize their net operating losses and other tax attributes.
RGA and its subsidiaries have a substantial amount of net operating losses, or NOLs, and other
tax attributes, for U.S. federal income tax purposes, that are available both currently and in the
future to offset taxable income and gains. Events outside of our control, such as certain
acquisitions and dispositions of Class A common stock and Class B common stock, may cause RGA (and,
consequently, its subsidiaries) to experience an ownership change under Section 382 of the
Internal Revenue Code and the related Treasury regulations, and limit the ability of RGA and its
subsidiaries to utilize fully such NOLs and other tax attributes. Moreover, the MetLife split-off
will increase the likelihood of RGA experiencing such an ownership change.
In general, an ownership change occurs when, as of any testing date, the percentage of stock of a
corporation owned by one or more 5-percent shareholders, as defined in the Internal Revenue Code
and the related Treasury regulations, has increased by more than 50 percentage points over the
lowest percentage of stock of the corporation owned by such shareholders at any time during the
three-year period preceding such date. In general, persons who own 5% or more (by value) of a
corporations stock are 5-percent shareholders, and all other persons who own less
60
than 5% (by value) of a corporations stock are treated, together, as a single, public group
5-percent shareholder, regardless of whether they own an aggregate of 5% or more (by value) of a
corporations stock. If a corporation experiences an ownership change, it is generally subject to
an annual limitation, which limits its ability to use its NOLs and other tax attributes to an
amount equal to the equity value of the corporation multiplied by the federal long term tax-exempt
rate.
If we were to experience an ownership change, we could potentially have in the future higher
U.S. federal income tax liabilities than we would otherwise have had and it may also result in
certain other adverse consequences to RGA. In this connection, we have adopted the
Section 382 shareholder rights plan and the acquisition restrictions set forth in Article Fourteen
to our articles of incorporation, in order to reduce the likelihood that RGA and its subsidiaries
will experience an ownership change under Section 382 of the Internal Revenue Code. There can be
no assurance, however, that these efforts will prevent the MetLife split-off, together with certain
other transactions involving our stock, from causing us to experience an ownership change and the
adverse consequences that may arise therefrom, as described above under The acquisition
restrictions contained in our articles of incorporation and our Section 382 shareholder rights
plan, which are intended to help preserve RGA and its subsidiaries NOLs and other tax attributes,
may not be effective or may have unintended negative effects.
Interest rate fluctuations could negatively affect the income we derive from the difference between
the interest rates we earn on our investments and interest we pay under our reinsurance contracts.
Significant changes in interest rates expose reinsurance companies to the risk of reduced
investment income or actual losses based on the difference between the interest rates earned on
investments and the credited interest rates paid on outstanding reinsurance contracts. Both rising
and declining interest rates can negatively affect the income we derive from these interest rate
spreads. During periods of rising interest rates, we may be contractually obligated to increase
the crediting rates on our reinsurance contracts that have cash values. However, we may not have
the ability to immediately acquire investments with interest rates sufficient to offset the
increased crediting rates on our reinsurance contracts. During periods of falling interest rates,
our investment earnings will be lower because new investments in fixed maturity securities will
likely bear lower interest rates. We may not be able to fully offset the decline in investment
earnings with lower crediting rates on underlying annuity products related to certain of our
reinsurance contracts. While we develop and maintain asset/liability management programs and
procedures designed to reduce the volatility of our income when interest rates are rising or
falling, we cannot assure you that changes in interest rates will not affect our interest rate
spreads.
Changes in interest rates may also affect our business in other ways. Lower interest rates may
result in lower sales of certain insurance and investment products of our customers, which would
reduce the demand for our reinsurance of these products.
Natural disasters, catastrophes, and disasters caused by humans, including the threat of terrorist
attacks and related events, epidemics and pandemics may adversely affect our business and results
of operations.
Natural disasters and terrorist attacks, as well as epidemics and pandemics, can adversely affect
our business and results of operations because they accelerate mortality and morbidity risk.
Terrorist attacks on the United States and in other parts of the world and the threat of future
attacks could have a negative effect on our business.
We believe our reinsurance programs are sufficient to reasonably limit our net losses for
individual life claims relating to potential future natural disasters and terrorist attacks.
However, the consequences of further natural disasters, terrorist attacks, armed conflicts,
epidemics and pandemics are unpredictable, and we may not be able to foresee events that could have
an adverse effect on our business.
We operate in a highly competitive industry, which could limit our ability to gain or maintain
market share.
The reinsurance industry is highly competitive, and we encounter significant competition in all
lines of business from other reinsurance companies, as well as competition from other providers of
financial services. Our competitors vary by geographic market. We believe our primary competitors
in the North American life reinsurance market are currently the following, or their affiliates:
Transamerica Occidental Life Insurance Company, a subsidiary of Aegon, N.V., Swiss Re Life of
America and Munich American Reinsurance Company. We believe our primary competitors in the
international life reinsurance markets are Swiss Re Life and Health Ltd., General Re, Munich
Reinsurance Company, Hannover Reinsurance and SCOR Global Reinsurance. Many of our competitors
have greater financial resources than we do. Our ability to compete depends on, among other
things, our ability to
61
maintain strong financial strength ratings from rating agencies, pricing and other terms and
conditions of reinsurance agreements, and our reputation, service, and experience in the types of
business that we underwrite. However, competition from other reinsurers could adversely affect our
competitive position.
Our target market is large life insurers. We compete based on the strength of our underwriting
operations, insights on mortality trends based on our large book of business, and responsive
service. We believe our quick response time to client requests for individual underwriting quotes
and our underwriting expertise are important elements to our strategy and lead to other business
opportunities with our clients. Our business will be adversely affected if we are unable to
maintain these competitive advantages or if our international strategy is not successful.
Tax law changes or a prolonged economic downturn could reduce the demand for some insurance
products, which could adversely affect our business.
Under the Internal Revenue Code, income tax payable by policyholders on investment earnings is
deferred during the accumulation period of some life insurance and annuity products. To the extent
that the Internal Revenue Code is revised to reduce the tax-deferred status of life insurance and
annuity products, or to increase the tax-deferred status of competing products, all life insurance
companies would be adversely affected with respect to their ability to sell such products, and,
depending on grandfathering provisions, by the surrenders of existing annuity contracts and life
insurance policies. In addition, life insurance products are often used to fund estate tax
obligations. Congress has adopted legislation to reduce, and ultimately eliminate, the estate tax.
Under this legislation, our U.S. life insurance company customers will face reduced demand for some
of their life insurance products, which in turn could negatively affect our reinsurance business.
We cannot predict what future tax initiatives may be proposed and enacted that could affect us.
In addition, a general economic downturn or a downturn in the equity and other capital markets
could adversely affect the market for many annuity and life insurance products. Because we obtain
substantially all of our revenues through reinsurance arrangements that cover a portfolio of life
insurance products, as well as annuities, our business would be harmed if the market for annuities
or life insurance were adversely affected. In addition, the market for annuity reinsurance
products is currently not well developed, and we cannot assure you that such market will develop in
the future.
The availability and cost of collateral, including letters of credit, asset trusts and other credit
facilities, could adversely affect our financial condition, operating costs, and new business
volume.
Regulatory requirements in various jurisdictions in which we operate may be significantly higher
than the reserves required under GAAP. Accordingly, we reinsure, or retrocede, business to
affiliated and unaffiliated reinsurers to reduce the amount of regulatory reserves and capital we
are required to hold in certain jurisdictions. A regulation in the U.S., commonly referred to as
Regulation XXX, has significantly increased the level of regulatory, or statutory, reserves that
U.S. life insurance and life reinsurance companies must hold on their statutory financial
statements for various types of life insurance business, primarily certain level term life
products. The reserve levels required under Regulation XXX increase over time and are normally in
excess of reserves required under GAAP. The degree to which these reserves will increase and the
ultimate level of reserves will depend upon the mix of our business and future production levels in
the United States. Based on the assumed rate of growth in our current business plan, and the
increasing level of regulatory reserves associated with some of this business, we expect the amount
of required regulatory reserves to grow significantly.
In order to reduce the effect of Regulation XXX, our principal U.S. operating subsidiary, RGA
Reinsurance, has retroceded Regulation XXX-related reserves to affiliated and unaffiliated
reinsurers. Additionally, some of our reinsurance subsidiaries in other jurisdictions enter into
various reinsurance arrangements with affiliated and unaffiliated reinsurers from time to time in
order to reduce their statutory capital and reserve requirements. As a general matter, for us to
reduce regulatory reserves on business that we retrocede, the affiliated or unaffiliated reinsurer
must provide an equal amount of collateral. Such collateral may be provided through a capital
markets securitization, in the form of a letter of credit from a commercial bank or through the
placement of assets in trust for our benefit.
In connection with these reserve requirements, we face the following risks:
|
|
|
The availability of collateral and the related cost of such collateral in the future
could affect the type and volume of business we reinsure and could increase our costs. |
62
|
|
|
We may need to raise additional capital to support higher regulatory reserves, which
could increase our overall cost of capital. |
|
|
|
|
If we, or our retrocessionaires, are unable to obtain or provide sufficient collateral
to support our statutory ceded reserves, we may be required to increase regulatory
reserves. In turn, this reserve increase could significantly reduce our statutory capital
levels and adversely affect our ability to satisfy required regulatory capital levels that
apply to us, unless we are able to raise additional capital to contribute to our operating
subsidiaries. |
|
|
|
|
Because term life insurance is a particularly price-sensitive product, any increase in
insurance premiums charged on these products by life insurance companies, in order to
compensate them for the increased statutory reserve requirements or higher costs of
insurance they face, may result in a significant loss of volume in their life insurance
operations, which could, in turn, adversely affect our life reinsurance operations. |
We cannot assure you that we will be able to implement actions to mitigate the effect of increasing
regulatory reserve requirements.
We could be forced to sell investments at a loss to cover policyholder withdrawals, recaptures of
reinsurance treaties or other events.
Some of the products offered by our insurance company customers allow policyholders and contract
holders to withdraw their funds under defined circumstances. Our reinsurance subsidiaries manage
their liabilities and configure their investment portfolios so as to provide and maintain
sufficient liquidity to support anticipated withdrawal demands and contract benefits and maturities
under reinsurance treaties with these customers. While our reinsurance subsidiaries own a
significant amount of liquid assets, a portion of their assets are relatively illiquid.
Unanticipated withdrawal or surrender activity could, under some circumstances, require our
reinsurance subsidiaries to dispose of assets on unfavorable terms, which could have an adverse
effect on us. Reinsurance agreements may provide for recapture rights on the part of our insurance
company customers. Recapture rights permit these customers to reassume all or a portion of the
risk formerly ceded to us after an agreed upon time, usually ten years, subject to various
conditions.
Recapture of business previously ceded does not affect premiums ceded prior to the recapture, but
may result in immediate payments to our insurance company customers and a charge for costs that we
deferred when we acquired the business but are unable to recover upon recapture. Under some
circumstances, payments to our insurance company customers could require our reinsurance
subsidiaries to dispose of assets on unfavorable terms.
Our reinsurance subsidiaries are highly regulated, and changes in these regulations could
negatively affect our business.
Our reinsurance subsidiaries are subject to government regulation in each of the jurisdictions in
which they are licensed or authorized to do business. Governmental agencies have broad
administrative power to regulate many aspects of the insurance business, which may include premium
rates, marketing practices, advertising, policy forms, and capital adequacy. These agencies are
concerned primarily with the protection of policyholders rather than shareholders or holders of
debt securities. Moreover, insurance laws and regulations, among other things, establish minimum
capital requirements and limit the amount of dividends, tax distributions, and other payments our
reinsurance subsidiaries can make without prior regulatory approval, and impose restrictions on the
amount and type of investments we may hold. The State of Missouri also regulates RGA as an
insurance holding company.
Recently, insurance regulators have increased their scrutiny of the insurance regulatory framework
in the United States and some state legislatures have considered or enacted laws that alter, and in
many cases increase, state authority to regulate insurance holding companies and insurance
companies. In light of recent legislative developments, the National Association of Insurance
Commissioners, or NAIC, and state insurance regulators have begun re-examining existing laws and
regulations, specifically focusing on insurance company investments and solvency issues, guidelines
imposing minimum capital requirements based on business levels and asset mix, interpretations of
existing laws, the development of new laws, the implementation of non-statutory guidelines, and the
definition of extraordinary dividends, including a more stringent standard for allowance of
extraordinary dividends. We are unable to predict whether, when or in what form the State of
Missouri will enact a new measure for extraordinary dividends, and we cannot assure you that more
stringent restrictions will not be adopted from time to time in other jurisdictions in which our
reinsurance subsidiaries are domiciled, which could, under certain
63
circumstances, significantly reduce dividends or other amounts payable to us by our subsidiaries
unless they obtain approval from insurance regulatory authorities. We cannot predict the effect
that any NAIC recommendations or proposed or future legislation or rule-making in the United States
or elsewhere may have on our financial condition or operations.
We are exposed to foreign currency risk.
We are a multi-national company with operations in numerous countries and, as a result, are exposed
to foreign currency risk to the extent that exchange rates of foreign currencies are subject to
adverse change over time. The U.S. dollar value of our net investments in foreign operations, our
foreign currency transaction settlements and the periodic conversion of the foreign-denominated
earnings to U.S. dollars (our reporting currency) are each subject to adverse foreign exchange rate
movements. Approximately 44% of our revenues and 32% of our fixed maturity securities available
for sale were denominated in currencies other than the U.S. dollar as of and for the nine months
ended September 30, 2008.
Acquisitions and significant transactions involve varying degrees of inherent risk that could
affect our profitability.
We have made, and may in the future make, strategic acquisitions, either of selected blocks of
business or other companies. Acquisitions may expose us to operational challenges and various
risks, including:
|
|
|
the ability to integrate the acquired business operations and data with our systems; |
|
|
|
|
the availability of funding sufficient to meet increased capital needs; |
|
|
|
|
the ability to fund cash flow shortages that may occur if anticipated revenues are not
realized or are delayed, whether by general economic or market conditions or unforeseen
internal difficulties; and |
|
|
|
|
the possibility that the value of investments acquired in an acquisition, may be lower
than expected or may diminish due to credit defaults or changes in interest rates and that
liabilities assumed may be greater than expected (due to, among other factors, less
favorable than expected mortality or morbidity experience). |
A failure to successfully manage the operational challenges and risks associated with or resulting
from significant transactions, including acquisitions, could adversely affect our financial
condition or results of operations.
We depend on the performance of others, and their failure to perform in a satisfactory manner would
negatively affect us.
In the normal course of business, we seek to limit our exposure to losses from our reinsurance
contracts by ceding a portion of the reinsurance to other insurance enterprises or
retrocessionaires. We cannot assure you that these insurance enterprises or retrocessionaires will
be able to fulfill their obligations to us. As of December 31, 2007, the reinsurers participating
in our retrocession facilities that have been reviewed by A.M. Best Company, were rated A-, the
fourth highest rating out of fifteen possible ratings, or better. We are also subject to the risk
that our clients will be unable to fulfill their obligations to us under our reinsurance agreements
with them.
We rely upon our insurance company clients to provide timely, accurate information. We may
experience volatility in our earnings as a result of erroneous or untimely reporting from our
clients. We work closely with our clients and monitor their reporting to minimize this risk. We
also rely on original underwriting decisions made by our clients. We cannot assure you that these
processes or those of our clients will adequately control business quality or establish appropriate
pricing.
For some reinsurance agreements, the ceding company withholds and legally owns and manages assets
equal to the net statutory reserves, and we reflect these assets as funds withheld at interest on
our balance sheet. In the event that a ceding company were to become insolvent, we would need to
assert a claim on the assets supporting our reserve liabilities. We attempt to mitigate our risk
of loss by offsetting amounts for claims or allowances that we owe the ceding company with amounts
that the ceding company owes to us. We are subject to the investment performance on the withheld
assets, although we do not directly control them. We help to set, and monitor compliance with, the
investment guidelines followed by these ceding companies. However, to the extent that such
investment guidelines are not appropriate, or to the extent that the ceding companies do not adhere
to such guidelines, our risk of loss could increase, which could materially adversely affect our
financial condition and results of operations. During 2007, interest earned on funds withheld
represented 4.8% of our consolidated
64
revenues. Funds withheld at interest totaled $4.8 billion at September 30, 2008 and $4.7 billion
as of December 31, 2007.
We use the services of third-party investment managers to manage certain assets where our
investment management expertise is limited. We rely on these investment managers to provide
investment advice and execute investment transactions that are within our investment policy
guidelines. Poor performance on the part of our outside investment managers could negatively
affect our financial performance.
As with all financial services companies, our ability to conduct business depends on consumer
confidence in the industry and our financial strength. Actions of competitors, and financial
difficulties of other companies in the industry, and related adverse publicity, could undermine
consumer confidence and harm our reputation.
The occurrence of events unanticipated in our disaster recovery systems and management continuity
planning could impair our ability to conduct business effectively.
In the event of a disaster such as a natural catastrophe, an industrial accident, a blackout, a
computer virus, a terrorist attack or war, unanticipated problems with our disaster recovery
systems could have a material adverse impact on our ability to conduct business and on our results
of operations and financial position, particularly if those problems affect our computer-based data
processing, transmission, storage and retrieval systems and destroy valuable data. We depend
heavily upon computer systems to provide reliable service, data and reports. Despite our
implementation of a variety of security measures, our servers could be subject to physical and
electronic break-ins, and similar disruptions from unauthorized tampering with our computer
systems. In addition, in the event that a significant number of our managers were unavailable in
the event of a disaster, our ability to effectively conduct business could be severely compromised.
These interruptions also may interfere with our clients ability to provide data and other
information and our employees ability to perform their job responsibilities.
We have risks associated with our international operations.
In 2007, approximately 31.4% of our net premiums and $107.6 million of income from continuing
operations before income taxes came from our operations in Europe, South Africa and Asia Pacific.
For the first nine months of 2008, approximately 33.4% of our net premiums and $104.9 million of
income from continuing operations before income taxes came from international operations. One of
our strategies is to grow these international operations. International operations subject us to
various inherent risks. In addition to the regulatory and foreign currency risks identified above,
other risks include the following:
|
|
|
managing the growth of these operations effectively, particularly given the recent rates
of growth; |
|
|
|
|
changes in mortality and morbidity experience and the supply and demand for our products
that are specific to these markets and that may be difficult to anticipate; |
|
|
|
|
political and economic instability in the regions of the world where we operate; |
|
|
|
|
uncertainty arising out of foreign government sovereignty over our international
operations; an |
|
|
|
|
potentially uncertain or adverse tax consequences, including regarding the repatriation
of earnings from our non-U.S. subsidiaries. |
We cannot assure you that we will be able to manage these risks effectively or that they will not
have an adverse effect on our business, financial condition or results of operations.
Risks Related to Ownership of Our Class A Common Stock or Common Stock
The right of the holders of RGA Class A common stock to elect up to 20% of RGAs directors will be
subject to RGAs existing shareholder nomination procedures, and such directors will act as
fiduciaries for all of the RGA shareholders, which factors may diminish the value and effectiveness
of the RGA Class A voting rights.
The holders of Class A common stock have the right to elect up to 20% of the members of our board
of directors. Currently, our board of directors consists of five members. Therefore, the holders
of Class A common stock have the right to elect one member of our board of directors, whom we refer
to as an RGA Class A director. The initial RGA Class A director is J. Cliff Eason, who
has been designated to serve as the initial RGA Class A director by a majority of the members of
our board of directors for a term that commenced on September 12, 2008 and will end on the third
annual meeting of RGA shareholders thereafter or until his successor is duly elected and qualified.
In the future, nominations of persons who are to stand for election as RGA Class A directors will
be made by the board
65
of directors upon the recommendation of the nominating committee of our board of directors or by a
shareholder entitled to vote for the election of such directors. Our articles of incorporation
impose significant limitations on the ability of the RGA shareholders to nominate directors,
including a 60-to-90 day advance notice requirement for nominations for election at an annual
meeting. In addition, we believe that, under Missouri law, a Class A director owes fiduciary
duties to RGA and all of RGAs shareholders, and accordingly does not act as an exclusive
representative of the holders of Class A common stock. These factors may tend to diminish the
value and effectiveness of the class voting rights of the holders of Class A common stock.
The Class B common stock controls the election of at least 80% of RGAs directors, which may render
RGA more vulnerable to unsolicited takeover bids, including bids that unfairly discriminate between
classes of RGA shareholders.
Holders of Class B common stock are entitled to elect at least 80% of our board of directors. If
any person or group of persons acquires the ability to control the voting of the outstanding shares
of Class B common stock, that person or group will be able to obtain control of RGA. This would
also have negative consequences under some of our agreements. The existence and issuance of the
Class B common stock could render RGA more susceptible to unsolicited takeover bids from third
parties. In particular, an unsolicited third party may be willing to pay a premium for shares of
Class B common stock not offered to holders of shares of Class A common stock.
The risk of an unsolicited takeover attempt may be mitigated in part by provisions of our articles
of incorporation that make it more difficult for third parties to gain control of our board of
directors, including through the acquisition of a controlling block of shares of Class B common
stock. For example, the limitations on voting power of Class B holders may have the effect of
discouraging unsolicited takeover attempts. Our articles of incorporation, however, do not provide
an absolute deterrent against unsolicited takeover attempts. For example, an unsolicited acquirer
may condition its takeover proposal on acquiring all, but not less than all, of the outstanding
shares of Class B common stock. Notwithstanding the Class B voting limitation, there would be no
other holder of Class B common stock to vote against the acquirer. If the unsolicited acquirer were
successful in acquiring all outstanding shares of Class B common stock, it would then be able to
control the election of Class B directors at each annual meeting of shareholders.
Class A common stock and Class B common stock may remain as separate classes for an indefinite
period of time.
On October 6, 2008, RGA announced that its Board of Directors had authorized and will recommend
that the holders of class A common stock and class B common stock approve a proposal to convert
class B common stock into class A common stock on a one-for-one basis, pursuant to the existing
conversion terms contained in RGAs articles of incorporation. The conversion proposal will require
the affirmative vote of the holders of a majority of class A common stock and the holders of a
majority of class B common stock, represented in person or by proxy at a special meeting of RGA
shareholders.
Since each class of common stock, voting separately, would need to approve the conversion, it is
possible that the proposal would fail because of opposition from holders of either class of common
stock. Depending on the facts and circumstances at the time a conversion is considered, including,
among other things, trading volumes and prices of the separate classes, it is possible that holders
of either class may view the benefits and detriments of a conversion differently.
We may not pay dividends on our Class A and Class B common stock.
Our shareholders may not receive future dividends. Historically, we have paid quarterly dividends
ranging from $0.027 per share in 1993 to $0.09 per share in 2008 to date. All future payments of
dividends, however, are at the discretion of our board of directors and will depend on our
earnings, capital requirements, insurance regulatory conditions, operating conditions, and such
other factors as our board of directors may deem relevant. The amount of dividends that we can pay
will depend in part on the operations of our reinsurance subsidiaries. Under certain
circumstances, we may be contractually prohibited from paying dividends on our Class A and Class B
common stock due to restrictions in certain debt and trust preferred securities.
66
RGAs anti-takeover provisions may delay or prevent a change in control of RGA, which could
adversely affect the price of our Class A and Class B common stock.
Certain provisions in our articles of incorporation and bylaws, as well as Missouri law, may delay
or prevent a change of control of RGA, which could adversely affect the prices of Class B common
stock and/or Class A common stock. Our articles of incorporation and bylaws contain some provisions
that may make the acquisition of control of RGA without the approval of our board of directors more
difficult, including provisions relating to the nomination, election and removal of directors, the
structure of the board of directors and limitations on actions by our shareholders. In addition,
Missouri law also imposes some restrictions on mergers and other business combinations between RGA
and holders of 20% or more of our outstanding common stock.
Furthermore, our articles of incorporation limit the voting right in any vote to elect or remove
directors, of any holder of more than 15% of the outstanding Class B common stock to 15% of the
outstanding Class B common stock; provided, that, if such holder also has in excess of 15% of the
Class A common stock, such holder of Class B common stock may exercise voting power of the Class B
common stock in excess of 15% to the extent that such holder has an equivalent percentage of shares
of Class A common stock. Furthermore, our articles of incorporation are intended to limit stock
ownership of RGA stock (other than shares acquired through the divestiture by MetLife or other
exempted transactions) to less than 5% of the value of the aggregate outstanding shares of RGA
stock during the restriction period. We have also adopted a Section 382 shareholder rights plan
designed to deter shareholders from becoming a 5-percent shareholder (as defined by Section 382
of the Internal Revenue Code and the related Treasury regulations) without the approval of our
board of directors.
Further, our articles of incorporation are intended to limit stock ownership of RGA stock (other
than any RGA common stock acquired through the split-off by MetLife or other exempted transactions)
to less than 5% of the value of the aggregate outstanding shares of RGA stock during the
restriction period. In connection with the split-off by MetLife, we have also adopted a
Section 382 shareholder rights plan designed to deter shareholders from becoming a 5-percent
shareholder (as defined by Section 382 of the Internal Revenue Code and the related Treasury
regulations) without the approval of our board of directors.
These provisions may have unintended anti-takeover effects. These provisions of our articles of
incorporation and bylaws and Missouri law may delay or prevent a change in control of RGA, which
could adversely affect the price of Class A common stock or Class B common stock.
Future stock sales, including sales by any selling shareholders, may affect the stock price of
Class A common stock.
MetLife has retained an approximate 5% interest in RGA through the retention of 3,000,000 shares of
Class A common stock. MetLife has agreed, subject to an exception, that during the period
commencing on June 1, 2008 and ending on the 60th day following the completion of the split-off on
September 12, 2008 (such period is referred to as the lock-up period) it will not sell, transfer
or otherwise dispose of such shares. MetLife has further agreed that, following the expiration of
the lock-up period, it will sell, exchange or otherwise dispose of the recently acquired stock
within 60 months from such completion date. Any disposition by MetLife of its remaining shares of
Class A common stock could result in a substantial amount of RGA equity securities entering the
market, which may adversely affect the price of such Class A common stock.
The market price for our classes of common stock may fluctuate significantly.
The overall market and the price of our Class A and Class B common stock may continue to fluctuate
as a result of many factors in addition to those discussed in the preceding risk factors. These
factors, some or all of which are beyond our control, include:
|
|
|
actual or anticipated fluctuations in our operating results; |
|
|
|
|
changes in expectations as to our future financial performance or changes in financial
estimates of securities analysts; |
|
|
|
|
success of our operating and growth strategies; |
|
|
|
|
investor anticipation of strategic and technological threats, whether or not warranted
by actual events; |
|
|
|
|
operating and stock price performance of other comparable companies; and |
67
|
|
|
realization of any of the risks described in these risk factors or those set forth in
any subsequent Annual Report on Form 10-K or Quarterly Reports on Form 10-Q. |
In addition, the stock market has historically experienced volatility that often has been unrelated
or disproportionate to the operating performance of particular companies. These broad market and
industry fluctuations may adversely affect the trading price of our common stock, regardless of our
actual operating performance. It is probably that either class of common stock will from time to
time trade at a premium or discount to the other class of common stock.
Future sales of either class of our common stock or other securities may dilute the value of our
common stock.
Our board of directors has the authority, without action or vote of the shareholders, to issue any
or all authorized but unissued shares of our Class A or Class B common stock, including securities
convertible into or exchangeable for either class of our common stock and authorized but unissued
shares under our stock option and other equity compensation plans. In the future, we may issue
such additional securities, through public or private offerings, in order to raise additional
capital. Any such issuance will dilute the percentage ownership of shareholders and may dilute the
per share projected earnings or book value of the common stock. In addition, option holders may
exercise their options at any time when we would otherwise be able to obtain additional equity
capital on more favorable terms.
Limited trading volume of our classes of common stock may contribute to price volatility.
Our Class A and Class B common stock only began trading on the NYSE on September 12, 2008, and we
cannot assure you that an active market will develop or be sustained. During the twelve months
ended September 12, 2008, the average daily trading volume for our former common stock as reported
by the NYSE was 186,509 shares. From September 15, 2008 through October 24, 2008, the average
daily trading volume as reported by the NYSE for our Class A and Class B common stock was 992,510
and 677,080 shares, respectively. As a result, relatively small trades may have a significant
effect on the price of our respective classes of common stock.
Applicable insurance laws may make it difficult to effect a change of control of RGA.
Before a person can acquire control of a U.S. insurance company, prior written approval must be
obtained from the insurance commission of the state where the domestic insurer is domiciled.
Missouri insurance laws and regulations provide that no person may acquire control of us, and thus
indirect control of our Missouri reinsurance subsidiaries, including RGA Reinsurance Company,
unless:
|
|
|
such person has provided certain required information to the Missouri Department of
Insurance; and |
|
|
|
|
such acquisition is approved by the Director of Insurance of the State of Missouri, whom
we refer to as the Missouri Director of Insurance, after a public hearing. |
Under Missouri insurance laws and regulations, any person acquiring 10% or more of the outstanding
voting securities of a corporation, such as our common stock, is presumed to have acquired control
of that corporation and its subsidiaries.
Canadian federal insurance laws and regulations provide that no person may directly or indirectly
acquire control of or a significant interest in our Canadian insurance subsidiary, RGA Life
Reinsurance Company of Canada, unless:
|
|
|
such person has provided information, material and evidence to the Canadian
Superintendent of Financial Institutions as required by him, and |
|
|
|
|
such acquisition is approved by the Canadian Minister of Finance. |
For this purpose, significant interest means the direct or indirect beneficial ownership by a
person, or group of persons acting in concert, of shares representing 10% or more of a given class,
and control of an insurance company exists when:
|
|
|
a person, or group of persons acting in concert, beneficially owns or controls an entity
that beneficially owns securities, such as our common stock, representing more than 50% of
the votes entitled to be cast for |
68
|
|
|
the election of directors and such votes are sufficient to elect a majority of the directors
of the insurance company, or |
|
|
|
a person has any direct or indirect influence that would result in control in fact of an
insurance company. |
Prior to granting approval of an application to directly or indirectly acquire control of a
domestic or foreign insurer, an insurance regulator may consider such factors as the financial
strength of the applicant, the integrity of the applicants board of directors and executive
officers, the applicants plans for the future operations of the domestic insurer and any
anti-competitive results that may arise from the consummation of the acquisition of control.
After the divestiture by MetLife, we no longer benefit from MetLifes stature and industry
recognition.
After the divestiture by MetLife, we ceased to be a majority-owned subsidiary of MetLife. MetLife
has substantially greater stature and financial resources than RGA. By becoming independent from
MetLife, we have lost any positive perceptions from which we may have benefited as a result of
being associated with a company of MetLifes stature and industry recognition.
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds
Under a board of directors approved plan, the Company may purchase at its discretion up to $50
million of its common stock on the open market. As of September 30, 2008, the Company had
purchased 225,500 shares of treasury stock under this program at an aggregate price of $6.6
million. All purchases were made during 2002. The Company generally uses treasury shares to
support the future exercise of options granted under its stock option plans.
ITEM 4. Submission of Matters to a Vote of Security Holders
The Company held a special meeting of shareholders on September 5, 2008. At the special meeting,
the following proposals were voted upon by the shareholders as indicated below:
|
(1) |
|
Proposal to approve the recapitalization and distribution agreement dated June 1,
2008 by and between RGA and MetLife and the transactions contemplated thereby, was follows: |
(1a) Holders of the outstanding shares of RGA common stock
|
|
|
|
|
Voted For
|
|
Voted Against
|
|
Abstain |
|
|
|
|
|
56,401,657
|
|
222,881
|
|
37,495 |
(1b) Holders of the outstanding shares of RGA common stock other than MetLife and subsidiaries
|
|
|
|
|
Voted For
|
|
Voted Against
|
|
Abstain |
|
|
|
|
|
24,158,118
|
|
222,881
|
|
37,495 |
|
(2) |
|
Proposal to restrict the voting power with respect to directors of a holder of more than
15% of the outstanding RGA class B common stock to 15% of the outstanding
RGA class B common stock, was as follows: |
|
|
|
|
|
Voted For
|
|
Voted Against
|
|
Abstain |
|
|
|
|
|
56,535,480
|
|
84,221
|
|
42,332 |
|
(3) |
|
Proposal to restrict for a period of 36 months and one day from the completion of the
recapitalization, RGA shareholders from becoming a 5% holder from further
increasing its ownership interest in RGA,was as follows: |
|
|
|
|
|
Voted For
|
|
Voted Against
|
|
Abstain |
|
|
|
|
|
56,407,160
|
|
214,492
|
|
40,381 |
|
(4) |
|
Proposal to allow the RGA board of directors to convert the RGA class B common stock
into RGA class A common stock on a one-for-one basis, was as follows: |
|
|
|
|
|
Voted For
|
|
Voted Against
|
|
Abstain |
|
|
|
|
|
56,541,479
|
|
82,689
|
|
37,865 |
69
|
(5) |
|
Proposal to ratify the decision of the RGA Special committee to adopt and implement an
amended and restated Rights Plan in connection with the recapitalization and divestiture, was as
follows: |
|
|
|
|
|
Voted For
|
|
Voted Against
|
|
Abstain |
|
|
|
|
|
53,662,443
|
|
2,972,167
|
|
27,423 |
|
(6) |
|
Proposal to adjourn the RGA special meeting if necessary or appropriate to permit
further solicitation of proxies, was as follows: |
|
|
|
|
|
Voted For
|
|
Voted Against
|
|
Abstain |
|
|
|
|
|
55,478,455
|
|
1,150,705
|
|
32,873 |
ITEM 6. Exhibits
See index to exhibits.
70
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
|
Reinsurance Group of America, Incorporated |
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ A. Greig Woodring November 3, 2008
A. Greig Woodring
|
|
|
|
|
|
|
President & Chief Executive Officer |
|
|
|
|
|
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Jack B. Lay November 3, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Jack B. Lay |
|
|
|
|
|
|
Senior Executive Vice President & Chief Financial Officer |
|
|
|
|
|
|
(Principal Financial and Accounting Officer) |
|
|
71
INDEX TO EXHIBITS
|
|
|
Exhibit |
|
|
Number |
|
Description |
2.1
|
|
Recapitalization and Distribution Agreement, dated as of June 1, 2008 (the R&D Agreement),
by and between Reinsurance Group of America, Incorporated (RGA) and MetLife, Inc. (the
schedules of which have been omitted pursuant to Item 601(b)(2) of Regulation S-K and will be
furnished supplementally to the SEC upon request), incorporated by reference to Exhibit 2.1 of
Current Report on Form 8-K filed June 5, 2008. |
|
|
|
3.1
|
|
Amended and Restated Articles of Incorporation, incorporated by reference to Exhibit 3.1 of
Current Report on Form 8-K filed September 12, 2008. |
|
|
|
3.2
|
|
Amended and Restated Bylaws, incorporated by reference to Exhibit 3.2 of Current Report on
Form 8-K filed September 12, 2008. |
|
|
|
4.1
|
|
Amended and Restated Section 382 Rights Agreement, dated as of September 12, 2008, between
RGA and Mellon Investor Services LLC, as Rights Agent (which includes the form of Amended and
Restated Certificate of Designation, Preferences and Rights of Series A-1 Junior Participating
Preferred Stock as Exhibit A-1, the form of Certificate of Designation, Preferences and Rights
of Series B-1 Junior Participating Preferred Stock as Exhibit A-2, the form of Right
Certificate for Class A Rights as Exhibit B-1 and the Form of Right Certificate for Class B
Rights as Exhibit B-2) (incorporated by reference to Exhibit 4.1 to Current Report on Form 8-K
filed September 12, 2008). |
|
|
|
4.2
|
|
First Amendment to Warrant Agreement, dated as of September 12, 2008, between RGA and The
Bank of New York Mellon Trust Company, N.A., as successor warrant agent to The Bank of New
York, incorporated by reference to Exhibit 4.2 of Current Report on Form 8-K filed September
12, 2008. |
|
|
|
4.3
|
|
First Supplement to Unit Agreement, dated as of September 12, 2008, between RGA and The Bank
of New York Mellon Trust Company, N.A., as successor agent to The Bank of New York,
incorporated by reference to Exhibit 4.3 of Current Report on Form 8-K filed September 12,
2008. |
|
|
|
31.1
|
|
Certification of Chief Executive Officer pursuant to section 302 of the Sarbanes-Oxley Act of
2002. |
|
|
|
31.2
|
|
Certification of Chief Financial Officer pursuant to section 302 of the Sarbanes-Oxley Act of
2002. |
|
|
|
32.1
|
|
Certification of Chief Executive Officer pursuant to section 906 of the Sarbanes-Oxley Act of
2002. |
|
|
|
32.2
|
|
Certification of Chief Financial Officer pursuant to section 906 of the Sarbanes-Oxley Act of
2002. |
|
|
|
99.1
|
|
Irrevocable proxy of MetLife, Inc. and certain of its subsidiaries, dated September 12, 2008,
incorporated by reference to Exhibit 99.4 of Current Report on Form 8-K filed September 12,
2008. |
72